Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACY1,Aminoacylase-1,29478,0.173203870903035,0.00421323506410654,0.164945930177387,0.181461811628684,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.273426581095904,0.00565969151461573,0.262333585727258,0.284519576464551,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADIPOQ,Adiponectin,24966,-0.233238581281634,0.00452491527570683,-0.24210741522202,-0.224369747341249,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFM,Afamin,24966,0.0564208728633104,0.00132589693449027,0.0538221148717095,0.0590196308549113,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGR3,Anterior gradient protein 3,28764,0.162514010080313,0.00407704839556214,0.154522995225011,0.170505024935615,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGRP,Agouti-related protein,29786,0.283734642973202,0.00333335818113134,0.277201260938184,0.290268025008219,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APCS,Serum amyloid P-component,24726,0.117964458833306,0.00232867360535862,0.113400258566803,0.122528659099808,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,29218,0.0841120418550673,0.00203609264423363,0.0801213002723694,0.0881027834377652,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCHE,Cholinesterase,24528,0.0909069308594393,0.00189171150004611,0.087199176319349,0.0946146853995297,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C9,Complement component C9,24951,-0.152375872001417,0.00362122673860218,-0.159473476409078,-0.145278267593757,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.202544433505421,0.00504384350688558,0.192658500231925,0.212430366778917,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL16,C-C motif chemokine 16,29820,0.139840367424321,0.00358586661030684,0.132812068868119,0.146868665980522,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL23,C-C motif chemokine 23,29581,0.14212119951573,0.00280331562379353,0.136626700893094,0.147615698138365,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL27,C-C motif chemokine 27,29478,0.239688230689466,0.0040743323680287,0.23170253924813,0.247673922130803,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN1,CCN family member 1,29301,0.376426047809601,0.0048288373325856,0.366961526637733,0.385890568981469,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD4,T-cell surface glycoprotein CD4,29383,0.101967062145047,0.00201682993104565,0.098014075480198,0.105920048809897,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.333626046329603,0.00717322514425533,0.319566525046863,0.347685567612344,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES1,Liver carboxylesterase 1,29489,0.310535667907325,0.00538563947855387,0.29997981452936,0.321091521285291,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFH,Complement factor H,23693,0.0702298093413695,0.00158279443441129,0.0671275322499234,0.0733320864328157,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFI,Complement factor I,24966,0.0589168560523763,0.00135380964299867,0.0562633891520989,0.0615703229526537,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFP,Properdin,24966,0.0707728952989758,0.00156127358684865,0.0677127990687524,0.0738329915291991,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHMP6,Charged multivesicular body protein 6,24922,0.161503848357689,0.00384900365254577,0.1539598011987,0.169047895516679,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN3,Contactin-3,29443,0.100829703577734,0.00219204550949882,0.0965332943791162,0.105126112776352,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPM,Carboxypeptidase M,29584,0.108129573501582,0.00232623973370692,0.103570143623516,0.112689003379647,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRIP2,Cysteine-rich protein 2,29218,0.108748779378706,0.00247284537922628,0.103902002435423,0.11359555632199,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL6,C-X-C motif chemokine 6,29786,0.236990861809756,0.00522445543876188,0.226750929149782,0.247230794469729,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.474385238431148,0.00997825723066957,0.454827854259036,0.49394262260326,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.29088919890892,0.00586511213670408,0.27939357912098,0.30238481869686,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG2,Desmoglein-2,29443,-0.0856930198044095,0.00183260106207963,-0.0892849178860855,-0.0821011217227334,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO3,Beta-enolase,24240,0.163183328847945,0.00411459983643392,0.155118713168534,0.171247944527355,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.0610426813705458,0.00132399459012806,0.0584476519738948,0.0636377107671968,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F7,Coagulation factor VII,29544,0.120064031104528,0.00203676937717319,0.116071963125269,0.124056099083788,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F9,Coagulation factor IX,29545,0.0510449028877643,0.00124265446791838,0.0486093001306443,0.0534805056448843,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,28797,0.305420401196349,0.00753946532416355,0.290643049160989,0.32019775323171,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FURIN,Furin,29566,0.127690000121647,0.00223606809766055,0.123307306650233,0.132072693593062,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCG,Pro-glucagon,28797,0.46111714827574,0.00832703790280035,0.444796153986251,0.477438142565229,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHR,Growth hormone receptor,24381,0.110107896310878,0.00189905181572014,0.106385754752067,0.11383003786969,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR37,Prosaposin receptor GPR37,28916,0.209686820134228,0.0044912701399641,0.200883930659898,0.218489709608558,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTA1,Glutathione S-transferase A1,29426,0.242920262317507,0.0057426328872638,0.23166470185847,0.254175822776544,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTA3,Glutathione S-transferase A3,28797,0.221502945240744,0.00522899221917717,0.211254120491156,0.231751769990331,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUSB,Beta-glucuronidase,29604,0.175444353647656,0.00407468515130664,0.167457970751095,0.183430736544217,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.296067570362291,0.00503541758433633,0.286198151896991,0.30593698882759,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.107860579010697,0.00232322696701232,0.103307054155353,0.112414103866041,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.357611770740011,0.00831525093936225,-0.373909662581161,-0.341313878898861,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.182369888350797,0.00424665253264406,-0.19069332731478,-0.174046449386815,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF9,Protein turtle homolog A,24922,0.296690846824514,0.00553135882393398,0.285849383529604,0.307532310119425,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INHBC,Inhibin beta C chain,29443,0.142874892341201,0.00278306380527662,0.137420087282859,0.148329697399544,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KYNU,Kynureninase,29786,0.125411550008568,0.00310577482411958,0.119324231353294,0.131498868663843,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0568091869216404,0.00133825898022961,0.0541861993203903,0.0594321745228904,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.0905146895079706,0.00145738021035331,0.0876582242956782,0.0933711547202631,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LDLR,Low-density lipoprotein receptor,29500,0.432805003782927,0.00271864516719062,0.427476459255233,0.43813354831062,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPL,Lipoprotein lipase,29478,-0.184272516793101,0.00312435037730873,-0.190396243532626,-0.178148790053575,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFGE8,Lactadherin,29443,0.232889373224293,0.0027696508629521,0.227460857532907,0.238317888915679,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0847939896793924,0.00208952545630069,-0.0888894595737418,-0.080698519785043,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCS1,Neuronal calcium sensor 1,29725,0.0785067741322789,0.00195945703181928,0.0746662383499131,0.0823473099146446,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.0924627241626793,0.00233811345360737,-0.0970454265317497,-0.0878800217936088,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPY,Pro-neuropeptide Y,29725,0.365185222362057,0.00411515791659807,0.357119512845525,0.373250931878589,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRP1,Neuropilin-1,29628,-0.0892789315377721,0.00188418477468245,-0.0929719336961497,-0.0855859293793945,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,P4HB,Protein disulfide-isomerase,29313,0.105374782408635,0.00265424789805209,0.100172456528453,0.110577108288817,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAMR1,Inactive serine protease PAMR1,29443,0.0858300468177466,0.00187481987590277,0.0821553998609772,0.089504693774516,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.167376555340846,0.00403665365384959,-0.175288396502391,-0.1594647141793,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.139831601207081,0.00208618696435597,0.135742674756944,0.143920527657219,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAT,Tissue-type plasminogen activator,29736,0.149006099067712,0.00342606899506404,0.142291003837387,0.155721194298038,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLTP,Phospholipid transfer protein,29702,-0.112127669532786,0.00243997440901605,-0.116910019374457,-0.107345319691115,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRAP1,Proline-rich acidic protein 1,24938,0.142055932667101,0.00273574513631112,0.136693872199931,0.14741799313427,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.0866370154342826,0.00215105309776037,0.0824209513626722,0.0908530795058929,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROC,Vitamin K-dependent protein C,29545,0.0951074756893764,0.00173165394290201,0.0917134339612884,0.0985015174174643,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROS1,Vitamin K-dependent protein S,24966,0.0687972976007063,0.00174524758290089,0.0653766123382205,0.072217982863192,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.16884375758407,0.00404502240389527,0.160915513672435,0.176772001495705,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTH,Parathyroid hormone,24195,0.291493255979875,0.00539290463122866,0.280923162902667,0.302063349057083,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,29628,0.181121711683109,0.00314646046240129,0.174954649176803,0.187288774189416,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP5,Retinol-binding protein 5,29349,0.15475860959947,0.00384047417573411,0.147231280215031,0.162285938983909,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA4,Kallistatin,24557,0.0727984835037906,0.00161829349584046,0.0696266282519433,0.0759703387556379,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA5,Plasma serine protease inhibitor,24644,0.099252358600604,0.00215472147768776,0.095029104504336,0.103475612696872,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPIND1,Heparin cofactor 2,24914,0.0782193179100726,0.001924974755314,0.0744463673896571,0.081992268430488,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINF1,Pigment epithelium-derived factor,24579,0.0737025661297949,0.00178291753382584,0.0702080477634962,0.0771970844960935,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHBG,Sex hormone-binding globulin,24951,-0.143565094619203,0.00352133928343014,-0.150466919614726,-0.13666326962368,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC39A5,Zinc transporter ZIP5,29434,0.176028836404668,0.00360897417826865,0.168955247015261,0.183102425794075,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.278460352991908,0.00554451330939712,0.267593106905489,0.289327599078326,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.130666187990219,0.00218055990382144,0.126392290578729,0.134940085401709,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNCA,Alpha-synuclein,24381,0.33417683859596,0.0078821286386101,0.318727866464284,0.349625810727636,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.359666601886893,0.00774786071641126,0.344480794882727,0.374852408891059,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.158123817787575,0.00284355606770661,0.15255044789487,0.16369718768028,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.14795776535103,0.00356952414778604,0.14096149802137,0.154954032680691,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFPI,Tissue factor pathway inhibitor,29435,0.104498862048251,0.00214121570528158,0.1003020792659,0.108695644830603,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS15,Enteropeptidase,29349,0.274244425366851,0.00614591908456839,0.262198423961097,0.286290426772605,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTR,Transthyretin,24707,0.0823787230344716,0.00170979251729913,0.0790275297005654,0.0857299163683779,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPB1,Beta-ureidopropionase,24922,0.250550091473121,0.00624996542277695,0.238300159244478,0.262800023701764,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.208165668971523,0.00462587376644705,0.199098956389287,0.217232381553759,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.255782520236609,0.00538701315537493,0.245223974452074,0.266341066021144,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.0661535946625226,0.00170151344341962,0.0628186283134201,0.069488561011625,1.11253692925361e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,29566,0.067613522987549,0.0017413340751659,0.0642005082002238,0.0710265377748742,1.11253692925365e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300LG,CMRF35-like molecule 9,29443,-0.0999281370561411,0.00257620313334796,-0.104977495197503,-0.0948787789147791,1.11253692925384e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,29301,0.068558385117768,0.00177212346772816,0.0650850231210208,0.0720317471145152,1.11253692926489e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,29566,0.0583906285708949,0.00151486415505954,0.0554214948269783,0.0613597623148116,1.11253693103918e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F10,Coagulation factor X,24951,0.072707276774962,0.00188508133601816,0.0690125173563664,0.0764020361935576,1.11253694746382e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",28774,0.139035546627353,0.00362630410411371,0.13192799058329,0.146143102671416,1.11254202488187e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.0539059002268693,0.00140733161775743,0.0511475302560647,0.0566642701976738,1.11254815479349e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.182101991375961,0.00474946739503779,0.172793035281687,0.191410947470235,1.11261960763465e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUMB,Protein numb homolog,24229,0.219229399887781,0.00572547415324217,0.208007470547427,0.230451329228136,1.11338506019782e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,29478,0.0797318634024883,0.00208998904080146,0.0756354848825175,0.0838282419224592,1.11613117233808e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATRN,"Attractin, Isoform 2",24966,0.0434919127946824,0.00113887052360519,0.0412597265684162,0.0457240990209486,1.13067594622977e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,24229,0.222978793112599,0.0058471522946524,0.21151837461508,0.234439211610117,1.34436389304357e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.14345703709496,0.00377457545892908,0.136058869195459,0.150855204994461,2.01573804257035e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAT2,Linker for activation of T-cells family member 2,29349,0.32334585865972,0.00851693920400809,0.306652657819864,0.340039059499576,6.23761503898939e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRP,Gastrin-releasing peptide,24240,0.140757786991545,0.00369822171007422,0.133509272439799,0.14800630154329,6.49882486459585e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLKB1,Plasma kallikrein,24454,0.0653249675349749,0.00172330812794325,0.0619472836042062,0.0687026514657437,1.38127106750169e-305
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.176085613454015,0.00465819169119164,0.16695555773928,0.185215669168751,3.17217105818192e-305
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR2,Cadherin-related family member 2,29349,0.187460913920315,0.00497921896746532,0.177701644744083,0.197220183096547,5.64598247781128e-303
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.188269647808126,0.005001157121734,0.178467379849527,0.198071915766725,7.07996481675771e-303
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.0770001802751947,0.002046283256851,0.0729894650917667,0.0810108954586226,9.91301767935349e-303
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR5,Cadherin-related family member 5,29478,0.1001812444529,0.00267138778150376,0.094945324401153,0.105417164504648,1.03090821767265e-300
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.0817863744959115,0.00218319902626203,0.0775073044044379,0.0860654445873851,4.60271549341577e-300
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,29491,0.102092253948752,0.00273590153848873,0.0967298869333142,0.10745462096419,7.83740965802294e-298
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTYMK,Thymidylate kinase,24922,0.175406734153874,0.00469535086367835,0.166203846461064,0.184609621846683,3.01309448064487e-297
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAB2,Stabilin-2,24938,0.0720737128452524,0.00193334617217642,0.0682843543477866,0.0758630713427182,4.74564708707408e-296
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAPIN,SNARE-associated protein Snapin,24867,0.147669367059754,0.0039708541534959,0.139886492918902,0.155452241200606,1.2377126238144e-294
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.356187770233961,0.0095952078324462,0.337381162882366,0.374994377585555,1.3653226027228e-293
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.216428955107176,0.00584575919306904,0.204971267088761,0.227886643125591,4.30878868752008e-292
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYAP1,Synapse-associated protein 1,24381,0.145622748935949,0.00394660428545406,0.137887404536459,0.153358093335439,4.66441912402368e-290
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINF2,Alpha-2-antiplasmin,24515,0.0344667942030667,0.000935806472499534,0.0326326135169677,0.0363009748891658,4.42267579385334e-289
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEG1,Protein HEG homolog 1,24381,0.0688865986455252,0.00187064661797389,0.0652201312742964,0.072553066016754,6.02363034277669e-289
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF21,Fibroblast growth factor 21,29674,0.298620863669694,0.00815002432608286,0.282646815990571,0.314594911348816,1.6858167982027e-287
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOMO1,Nodal modulator 1,29443,0.0591162023840985,0.00161823255904962,0.0559444665683612,0.0622879381998357,8.62462984031739e-286
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLA,Alpha-galactosidase A,24329,0.0944828945374225,0.00258106469941279,0.0894240077265735,0.0995417813482716,1.27338190990089e-285
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.118933223123644,0.00326294923649,0.112537842620124,0.125328603627165,1.7713913799184e-284
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORT1,Sortilin,29433,0.0931752613404097,0.00255953090819302,0.0881585807603514,0.098191941920468,7.58719641088094e-284
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON3,Serum paraoxonase/lactonase 3,29581,-0.0709704985808342,0.00195041230522574,-0.0747933066990766,-0.0671476904625917,1.22745065057223e-283
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTSS1,Protein MTSS 1,24805,0.277674852591723,0.00762233549476556,0.262735075021982,0.292614630161463,4.24780688430892e-283
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL16,Pro-interleukin-16,29786,0.103003987913787,0.00284377219780658,0.0974301944060858,0.108577781421488,3.65938796592073e-281
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP29,Synaptosomal-associated protein 29,29566,0.226328454745384,0.00628648239902714,0.214006949243291,0.238649960247478,7.79866569343165e-278
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.0541910567165309,0.00150214668699672,0.0512468492100173,0.0571352642230445,1.08683703125619e-277
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GH1,Somatotropin,29433,-0.438757786477161,0.0122079690910652,-0.462685405895648,-0.414830167058673,7.05896454986843e-277
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCN2,Ficolin-2,29381,0.101393243752334,0.002823258958237,0.095859656194189,0.106926831310478,1.81492467435582e-276
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKB,Creatine kinase B-type,24938,-0.146413976694323,0.00407003114509521,-0.15439123773871,-0.138436715649937,2.49734130004234e-276
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA1,Ephrin type-A receptor 1,29536,0.0822016655921649,0.00229105263396344,0.0777112024295966,0.0866921287547332,5.47422400828072e-276
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EEF1D,Elongation factor 1-delta,24922,0.22492853110644,0.00627591140657138,0.21262774474956,0.23722931746332,2.43033869477838e-274
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAA80,N-alpha-acetyltransferase 80,24195,0.297535933614165,0.00830437682376006,0.281259355039595,0.313812512188735,5.66442451175359e-274
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.0973073571532483,0.0027258167795031,0.0919647562654222,0.102649958041074,2.97091181549885e-273
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPY30,Protein dpy-30 homolog,29604,0.14618234043138,0.00411637702215009,0.138114241467966,0.154250439394794,1.52991173412224e-270
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH9,Myosin-9,24938,0.275906737609152,0.00776280124240673,0.260691647174034,0.291121828044269,5.97873324238069e-270
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM20A,Pseudokinase FAM20A,24922,0.0690534468225053,0.00195056826991532,0.0652303330134713,0.0728765606315393,6.95218635600561e-268
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MLN,Promotilin,29434,0.215801339899886,0.0061329855937934,0.203780688136051,0.227821991663721,1.02857079356241e-265
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YES1,Tyrosine-protein kinase Yes,29349,0.275434791207919,0.00783159874440061,0.260084857668894,0.290784724746944,1.91371218210583e-265
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMBP,Protein AMBP,29683,0.0486562882445688,0.00138607172145455,0.0459395876705179,0.0513729888186197,1.54284160147222e-264
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,24381,0.182671982444188,0.00520046716193587,0.172479066806794,0.192864898081582,1.00971153941927e-263
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFB1,BPI fold-containing family B member 1,29333,-0.151633482518199,0.00434219006974267,-0.160144175054895,-0.143122789981504,8.33474995915257e-262
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCLY,Selenocysteine lyase,29632,0.116532934704693,0.00333858405688232,0.109989309953204,0.123076559456182,1.26582844514493e-261
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELN,Elastin,24922,0.0845498883323545,0.00241786117648419,0.0798108804264455,0.0892888962382635,1.40609642055411e-261
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,29349,0.162560018464371,0.0046632267635848,0.153420094007744,0.171699942920997,6.39746334350129e-261
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FYB1,FYN-binding protein 1,29400,0.220434769706081,0.00633525391481765,0.208017672033038,0.232851867379123,5.52903499437453e-260
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.0913079184643595,0.00262731392665056,-0.0964574537605946,-0.0861583831681244,2.05623603917754e-259
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0964864211428455,0.00277680665959529,-0.101928962195652,-0.0910438800900387,2.67481718664939e-259
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.190593423045322,0.00547554619906788,0.179861352495149,0.201325493595495,3.18880328575349e-259
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F11R,Junctional adhesion molecule A,29443,0.1342423281614,0.00387172565136632,0.126653745884723,0.141830910438078,3.24423950814586e-258
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORD,Sorbitol dehydrogenase,29595,0.162223962869965,0.00469260382306225,0.153026459376763,0.171421466363167,9.22971456198716e-257
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.162389820846041,0.00468925644315774,0.153198878217452,0.17158076347463,1.70488066282315e-256
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL22,C-C motif chemokine 22,29169,0.122643140535993,0.00356146133801789,0.115662676313478,0.129623604758508,9.29046773138117e-255
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YTHDF3,YTH domain-containing family protein 3,28931,0.20207657598893,0.00587166728197544,0.190568108116258,0.213585043861602,2.02199867693315e-254
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOST,Sclerostin,29433,0.0917618799072079,0.0026669938392853,0.0865345719822087,0.096989187832207,2.24163414661158e-254
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.135693922371871,0.0039468522834978,0.127958091896216,0.143429752847527,5.91117070530399e-253
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.210269941533367,0.00616660471052056,0.198183396300747,0.222356486765987,6.42279847127068e-250
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL17,C-X-C motif chemokine 17,29786,0.0986598279341255,0.00289637767472857,0.0929829276916575,0.104336728176593,1.61210019091873e-249
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.155012559641262,0.00454236916658686,0.146109516074752,0.163915603207772,1.68697735732026e-249
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FN1,Fibronectin,24966,0.0628612630289722,0.00184426580465602,0.0592465020518464,0.066476024006098,6.32569692454002e-249
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SARG,Specifically androgen-regulated gene protein,24820,0.256030423523087,0.00752311417937047,0.241285119731521,0.270775727314653,3.73244242056797e-248
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.102239310728266,0.00301132498984999,0.0963371137481596,0.108141507708372,7.30678128920461e-248
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18R1,Interleukin-18 receptor 1,29786,0.0767688230447468,0.0022632599027543,0.0723328336353483,0.0812048124541452,1.77748084359665e-247
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL13,C-X-C motif chemokine 13,29694,0.141979283039359,0.00419740975745054,0.133752359914756,0.150206206163962,3.96592574795365e-246
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.147750305037926,0.00437449773697807,0.139176289473449,0.156324320602403,2.80555242025162e-245
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KHK,Ketohexokinase,24240,0.149164181082947,0.00441755030344436,0.140505782488196,0.157822579677698,2.81693005347308e-244
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,29434,0.0645267616851876,0.00191686035694032,0.0607697153855845,0.0682838079847906,8.63785662903445e-244
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.0685858907255473,0.00203626789709137,0.0645948056472482,0.0725769758038463,3.00973208768737e-243
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,29478,-0.0915535229293272,0.0027357943883015,-0.0969156799303982,-0.0861913659282563,5.09849099531731e-241
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TJAP1,Tight junction-associated protein 1,29566,0.191152352510544,0.00571564364627505,0.179949690963844,0.202355014057243,9.84930047649962e-241
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPPC,C-type natriuretic peptide,29434,0.110241234888977,0.00330401291301222,0.103765369579473,0.116717100198481,1.26538044746254e-239
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.194103023207487,0.00582987563698906,0.182676466958988,0.205529579455986,1.04775819043767e-237
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTD,Biotinidase,24966,0.0474098880444847,0.00142797876942068,0.0446110496564201,0.0502087264325492,1.47108914881444e-236
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLUL1,Clusterin-like protein 1,29435,-0.103038720368878,0.00311279199650853,-0.109139792682034,-0.0969376480557209,6.02666488379029e-236
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA3F,Semaphorin-3F,29478,0.0600135265545996,0.00181888550952311,0.0564485109559343,0.0635785421532649,1.80543430606731e-234
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.113911894165676,0.00347462490306978,0.107101629355659,0.120722158975692,1.495663993462e-231
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.0456954171595313,0.00139664036497581,0.0429580020441787,0.0484328322748839,1.20764799829148e-230
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXLNA,Alpha-taxilin,29218,0.19991952897565,0.00612216929485246,0.187920077157739,0.211918980793561,9.28366079936923e-230
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.0918351441280094,0.00280791505167574,0.086331630626725,0.0973386576292939,9.63683209346222e-230
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.111663868769144,0.0034137972509192,0.104972826157343,0.118354911380946,1.05394959150352e-229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.184397233216531,0.00565307656166001,0.173317203155678,0.195477263277385,2.48887728113068e-229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.0675711562565209,0.0020687179142653,0.0635164691445609,0.0716258433684809,3.7207577473475e-229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.219374282406817,0.00673414876095207,0.206175350835351,0.232573213978283,1.03244862037271e-228
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.117579073372247,0.00361911507626449,0.110485607822768,0.124672538921725,8.88463240870893e-227
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES3,Carboxylesterase 3,29349,0.156239618545279,0.00481923992273086,0.146793908296726,0.165685328793831,1.44007857142761e-226
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0580688606912535,0.00179843556818847,0.0545439269776041,0.0615937944049029,7.70421639734602e-225
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.12036272979056,0.00373003805173762,0.113051855209154,0.127673604371966,1.62506994820967e-224
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.21676332900316,0.00672532218308058,0.203581697524322,0.229944960481998,5.29142334549572e-224
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EHBP1,EH domain-binding protein 1,24922,0.165795955611778,0.00515998949737518,0.155682376196923,0.175909535026634,5.50804974448582e-222
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPB2,Carboxypeptidase B2,24914,0.0501511453053641,0.00156109083466146,0.0470914072694277,0.0532108833413006,6.52042038918494e-222
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.180242374519243,0.00561813826857218,0.169230823512841,0.191253925525644,2.60772128694276e-221
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.118378700250138,0.00369863697068725,0.111129371787591,0.125628028712685,5.93655600329545e-221
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,29434,0.0949630430517815,0.00296825953282097,0.0891452543674524,0.100780831736111,8.38546129481189e-221
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MME,Neprilysin,29349,0.177086321975244,0.00554688234266326,0.166214432583624,0.187958211366864,6.91706295948421e-220
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK1,Dickkopf-related protein 1,29694,0.130825658381426,0.00410205707749396,0.122785626509538,0.138865690253314,1.71971369738983e-219
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.104160660941948,0.00326415962920513,0.0977629080687062,0.11055841381519,6.15517515096404e-219
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD2AP,CD2-associated protein,29478,0.139792972680246,0.00438997414054548,0.131188623364777,0.148397321995715,8.28574794260565e-219
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.24812335262934,0.0077812689198389,0.232872065546456,0.263374639712224,1.21061739882386e-218
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BECN1,Beclin-1,24240,0.132586286270902,0.00416482314722624,0.124423232902339,0.140749339639466,6.56704186998948e-218
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP20,Centrosomal protein 20,28797,0.163219222024376,0.00514191756321501,0.153141063600474,0.173297380448277,2.24035924634091e-217
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTN4R,Reticulon-4 receptor,29725,0.0742180215433206,0.00233895361390636,0.0696336724600642,0.0788023706265771,2.45615962796032e-217
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.120764786623655,0.00380539658073946,0.113306209325406,0.128223363921904,2.97226982961794e-217
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCXR,L-xylulose reductase,29566,0.117544459483782,0.00370995577993701,0.110272946155106,0.124815972812459,1.11220988582818e-216
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.23226585861546,0.00733897060086466,0.217881476237765,0.246650240993155,3.39719857125497e-216
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.213409070996663,0.00674167280601265,0.200195392296878,0.226622749696448,1.22706509675692e-215
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.158658823510232,0.00502305791647502,0.148813629993941,0.168504017026524,2.15888398233427e-215
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HJV,Hemojuvelin,24867,0.0965643460312294,0.00305884541907855,0.0905690090098354,0.102559683052623,1.69558553462909e-214
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.0600406101903666,0.00190255716567955,0.0563115981456347,0.0637696222350985,2.42804441068384e-214
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.18098786282811,0.00573601253624049,0.169745278257079,0.192230447399141,3.32827440055994e-214
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.0781059321791162,0.00248305678588993,0.0732391408787719,0.0829727234794604,1.18234100297224e-213
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD63,CD63 antigen,29169,0.111588075320174,0.00355145013147333,0.104627233062486,0.118548917577861,3.83782094647473e-213
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,29163,0.0513497756821247,0.00163482639897995,0.048145515940124,0.0545540354241254,5.29062685698401e-213
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,28774,0.171406515075016,0.00546387705088597,0.16069731605528,0.182115714094753,1.93179482983002e-212
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN1,Dynactin subunit 1,29725,0.140649801093656,0.00448978686860699,0.131849818831186,0.149449783356125,5.72131853558253e-212
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MVK,Mevalonate kinase,28931,0.172526756155277,0.00550861584142295,0.161729869106088,0.183323643204466,8.80254849373765e-212
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTSS2,Protein MTSS 2,24793,0.21499842621331,0.00686023125022935,0.20155237296286,0.228444479463759,1.79334430885744e-211
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AXIN1,Axin-1,29434,0.205784512211297,0.00658047061202115,0.192886789811736,0.218682234610859,3.23553867172062e-211
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.144224463830619,0.00461695241014117,0.135175237106743,0.153273690554496,1.07505468573627e-210
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARF6,ADP-ribosylation factor 6,24805,0.231042564743632,0.00738786007484575,0.216562358996934,0.245522770490329,1.32742543600431e-210
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGRN,Agrin,29581,0.0743258838796147,0.00238201672114418,0.0696571311061721,0.0789946366530573,2.51936048324757e-210
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,24845,0.101944088875181,0.00327042102874904,0.0955340636588332,0.108354114091529,2.78734683923598e-209
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.111047664068444,0.003575313373633,0.104040049856124,0.118055278280765,2.35494644049391e-208
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,24111,0.133970742345704,0.00431316927013419,0.12551693057624,0.142424554115167,1.01002346351417e-207
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.153305718748588,0.00494694614489357,0.143609704304597,0.16300173319258,1.89466993642544e-207
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THOP1,Thimet oligopeptidase,29343,0.0660845642407125,0.00213459878713196,0.0619007506179338,0.0702683778634911,4.18951223023391e-207
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.23106483622036,0.00746826049374418,0.216427045652621,0.245702626788098,2.88381664798329e-206
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFC,Platelet-derived growth factor C,28797,0.0618845579156273,0.00200347423485605,0.0579577484153095,0.0658113674159452,3.95260998337404e-206
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A4,Protein S100-A4,29566,0.1217311488529,0.003944480994477,0.113999966103725,0.129462331602075,7.38866166191174e-206
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0498710535394493,0.00162112906847159,0.046693640565245,0.0530484665136536,1.38310581818145e-204
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL10,C-X-C motif chemokine 10,29581,0.142060244072289,0.00462500664919476,0.132995231039867,0.151125257104711,5.66665713868417e-204
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EZR,Ezrin,29694,0.051001077487749,0.00166395222252188,0.0477397311316061,0.0542624238438918,3.83101724397129e-203
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.15378535874043,0.00501890409175036,0.143948306720599,0.163622410760261,2.5042597804682e-202
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP85,Centrosomal protein of 85 kDa,28797,0.135363915102417,0.00442853977362345,0.126683977146115,0.144043853058719,5.8403777119084e-202
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAXX,Protein PAXX,24381,0.0969019563174997,0.00316869006699938,0.0906913237861809,0.103112588848818,1.40507401527489e-201
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KAZN,Kazrin,24805,0.220111153463213,0.00720930804029207,0.20598090970424,0.234241397222185,5.23085808296188e-201
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,29694,0.202230707212603,0.0066420580260701,0.189212273481505,0.2152491409437,1.6017387781895e-200
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLIN1,Perilipin-1,28774,0.0732601482744469,0.00241503579752585,0.0685266781112962,0.0779936184375976,5.42991943985856e-199
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPL,N-acetylneuraminate lyase,24922,0.0943293614970054,0.00310577804125121,0.088242036536153,0.100416686457858,5.43159487604332e-199
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",29349,0.170503354058041,0.00562579906629384,0.159476787888105,0.181529920227977,1.06539925718547e-198
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAB2,Disabled homolog 2,29725,0.231695832340445,0.00765180360720127,0.216698297270331,0.24669336741056,2.19223728311537e-198
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.151970879881095,0.00502021138553996,0.142131265565437,0.161810494196754,1.02676256062447e-197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNA4,Plexin-A4,29434,0.17064114362669,0.00565183574352002,0.15956354556939,0.181718741683989,3.08109221819055e-197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.115461398840106,0.00382382421330518,0.107966703382028,0.122956094298184,3.16582560112674e-197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.046718459084129,0.0015522253204447,0.0436760974560574,0.0497608207122006,5.38217775280227e-196
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBIN,Erbin,29349,0.212938793038018,0.00709018718782868,0.199042026149874,0.226835559926162,3.31113001903065e-195
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUCB2,Nucleobindin-2,29652,0.0775365050018802,0.0025821095346929,0.0724755703138821,0.0825974396898782,3.52982752606512e-195
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.0578220490029214,0.00192722546169488,0.0540446870979994,0.0615994109078433,7.78712282501466e-195
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,29581,0.259500090399684,0.00866748752888366,0.242511814843072,0.276488365956296,4.77570470239603e-194
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPY,Pancreatic prohormone,29400,0.210734058710548,0.007052749799231,0.196910669104056,0.224557448317041,2.8246546415042e-193
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STC1,Stanniocalcin-1,29694,0.089896165476394,0.00301208675761585,0.083992475431467,0.0957998555213211,7.21853607151781e-193
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAMDC4,Apical endosomal glycoprotein,24793,0.114819136224096,0.00384657375721894,0.107279851659947,0.122358420788245,2.24983441122194e-192
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREG1,Protein CREG1,29079,0.0785499105411285,0.00263948530047767,0.0733765193521922,0.0837233017300647,9.85666196713652e-192
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R9B,Neurabin-2,29786,0.19426196865378,0.00653036006434098,0.181462462927672,0.207061474379889,1.19673756242913e-191
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.224738404278839,0.00755082491217446,0.209938787450977,0.239538021106701,2.74654043154382e-191
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATG16L1,Autophagy-related protein 16-1,24805,0.17573608930942,0.00590827999567073,0.164155860517905,0.187316318100934,4.70239244584445e-191
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.215569024492611,0.00725830785542959,0.201342741095969,0.229795307889253,5.29345042641724e-191
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTBS,Di-N-acetylchitobiase,24653,0.0560943067429616,0.00188843418243814,0.0523929757453828,0.0597956377405403,1.54998859410831e-190
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.213295754529161,0.00719202863670133,0.199199378401226,0.227392130657096,1.74870803548618e-190
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUOM,Fucose mutarotase,24381,0.130822874673939,0.0044129231641858,0.122173545272135,0.139472204075743,9.08512707317172e-190
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELP,P-selectin,29594,0.116400129002526,0.00393488230271292,0.108687759689208,0.124112498315843,1.49243596360461e-189
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL17,C-C motif chemokine 17,29414,0.186186668819313,0.00630212686400394,0.173834500165865,0.198538837472761,4.64022919408474e-189
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCR,Breakpoint cluster region protein,29434,0.187484844229822,0.00634699288511381,0.175044738174999,0.199924950284645,5.22871217587235e-189
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD6,T-cell differentiation antigen CD6,29760,0.107562000115491,0.00364902761615046,0.100409905987836,0.114714094243145,2.91649389330102e-188
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL5,C-X-C motif chemokine 5,29384,0.232175920367052,0.00788082437889991,0.216729504584408,0.247622336149696,4.99265260760566e-188
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.100919747549894,0.00343054101410344,0.0941958871622514,0.107643607937537,1.92929159499968e-187
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFX1,Transcriptional repressor NF-X1,24111,0.137874679237408,0.00468744471419605,0.128687287597583,0.147062070877232,7.3659634809149e-187
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.218507084294006,0.0074348943338484,0.203934691399663,0.233079477188349,1.15154608154415e-186
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,24845,0.179830591589215,0.00612630009071906,0.167823043411406,0.191838139767025,3.23219675951497e-186
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.151157096646284,0.00515202570387832,0.141059126266682,0.161255067025885,6.06650113991938e-186
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSD,Cathepsin D,27442,0.0824453358236308,0.00281754514389473,0.0769229473415971,0.0879677243056645,2.27463609789374e-185
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.117178062108782,0.0040120187026588,0.10931450545157,0.125041618765993,7.27447380412428e-185
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FETUB,Fetuin-B,29545,0.0667871719561803,0.00228844159324219,0.0623018264334256,0.071272517478935,1.27859777816925e-184
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFC,Vascular endothelial growth factor C,29566,0.112559917698585,0.00385816048071433,0.104997923156385,0.120121912240785,1.69424895188794e-184
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSO,Cathepsin O,29786,0.0612986300056774,0.00210383732609247,0.0571751088465362,0.0654221511648186,4.75744817807766e-184
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP23,Synaptosomal-associated protein 23,29478,0.174641029725338,0.00602286894749977,0.162836206588239,0.186445852862438,2.67407317733938e-182
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IKBKG,NF-kappa-B essential modulator,29434,0.184128274550969,0.00635382260271727,0.171674782249643,0.196581766852295,4.3805337157093e-182
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.122928977634482,0.00424577511473068,0.11460725840961,0.131250696859354,1.03742379015469e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.0408066395088891,0.00140965194195028,0.0380437217026666,0.0435695573151117,1.07075344942298e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEP,Leptin,29478,0.13466751001339,0.0046570919486353,0.125539609794064,0.143795410232715,2.52619883587661e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.149409920546196,0.00516391212769057,0.139288652775922,0.159531188316469,5.41705781930909e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NHLRC3,NHL repeat-containing protein 3,23825,0.0643142883779879,0.00222410383779323,0.0599550448559132,0.0686735319000627,9.70554243740377e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.0656794297676383,0.00227580838493172,0.0612188453331722,0.0701400142021045,1.22822051295112e-180
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F13B,Coagulation factor XIII B chain,24833,0.0516556907660681,0.00179244327723896,0.0481425019426798,0.0551688795894565,1.14126886853841e-179
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGF,Hepatocyte growth factor,29786,0.0685580135270922,0.00238576502836282,0.0638819140715011,0.0732341129826833,3.76836732312147e-179
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.0537739272140899,0.00187284835124857,0.0501031444456427,0.0574447099825371,7.96793734641005e-179
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.167510633129646,0.0058345019030404,0.156075009399687,0.178946256859605,2.3095901799203e-178
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.189025577989856,0.00659847111628239,0.176092574601942,0.201958581377769,4.77761688565852e-178
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,29349,0.272804088705182,0.00952448356944169,0.254136100909077,0.291472076501288,5.63760164968133e-178
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLA2,Src-like-adapter 2,24867,0.207917755495098,0.0072589813314449,0.193690152085466,0.22214535890473,1.50867642343013e-177
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5E,5'-nucleotidase,29566,0.111422337998984,0.00389571481234508,0.103786736966788,0.119057939031181,1.7048400549263e-177
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTUD7B,OTU domain-containing protein 7B,24867,0.125443367479876,0.00438142154354718,0.116855781254523,0.134030953705228,2.10978020841875e-177
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.137657787889037,0.00481655581978202,0.128217338482264,0.14709823729581,3.46160307629171e-177
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH2,Cadherin-2,29478,0.0699451975244696,0.00245550827246532,0.0651324013104376,0.0747579937385016,4.39168586007135e-176
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISM1,Isthmin-1,29434,0.077682080434406,0.00272754169660389,0.0723360987090624,0.0830280621597497,5.00195637576239e-176
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CMIP,C-Maf-inducing protein,24793,0.163767312501275,0.00575043181691592,0.15249646614012,0.17503815886243,1.42945697166112e-175
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPD52L2,Tumor protein D54,24381,0.213866251435119,0.00751391746830921,0.199138973197233,0.228593529673005,2.50638550354314e-175
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.194861262765318,0.00686190790186316,0.181411923277666,0.20831060225297,4.69537469883545e-175
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCK2,Cytoplasmic protein NCK2,29581,0.207913076768927,0.00732183933673602,0.193562271668924,0.222263881868929,5.04105647314855e-175
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS8,Prostasin,29347,0.0808616006163613,0.00284764746366972,0.0752802115875686,0.0864429896451539,5.31203705360187e-175
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MINK1,Misshapen-like kinase 1,24845,0.182884987420444,0.00643747733345458,0.170267531846873,0.195502442994015,9.64771237116661e-175
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRPK2,SRSF protein kinase 2,29434,0.16479988636319,0.00581555968038461,0.153401389389636,0.176198383336744,2.61158929757399e-174
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.202201295309871,0.00712669040255836,0.188232982120857,0.216169608498886,3.12628594494863e-174
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AAMDC,Mth938 domain-containing protein,24240,0.104916898502175,0.00370497875466353,0.0976551401430343,0.112178656861315,1.40024192484105e-173
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD5,Programmed cell death protein 5,29694,0.11336219677383,0.004016874303652,0.105489123138672,0.121235270408988,6.14953498590441e-173
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE4,Ribonuclease 4,24194,0.0539338942511978,0.00190968249640133,0.0501909165582512,0.0576768719441444,1.12180435767329e-172
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLSCR3,Phospholipid scramblase 3,24804,0.115246629779182,0.00408158424398301,0.107246724660975,0.123246534897388,1.14983846812441e-172
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BACH1,Transcription regulator protein BACH1,29434,0.144065633233996,0.00511156798440661,0.134046959984559,0.154084306483433,1.79307210703991e-172
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCTN3,Tectonic-3,24922,0.0582571398186667,0.00206776978173974,0.0542043110464568,0.0623099685908766,6.06948027015916e-172
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0719512720262884,0.00255868671431312,0.0669362460662347,0.0769662979863421,2.66694159260929e-171
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.0780480129488273,0.00278022824130158,0.0725987655958762,0.0834972603017784,9.93293399682234e-171
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLK1,Protein delta homolog 1,29820,0.10842083278059,0.00386808578829726,0.100839384635528,0.116002280925653,1.16352359777355e-170
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSP1,Lymphocyte-specific protein 1,29434,0.078140631884746,0.00278923582021186,0.0726737296771307,0.0836075340923612,1.84760443651594e-170
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.221809636954834,0.00791372674228275,0.20629873253996,0.237320541369709,3.30473151093049e-170
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0742871354320997,0.00265964075665251,0.0690742395490608,0.0795000313151387,1.72079465055276e-169
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.13610155341245,0.00487486461877154,0.126546818759658,0.145656288065243,2.76646277980591e-169
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.20232622454913,0.00725025348515565,-0.216536721380035,-0.188115727718225,3.58179945143901e-169
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINH1,Serpin H1,24445,0.249012838878451,0.00892427335253379,0.231521263107485,0.266504414649417,1.08684038806809e-168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.217167912985415,0.00779401766373728,0.20189163836449,0.23244418760634,1.15220518742789e-168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PYY,Peptide YY,24111,0.188069854148852,0.00674352689673702,0.174852541431247,0.201287166866456,1.7206130053954e-168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.163280482285369,0.00586522139806474,0.151784648345162,0.174776316225576,2.28371334110865e-168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOK2,Docking protein 2,29478,0.234977450576649,0.00844095794395277,0.218433173006501,0.251521728146796,2.29546199369634e-168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA5,Integrin alpha-5,29443,0.0483705995306848,0.0017385253078567,0.0449630899272856,0.0517781091340839,3.46925131513559e-168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP2B,DNA topoisomerase 2-beta,24229,0.153754991944504,0.00552650304470095,0.14292304597689,0.164586937912118,1.03708440217681e-167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.174251365085081,0.00627229935076219,0.161957658357587,0.186545071812574,2.65526012926434e-167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.133566354602281,0.00480908252993231,0.124140552843613,0.142992156360948,3.23559067647699e-167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,29434,0.122866805571933,0.0044301269835667,0.114183756684142,0.131549854459724,3.81453936124777e-167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL5,C-C motif chemokine 5,29594,0.193097052133321,0.00696681195221841,0.179442100706973,0.206752003559669,5.99356467313998e-167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAT,Linker for activation of T-cells family member 1,29786,0.145309258773451,0.00525128713991895,0.13501673597921,0.155601781567692,1.98939505741126e-166
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACE2,Angiotensin-converting enzyme 2,28916,0.0993269190339648,0.00358907578667063,0.0922923304920904,0.106361507575839,2.08270915557911e-166
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.122848665512631,0.00444909872316364,0.11412843201523,0.131568899010032,1.15433564501395e-165
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN2,CCN family member 2,29478,0.109281649345637,0.00396168739583787,0.101516742049795,0.117046556641479,2.15742912589141e-165
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXO1,Forkhead box protein O1,29434,0.163682031279481,0.00593535312266873,0.15204873915905,0.175315323399912,2.63409177892248e-165
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.0724398741346142,0.00262739229749115,0.0672901852315315,0.0775895630376968,3.13395342916024e-165
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.0448842203022456,0.0016294695645834,0.0416904599556621,0.048077980648829,6.2508771083952e-165
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.20737562296886,0.00753296821849221,0.192611005260615,0.222140240677105,2.33530863059026e-164
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP5,Fatty acid-binding protein 5,29624,0.129587993996762,0.00472503226728302,0.120326930752887,0.138849057240636,1.4982958626582e-163
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,29536,0.0989482127589437,0.00361113985990431,0.0918703786335312,0.106026046884356,2.96779411913622e-163
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.0554436356227433,0.00202452389606148,0.0514755687864628,0.0594117024590238,4.22094952290815e-163
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,24867,0.216637396923741,0.00791802027116438,0.201118077192259,0.232156716655223,2.09051665534413e-162
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCBP2,Poly(rC)-binding protein 2,24867,0.137239849524141,0.00502262596467317,0.127395502633381,0.1470841964149,5.40279231795706e-162
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.0747285398578221,0.0027431995856181,0.0693518686700106,0.0801052110456336,2.00177502643101e-161
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.145869147421005,0.00534914605333303,0.135384821156473,0.156353473685538,2.28034819869089e-161
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USO1,General vesicular transport factor p115,29349,0.169872969465703,0.00623672260005621,0.157648993169593,0.182096945761813,2.38252627777152e-161
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.04943974989351,0.0018134646285569,0.0458853592215385,0.0529941405654815,3.19261816660495e-161
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.178972060456801,0.00657874949368596,0.166077711449176,0.191866409464425,5.84113855657972e-161
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.120385106299432,0.00442471743098887,0.111712660134694,0.12905755246417,1.18442306223162e-160
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP43,Centrosomal protein 43,28705,0.131389813628916,0.00483464779242369,0.121913903955765,0.140865723302066,1.327365089271e-160
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,29820,0.126434565314101,0.00465413741542084,0.117312455979876,0.135556674648326,1.48219652486389e-160
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.0618704770058981,0.0022789202972173,0.0574037932233521,0.066337160788444,2.49065850743222e-160
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.180778443370005,0.0066585667218181,0.167727652595242,0.193829234144769,2.62344068393748e-160
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LBR,Delta(14)-sterol reductase LBR,29694,0.125378366020567,0.00463574923536873,0.116292297519244,0.13446443452189,3.63408065573783e-159
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK11,Serine/threonine-protein kinase STK11,28916,0.13703708269095,0.00506755480631169,0.127104675270579,0.146969490111321,4.53453647710484e-159
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.0615902773656443,0.00227868190482382,0.0571240608321896,0.066056493899099,5.78181229303819e-159
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0704933402287305,0.00260645197506295,0.0653846943576071,0.0756019860998539,9.46870399145737e-159
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGFR,Opioid growth factor receptor,29349,0.0613088784525376,0.00227022563867065,0.0568592362007431,0.065758520704332,1.11018107712731e-158
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.143340596715322,0.00532852811416294,0.132896681611563,0.153784511819082,1.7652510511374e-157
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.15440700854234,0.00573924526588419,0.143158087821207,0.165655929263473,1.76738809208358e-157
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.125352269166867,0.00465935986276726,0.116219923835843,0.134484614497891,1.79185974851706e-157
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL13,C-C motif chemokine 13,29732,0.128828380543209,0.00479487048527797,0.119430434392064,0.138226326694354,3.9365789435848e-157
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSME1,Proteasome activator complex subunit 1,29192,0.0691872507344117,0.00257824753789922,0.0641338855601292,0.0742406159086941,1.01162286298456e-156
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1R2,Interleukin-1 receptor type 2,29404,0.0371059952319691,0.00138351841987483,0.0343942991290144,0.0398176913349237,1.45203325917101e-156
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEXIM1,Protein HEXIM1,29434,0.151325881674623,0.00564257690835258,0.140266430934252,0.162385332414994,1.501569259669e-156
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.170931451410178,0.00637993315104852,0.158426782434123,0.183436120386233,3.24757731231573e-156
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.190963758781747,0.00712405751005562,0.177000606062038,0.204926911501456,4.67831584989267e-156
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.103319662046054,0.00386273428016129,0.0957487028569377,0.11089062123517,9.11128351290244e-156
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP3B1,AP-3 complex subunit beta-1,24805,0.142388686839191,0.00532400952675295,0.131953628166755,0.152823745511626,2.28379372970525e-155
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,24381,0.144764936995856,0.00542445493850248,0.134133005316391,0.155396868675321,1.10065838776653e-154
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.128308253261105,0.00482150544505312,0.118858102588801,0.137758403933409,8.08905678863405e-154
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEC31A,Protein transport protein Sec31A,24240,0.142214439097022,0.0053455626231272,0.131737136355692,0.152691741838351,9.81077211999721e-154
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.156753571263331,0.00589297596865217,0.145203338364772,0.168303804161889,1.10777916685667e-153
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.20625051636828,0.00776359643436015,0.191033867356934,0.221467165379626,1.12661748969492e-153
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NIT2,Omega-amidase NIT2,24813,0.13745051244808,0.00517425526692584,0.127308972124906,0.147592052771255,2.45527880320071e-153
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP10,Stromelysin-2,29439,-0.108763266470103,0.00410578301503608,-0.116810601179573,-0.100715931760632,7.80490130376646e-153
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.167021028143867,0.00630232272035959,0.154668475611962,0.179373580675772,1.24594475900524e-152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.11593280308693,0.00438684395874909,0.107334588927781,0.124531017246078,8.35310215599632e-152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.142140546060092,0.00538249978314925,0.131590846485119,0.152690245635064,1.37305886901429e-151
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0514216844885956,0.00195142990602816,0.0475968818727804,0.0552464871044108,2.85605196474504e-151
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BID,BH3-interacting domain death agonist,29434,0.121930612388128,0.00463359826007189,0.112848759798387,0.131012464977869,7.32310862885234e-151
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.18808721454729,0.0071615947067868,0.174050488921988,0.202123940172592,2.66657269163456e-150
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.0911523788650438,0.00347374361745661,0.0843438413748288,0.0979609163552587,4.67446137846317e-150
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.0803250020486347,0.00306257080845479,0.0743223632640633,0.0863276408332061,6.84200875224133e-150
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC27,Cell division cycle protein 27 homolog,28797,0.110965494511037,0.00423134705861337,0.102672054276155,0.119258934745919,8.03598414495999e-150
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNMBP,Dynamin-binding protein,29218,0.111446778452146,0.00425041211087339,0.103115970714835,0.119777586189458,8.49247308006151e-150
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,24229,0.17767632788889,0.00676831779555401,0.164410425009605,0.190942230768176,8.64007334798171e-150
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP2,Methionine aminopeptidase 2,29674,0.104624423833991,0.00399391583936479,0.0967963487888361,0.112452498879146,1.49015021348079e-149
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMPR,GMP reductase 1,29786,0.0903516378906624,0.00345015395004947,0.0835893361485654,0.0971139396327593,1.81410719145609e-149
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTBDN,Retbindin,29349,0.0538686584640677,0.00206133724417213,0.0498284374654904,0.0579088794626451,7.82116892509249e-149
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,24867,-0.081659406231341,0.003123796031017,-0.0877820464521343,-0.0755367660105477,1.27166799205603e-148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELE,E-selectin,29820,0.091400649668983,0.00350144413636186,0.0845378191617137,0.0982634801762522,1.55122312610174e-148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS9,Galectin-9,29453,0.0578883026158053,0.00221785718211577,0.0535413025388584,0.0622353026927522,1.7421843851359e-148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.130844869144851,0.0050184971716373,0.121008614688441,0.14068112360126,7.37755809574278e-148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINC1,Antithrombin-III,24914,0.0268055030909701,0.00102836838689363,0.0247899010526585,0.0288211051292816,8.50731596691425e-148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.0964213475308956,0.00370302747676122,0.0891634136764436,0.103679281385348,1.86515393347118e-147
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAG1,Dystroglycan,29581,0.0857197955287518,0.00329722904236988,0.0792572266057068,0.0921823644517968,2.39871807075381e-147
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH2B3,SH2B adapter protein 3,28797,0.177238396008709,0.00681898550840908,0.163873184412227,0.19060360760519,3.06588974673066e-147
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1S,Complement C1s subcomponent,24966,0.0378297465585943,0.00145510029392875,0.034977749982494,0.0406817431346947,4.73673934944051e-147
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QDPR,Dihydropteridine reductase,29345,0.0778043898529051,0.00299760955665832,0.0719290751218548,0.0836797045839554,7.20246894628792e-147
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,24922,0.163455601831223,0.00629961637077074,0.151108353744512,0.175802849917934,1.74230034971758e-146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,24209,0.102685724681867,0.00395700372204287,0.0949299973866626,0.110441451977071,1.81742749441284e-146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGCC,Regulator of cell cycle RGCC,24867,0.136399028293048,0.00525749218947253,0.126094343601682,0.146703712984414,1.9062777274667e-146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOLM2,Protein GOLM2,29694,0.0407397912761991,0.00157216486660609,0.0376583481376512,0.043821234414747,2.01743790509695e-146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYN,Tyrosine-protein kinase Lyn,29349,0.151955777384083,0.0058638223399543,0.140462685597773,0.163448869170394,2.05759223199661e-146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,29581,0.154228738867892,0.00595401510277673,0.142558869266449,0.165898608469334,2.62793692754244e-146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYTL4,Synaptotagmin-like protein 4,24922,0.13151232658162,0.00507209164467731,0.121571026958052,0.141453626205187,2.76753986073863e-146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASAH2,Neutral ceramidase,29218,0.0953549995905844,0.00368300798306538,0.0881363039437762,0.102573695237393,3.80620864206766e-146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBPL,FK506-binding protein-like,24805,0.1065734938774,0.00411495925867554,0.0985081737303964,0.114638814024405,5.9658792937823e-146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAO1,Hydroxyacid oxidase 1,29725,0.229976854601751,0.00890362131743583,0.212525756819577,0.247427952383925,1.67125709896473e-145
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.187018225085223,0.00724307981620765,0.172821788645456,0.20121466152499,2.15362315044776e-145
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNST,Consortin,29478,0.194082902269552,0.00752799559739436,0.179328030898659,0.208837773640445,5.81137408172521e-145
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAMBP,STAM-binding protein,29163,0.114460075310441,0.00444694112621369,0.105744070703062,0.12317607991782,1.76273473872119e-144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNB3,Plexin-B3,29383,0.0845872320224079,0.00329129761214445,0.0781362887026048,0.091038175342211,4.55654016911315e-144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EREG,Proepiregulin,29163,0.143393428989083,0.00558225301813421,0.13245221307354,0.154334644904626,6.47711299388484e-144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,28916,0.062007349589655,0.00241470780273013,0.057274522296304,0.0667401768830061,8.24211770850293e-144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMN,Protein amnionless,28931,0.0847761615162213,0.00330168689592428,0.0783048552002097,0.0912474678322329,8.73985487793693e-144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM5,Tripartite motif-containing protein 5,29434,0.153079562055642,0.0059721103807199,0.141374225709431,0.164784898401853,2.49403774851924e-143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX15,Sorting nexin-15,24381,0.0965664901787385,0.0037631549102775,0.0891907065545946,0.103942273802882,2.55038429454122e-143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES2,Cocaine esterase,29349,0.0973323770190477,0.00380177956098973,0.0898808890795079,0.104783864958588,5.43288079010163e-143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.166161352459222,0.00650142999900268,0.153418549661177,0.178904155257267,1.73127993069614e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NSFL1C,NSFL1 cofactor p47,29694,0.115490575263365,0.00452209097525513,0.106627276951865,0.124353873574865,2.50160618530713e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,24951,0.0478015342415297,0.00187112781045602,0.0441341237330359,0.0514689447500235,4.00275398396931e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANG,Angiogenin,29435,0.0598526523023191,0.00234528273118053,0.0552558981492053,0.0644494064554329,4.12403154178928e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,29820,0.0395384833296711,0.00155005699622947,0.0365003716170614,0.0425765950422809,5.41181818726605e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.112312761424971,0.00440468654540031,0.103679575795986,0.120945947053956,7.71851601491917e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.127293659692054,0.00498752945074839,0.117518101968588,0.137069217415521,8.12168640715915e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,29349,0.063588360305783,0.00249683438391482,0.05869456491331,0.068482155698256,1.56003846904817e-141
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.0888773595936485,0.00348939347873028,0.0820381483753371,0.0957165708119598,3.0623674253062e-141
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,24805,0.169692226627687,0.00666743506173069,0.156624053906695,0.182760399348679,4.47273111458229e-141
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTDH,Protein LYRIC,24229,0.164782282009289,0.00647964192592378,0.152082183834478,0.177482380184099,8.12610498648891e-141
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGF,Placenta growth factor,29786,0.0463303329741388,0.00182550394645534,0.0427523452390864,0.0499083207091913,1.33224209972103e-140
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AZI2,5-azacytidine-induced protein 2,24867,0.0976751569331126,0.00384524224233694,0.0901384821381322,0.105211831728093,1.50647378259088e-140
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST3,Cystatin-C,29530,0.0500214403716891,0.00197205545841168,0.0461562116732022,0.053886669070176,1.96033621631664e-140
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0492631122130497,0.00194626650054361,0.0454484298719842,0.0530777945541152,8.09925146501002e-140
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PXN,Paxillin,28774,0.0906247579985298,0.00358385827034895,0.0836003957886459,0.0976491202084138,1.49286836959085e-139
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GASK1A,Golgi-associated kinase 1A,24111,0.0756716085494314,0.00299760529410581,0.069796302172984,0.0815469149258788,8.38546982068012e-139
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.177150780157696,0.00703045960823268,0.16337107932556,0.190930480989832,1.25936388296765e-138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGLN1,Egl nine homolog 1,29434,0.0952328279871709,0.00378107675791903,0.0878219175416496,0.102643738432692,1.64903848037976e-138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.185408635961402,0.00736190713327667,0.170979297980179,0.199837973942624,3.4011628848602e-138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.140093849735821,0.0055678296200689,0.129180903680486,0.151006795791156,5.67239441516914e-138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,29443,0.0930427676493934,0.00370475033923358,0.0857814569844956,0.100304078314291,9.78399938877589e-138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRAP,BRCA1-associated protein,24565,0.191749194719996,0.00763192176932824,0.176790628052112,0.206707761387879,1.46451344377762e-137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPHN1,Oligophrenin-1,24845,0.187928437201095,0.0074810259184689,0.173265626400896,0.202591248001294,1.54355553789339e-137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,24867,0.132777897397358,0.00529009196262422,0.122409317150614,0.143146477644101,2.59508404581954e-137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MITD1,MIT domain-containing protein 1,29218,0.168472262027842,0.00672196283563404,0.155297214869999,0.181647309185685,3.56158757143034e-137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.134002456343223,0.00534881758633413,0.123518773874008,0.144486138812438,4.4702328491981e-137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.114748515445384,0.00458088627052338,0.105769978355158,0.12372705253561,8.81901457868434e-137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL3,C-X-C motif chemokine 3,29453,0.163642537337105,0.00654805316273335,0.150808353138148,0.176476721536063,2.0277800593841e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VNN1,Pantetheinase,24951,0.12667374721832,0.00506461813013755,0.116747095683251,0.13660039875339,2.19975388127259e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,28931,0.0683621396390731,0.0027385347673262,0.0629946114951138,0.0737296677830325,4.26569573481805e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3GLB2,Endophilin-B2,24845,0.115520664014909,0.0046284963942715,0.106448811082137,0.124592516947681,8.14060395053063e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OXT,Oxytocin-neurophysin 1,29694,0.241228817030538,0.00968104291506245,0.222253972917016,0.260203661144061,1.19047494410083e-135
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,24381,0.143346411795491,0.00575194168856339,0.132072606085907,0.154620217505075,2.16418149762547e-135
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,29443,0.088602801357657,0.00356307710736328,0.081619170227225,0.0955864324880891,4.219549511798e-135
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.0773165231825328,0.00311327289657806,0.0712145083052398,0.0834185380598258,9.40223089742954e-135
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAX1BP1,Tax1-binding protein 1,24845,0.109242387275657,0.00439526878837782,0.100627660450437,0.117857114100878,1.02396350313478e-134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THPO,Thrombopoietin,28916,0.0665860234269204,0.00268706982451694,0.0613193665708672,0.0718526802829736,3.69642133941024e-134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYDGF,Myeloid-derived growth factor,24922,0.17245455813405,0.00695619339281297,0.158820419084137,0.186088697183964,4.67108394850156e-134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.153585689913827,0.00619610240709078,0.141441329195929,0.165730050631725,5.2423641558369e-134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,29434,0.0984660078841427,0.00397749984626154,0.09067010818547,0.106261907582815,6.32468674864019e-134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCC,Tubulin-specific chaperone C,29218,0.139294031468617,0.00562792773003882,0.128263293117741,0.150324769819493,7.3526468991018e-134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRKL,Crk-like protein,29491,0.18247151053417,0.00737900269239687,0.168008665257072,0.196934355811268,1.2190217622953e-133
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAS6,Growth arrest-specific protein 6,29639,-0.0438478498433237,0.00177388889708837,-0.0473246720816169,-0.0403710276050305,1.52960281692926e-133
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM13A,Protein FAM13A,24805,0.116041399438288,0.00470408734015914,0.106821388251576,0.125261410625,9.36482705686311e-133
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPC5,Glypican-5,29218,0.0964119028511486,0.00391759426273612,0.0887334180961858,0.104090387606111,2.20950807723023e-132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.154668842282544,0.00628164167605236,0.142356824597482,0.166980859967607,3.07927406224847e-132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARSB,Arylsulfatase B,29349,0.0943129143036329,0.00383824665192429,0.0867899508658613,0.101835877741405,5.46649303191023e-132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.0542446140598422,0.00220527597279247,0.049922273153169,0.0585669549665155,5.56888514965119e-132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.0567889337329979,0.00230863435663657,0.0522640103939902,0.0613138570720055,5.79463758219093e-132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.102022270908391,0.00414990258162999,0.0938884618483966,0.110156079968386,7.06885427067759e-132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.0750579188971975,0.00305650944844493,0.0690671603782454,0.0810486774161495,8.2248307676368e-132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.183145103838685,0.00745530161365791,0.168532712675916,0.197757495001455,1.09290831646218e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDUA,Alpha-L-iduronidase,29725,0.0787203978110255,0.0032100711236246,0.0724286584087213,0.0850121372133297,1.71054834059398e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,29349,0.10153739054193,0.00414224684102176,0.0934185867335269,0.109656194350332,2.2773030332897e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEFTY2,Left-right determination factor 2,29674,0.0885851848646513,0.00361455186074045,0.0815006632176,0.0956697065117026,2.46775263201209e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IST1,IST1 homolog,24636,0.169637863885457,0.00692018926395494,0.156074292928105,0.183201434842809,3.96164463227191e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.198048341297376,0.00809570317249771,0.182180763079281,0.213915919515472,7.43911347806364e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,24805,0.080570288108289,0.00329122348710764,0.074119490073558,0.0870210861430199,8.55059061742779e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMMD1,COMM domain-containing protein 1,24240,0.104529004698514,0.00426936210760681,0.096161054967605,0.112896954429424,8.6032295471454e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDHD2,Phospholipase DDHD2,24867,0.112914768233315,0.00461513979377591,0.103869094237514,0.121960442229116,1.19016540038735e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,24846,0.0340667000890337,0.00139419026768083,0.0313340871643793,0.0367993130136881,2.52989867643417e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNLR1,Interferon lambda receptor 1,29434,0.0630104785420866,0.00258144933151567,0.0579508378523159,0.0680701192318573,2.72225842281588e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,29434,-0.0594494003831103,0.00243675691487991,-0.0642254439362749,-0.0546733568299456,3.63069808171438e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.103968992263593,0.00426159964362795,0.0956162569620821,0.112321727565104,3.65362832867241e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,A1BG,Alpha-1B-glycoprotein,24966,0.0290763055719511,0.00119094022289126,0.0267420627350843,0.031410548408818,4.02894203845124e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.146373580242512,0.00600289239457213,0.13460791114915,0.158139249335873,4.91761654089643e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC13,Mucin-13,28774,0.0874419587796894,0.00358590110395622,0.0804135926159352,0.0944703249434436,5.17677843999083e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBNL,Drebrin-like protein,29581,0.156854983277446,0.00643688782804525,0.144238683134478,0.169471283420415,7.12932799085283e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,28916,0.128405961391659,0.00527182509591091,0.118073184203674,0.138738738579644,9.9450497478635e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COCH,Cochlin,24922,0.0785140757814478,0.00322347698426361,0.0721960608922911,0.0848320906706044,1.6029725853536e-129
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFA,Vascular endothelial growth factor A,29683,0.0977403132830784,0.00401951534388105,0.0898620632090715,0.105618563357085,2.42901648445593e-129
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,29581,0.21987390231731,0.00904528123702623,0.202145151092739,0.237602653541882,2.99159132780262e-129
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS8,Galectin-8,29694,0.102614246880015,0.00422350277760756,0.0943361814359038,0.110892312324125,3.95226415633872e-129
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D23,TBC1 domain family member 23,29349,0.151685624066763,0.00624919185974473,0.139437208021663,0.163934040111863,7.10263986531664e-129
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,24229,0.149188412344547,0.00615066925226812,0.137133100610102,0.161243724078993,1.96501013761828e-128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST13,Hsc70-interacting protein,24381,0.0943726111196538,0.00389100937139954,0.0867462327517107,0.101998989487597,1.99827909960443e-128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOLGA3,Golgin subfamily A member 3,24867,0.131706028723368,0.00543116541558767,0.121060944508817,0.14235111293792,2.05231235982678e-128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.102940552886262,0.00425521434939547,0.0946003327614472,0.111280773011077,4.86592976445277e-128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NIT1,Deaminated glutathione amidase,24240,0.0798461026161542,0.0032978351578412,0.0733823457067855,0.086309859525523,5.56196179462915e-128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA1,GDNF family receptor alpha-1,29674,0.0476482480031326,0.0019712536830627,0.0437845907843297,0.0515119052219355,7.66169476167573e-128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASHC3,WASH complex subunit 3,24845,0.127016050688502,0.00525141139848993,0.116723284347462,0.137308817029542,9.16586892344525e-128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,24867,0.199253619162089,0.00824717471957281,0.183089156711726,0.215418081612451,1.72299497004499e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",28774,0.0856503602690152,0.0035494840181653,0.0786933715934112,0.0926073489446192,2.22105712190426e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD1,Sushi domain-containing protein 1,28916,0.0822879324050474,0.00341077243628144,0.0756028184299357,0.088973046380159,2.43483502071693e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.0448986189679682,0.00186133420398529,0.0412504039281571,0.0485468340077794,2.53925860608583e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.139625580109248,0.00578834094993635,0.128280431847372,0.150970728371123,4.30767480830135e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD5,T-cell surface glycoprotein CD5,29683,0.0576564709663887,0.00239604168404171,0.052960229265667,0.0623527126671105,9.9696885709543e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.113254076367897,0.00470444477267266,0.104033364613458,0.122474788122335,1.3239380997685e-126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.184179182590421,0.007658022081429,0.16916945931082,0.199188905870022,1.3597603698128e-126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.130317421297061,0.00542476177367062,0.119684888220667,0.140949954373456,2.82527843858793e-126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD36,Platelet glycoprotein 4,24229,0.0758970301507499,0.00315839697077034,0.06970657208804,0.0820874882134598,4.02829435626519e-126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TALDO1,Transaldolase,24888,0.0745299500118558,0.00310220150558333,0.0684496350609125,0.0806102649627992,4.18358610237426e-126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB27B,Ras-related protein Rab-27B,24922,0.137446984968076,0.00572406947587526,0.126227808795361,0.148666161140792,5.62090613550812e-126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,24229,0.0828688802011727,0.00345167294094408,0.0761036012369223,0.0896341591654231,6.7419522370477e-126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,29518,0.0594353501196315,0.00248073483715598,0.0545731098388057,0.0642975904004572,1.18998461045724e-125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.103954080574672,0.00433837036448346,0.0954508746602849,0.11245728648906,2.05378093671432e-125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF2,TNF receptor-associated factor 2,29434,0.117177092773082,0.00490274923493531,0.107567704272609,0.126786481273556,4.74422445252903e-125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.125842225715839,0.00526718592782994,0.115518541297292,0.136165910134386,5.87011590172269e-125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS1BP3,HCLS1-binding protein 3,24240,0.150253549894806,0.00629012772134827,0.137924899560964,0.162582200228649,1.15039225134052e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PENK,Proenkephalin-A,24381,0.0514598750467857,0.0021548097324643,0.0472364479711556,0.0556833021224157,1.29279224047726e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.0850436907724723,0.00356283635023966,0.0780605315260026,0.0920268500189421,1.60924106062911e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDRKH,Tudor and KH domain-containing protein,28774,0.14122072069026,0.00592172772148209,0.129614134356155,0.152827307024364,1.72493474165628e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.0961762238670308,0.0040363582444393,0.0882649617079297,0.104087486026132,2.57646297738834e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAT2,Signal transducer and activator of transcription 2,24229,0.128879347317,0.00540626828087865,0.118283061486478,0.139475633147522,3.5619702729991e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.202393261998771,0.00849828804048316,0.185736617439424,0.219049906558118,3.74285429061988e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIAE,Sialate O-acetylesterase,29495,0.0772802608173321,0.00324744126274792,0.0709152759423461,0.083645245692318,5.27514612293374e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGA,Protein O-GlcNAcase,24805,0.117187441769285,0.00492703331688425,0.107530456468192,0.126844427070378,1.17158766128876e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.242774286455282,0.0102230159132196,0.222737175265371,0.262811397645192,2.75740064503243e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F2,Prothrombin,24966,0.0245062605807433,0.0010327070941438,0.0224821546762215,0.0265303664852651,4.07835143113151e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL11,Eotaxin,29786,0.0622026454447884,0.00262400298939773,0.0570595995855689,0.0673456913040079,4.40761857123421e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0823769615892912,0.00347823047530139,0.0755596298577005,0.0891942933208819,7.51830794703198e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.0759997409853059,0.00321016350662173,0.0697078205123274,0.0822916614582845,9.24805528608936e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNCG,Gamma-synuclein,29218,0.110202583612095,0.00465807032677094,0.101072765771624,0.119332401452566,1.37887269085547e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,29386,0.106477652264919,0.00451322472165052,0.097631731810484,0.115323572719354,6.29919280120907e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.0926608661172444,0.00392822084699926,0.0849615532571259,0.100360178977363,6.86010892038299e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.118912588039009,0.00504216404719438,0.109029946506508,0.12879522957151,7.59182590091364e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,29566,0.0551964497092868,0.00234122366327472,0.0506076513292684,0.0597852480893053,9.08487844855419e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0691866374197067,0.00293679563055299,0.0634305179838228,0.0749427568555905,1.34558091155648e-121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GTPBP2,GTP-binding protein 2,24195,0.132916309874876,0.00563679871285758,0.121868184397675,0.143964435352077,1.45297714155756e-121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGKA,Diacylglycerol kinase alpha,24229,0.0899708743174839,0.00381747172000407,0.0824886297462759,0.0974531188886919,1.90501042997729e-121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEP1A,Meprin A subunit alpha,24805,0.118151675096214,0.00502162214949558,0.108309295683203,0.127994054509225,4.41967473592105e-121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.0835597823340822,0.00355526371178456,0.0765914654589844,0.0905280992091799,5.23950084163568e-121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.118284116444084,0.00504373262035809,0.108398400508182,0.128169832379985,1.62339559865443e-120
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.140303998848903,0.00597729499959796,0.128588500649691,0.152019497048115,1.69229352213033e-120
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,24867,0.0992038839202063,0.00423016586535085,0.0909127588241187,0.107495009016294,2.58521896910657e-120
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASC3,Protein CASC3,24195,0.0686254914894381,0.00292614842925659,0.0628902405680952,0.074360742410781,2.74579998481969e-120
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.0949861841480493,0.00405044730551803,0.0870473074292339,0.102925060866865,2.79015605522324e-120
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0466522207190668,0.0019964295628157,0.0427392187759481,0.0505652226621856,1.08729478220711e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TWF2,Twinfilin-2,24938,0.136676725965858,0.00584719016401265,0.125216233244393,0.148137218687323,1.49273016879148e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.0725585016616215,0.00310737924556543,0.0664680383403133,0.0786489649829298,1.76565155457264e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNPY4,Protein canopy homolog 4,29349,0.121669848758129,0.00522116909780167,0.111436357326438,0.131903340189821,4.97283219139142e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,29434,0.0539621240504434,0.00231865572355121,0.049417558832283,0.0585066892686038,9.85318290850895e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDC4,Syndecan-4,29478,0.0750308224649493,0.00322850645124937,0.0687029498205006,0.0813586951093981,2.08488526881913e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.137459435900613,0.00591580950384205,0.125864449273083,0.149054422528143,2.42794124693369e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.077957361572907,0.00336140200681706,0.0713690136395456,0.0845457095062685,9.86514537846211e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.045089340714262,0.00194732916585258,0.0412725755491909,0.0489061058793331,1.488057482511e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPART,Spartin,24381,0.125118857475697,0.00539886852736328,0.114537075162065,0.135700639789329,1.51997042548426e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RWDD1,RWD domain-containing protein 1,29694,0.102398075383138,0.00442446217774585,0.0937261295147562,0.11107002125152,1.85210293512598e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLB1,Beta-galactosidase,29218,0.0675527919495844,0.00291866628961181,0.0618322060219452,0.0732733778772235,1.86168643747479e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHRL,Appetite-regulating hormone,29478,0.130231240804014,0.00562877431225049,0.119198843152003,0.141263638456025,2.20638760963272e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELOA,Elongin-A,29349,0.0840669417848587,0.00364240897393822,0.0769278201959398,0.0912060633737776,8.0855236392388e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAX,Protein max,28774,0.169160521468778,0.00733580610947899,0.154782341494199,0.183538701443357,1.34905710452486e-116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS1,Galectin-1,29478,0.0550218490691609,0.00238824227613434,0.0503408942079376,0.0597028039303843,2.04752714560787e-116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",28916,0.148826446909094,0.00647779708918162,0.136129964614298,0.16152292920389,9.07884443087376e-116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMPR2,GMP reductase 2,24381,0.107756091673232,0.00468817982388842,0.0985672592184108,0.116944924128053,1.12923636469058e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUS,RNA-binding protein FUS,28765,0.0633168551358066,0.00275784299351709,0.0579114828685131,0.0687222274031001,1.32021908257789e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA2,Apolipoprotein A-II,24951,-0.0774647055956307,0.00337358552591575,-0.0840769332264255,-0.0708524779648358,1.75928198366742e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.108344557687469,0.00472758169334481,0.0990784975685136,0.117610617806425,3.11442184674283e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMOX2,Heme oxygenase 2,28774,0.0745414685362618,0.00325633732198522,0.0681590473851708,0.0809238896873529,6.06536807845443e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RILPL2,RILP-like protein 2,24922,0.156436422967866,0.00682965864292667,0.143050292027729,0.169822553908002,6.31801207546343e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,29478,0.127240894694749,0.00556489090135034,0.116333708528102,0.138148080861396,1.0361669867882e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.137771813879112,0.00602817791922141,0.125956585157438,0.149587042600786,2.00501937967833e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD22,B-cell receptor CD22,29786,0.066545374389246,0.00291772105022383,0.0608266411308073,0.0722641076476847,3.69805844894811e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOK1,Docking protein 1,24845,0.217499758412078,0.00952895716681611,0.198823002365118,0.236176514459037,3.8619406170293e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.132321166315209,0.00580211355734294,0.120949023742817,0.143693308887601,3.92617843357479e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.14004102735208,0.00615551472992672,0.127976218481424,0.152105836222737,1.36686744214897e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,28797,0.145503482433372,0.00639952129558914,0.132960420694017,0.158046544172727,1.94667785085967e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA11,Annexin A11,29373,0.105726808303212,0.00465732228119299,0.0965984566320734,0.11485515997435,4.1114451679669e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK10,Kallikrein-10,29466,0.0632931155536405,0.00278998538029804,0.0578247442082564,0.0687614868990247,5.75692802943437e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C19orf12,Protein C19orf12,28774,0.101932131608465,0.00449792462219161,0.0931161993489699,0.110748063867961,1.03227856245452e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD99L2,CD99 antigen-like protein 2,29443,0.0382285266402886,0.00168927034999363,0.0349175567543011,0.0415394965262761,1.99499539024053e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBXN1,UBX domain-containing protein 1,24381,0.109024523163505,0.00481418049101033,0.0995887294011244,0.118460316925885,2.18302042010902e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESM1,Endothelial cell-specific molecule 1,29454,-0.0540503240632409,0.00238986135538159,-0.0587344523197889,-0.049366195806693,2.70429501736651e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICA1,Islet cell autoantigen 1,28931,0.1253606501329,0.00554959168963193,0.114483450421221,0.136237849844579,5.16943482864103e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMA,Granzyme A,29786,0.0544588778264128,0.0024176540696753,0.0497202758498492,0.0591974798029764,1.99656263948644e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL7,C-C motif chemokine 7,29434,0.0922095766363719,0.00409413765021229,0.0841850668419558,0.100234086430788,2.19664663653862e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.111179620926072,0.00494331704498427,0.101490719517903,0.120868522334241,4.37879806380775e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA4D,Semaphorin-4D,29694,0.0470068278823778,0.00209021482146883,0.0429100068322989,0.0511036489324567,4.51571290787636e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.108352179039135,0.00481533459205176,0.0989141232387133,0.117790234839556,5.53733604363782e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0888704757443958,0.00395519825061765,0.0811182871731852,0.0966226643156064,7.11315702257528e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.124202471249071,0.00552461237347142,0.113374230997067,0.135030711501074,7.99890796663215e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.105383108673928,0.00469465830768808,0.0961815783908593,0.114584638956997,1.78828192003853e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.163214253869235,0.00727959346887305,0.148946250670244,0.177482257068226,2.07983379685917e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YJU2,Splicing factor YJU2,24793,0.0508251021395354,0.00226622442549914,0.046383302265557,0.0552669020135137,2.67727198674042e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.0935428101238905,0.00417525248381217,0.0853593152556186,0.101726304992162,3.11806535258491e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBKS,Ribokinase,28795,0.0776778614776767,0.00347191205128244,0.0708729138571631,0.0844828090981903,6.22342010990237e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.0691284688808507,0.00309435471652665,0.0630635336364585,0.0751934041252429,1.8252684969082e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,29218,0.123476739130073,0.00553513140026739,0.112627881585549,0.134325596674597,2.54504400037885e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C3,Complement C3,23779,0.072482350284254,0.0032482290606446,0.0661158213253906,0.0788488792431174,3.54229342187131e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SULT2A1,Bile salt sulfotransferase,29434,0.0869932924795912,0.00390729668952556,0.0793349909681211,0.0946515939910613,6.51618213295423e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPP,Lipoma-preferred partner,24111,0.103370299829286,0.00464582616778057,0.0942644805404365,0.112476119118136,1.39546698128857e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.112266945806007,0.00504753680203708,0.102373773674014,0.122160117938,1.65545772448417e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP2B1,AP-2 complex subunit beta,24195,0.0756614950251799,0.00340470008685196,0.0689882828549501,0.0823347071954098,2.5210591233559e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD207,C-type lectin domain family 4 member K,28835,0.0598579562008657,0.00269717288421784,0.0545714973477988,0.0651444150539327,3.25198417618832e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53,Cellular tumor antigen p53,28797,0.0676592407910584,0.00304889206617378,0.0616834123413578,0.073635069240759,3.36458932266209e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL3,C-C motif chemokine 3,29434,0.09360262750475,0.00422170708991763,0.0853280816085115,0.101877173400989,4.94579724657853e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDC,Nuclear migration protein nudC,29786,0.097832810556728,0.00441751337195553,0.0891744843476951,0.106491136765761,8.36853065829456e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLG4,Disks large homolog 4,24845,0.109749384938649,0.00495257211366515,0.100042343595865,0.119456426281432,9.25060460988755e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCAM,Cell surface glycoprotein MUC18,29594,-0.0513461739983575,0.0023202341286909,-0.0558938328905917,-0.0467985151061233,1.22418299320325e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.121011840040554,0.00546913228086401,0.11029234077006,0.131731339311047,1.35279745821255e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN3,Ataxin-3,24845,0.095440865214202,0.00431119826073316,0.086990916623165,0.103890813805239,1.49906570485373e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM17,Splicing factor 45,24867,0.11817239329309,0.00533839857731272,0.107709132081557,0.128635654504623,1.54882285989989e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADD1,Alpha-adducin,24381,0.107975192406017,0.00488850999347437,0.0983937128188072,0.117556671993227,4.68137682174172e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH9,Protocadherin-9,24805,0.0522098401430671,0.00236423636744742,0.0475759368628701,0.056843743423264,4.94150480368579e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CETN3,Centrin-3,24805,0.119460793431818,0.00541495653619332,0.108847478620879,0.130074108242757,7.9475473139151e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRY2,Protein sprouty homolog 2,28931,0.142016862944268,0.00644704107533763,0.129380662436606,0.15465306345193,1.16650675307178e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN2L,Ataxin-2-like protein,24867,0.0740362164747466,0.00336027792212772,0.0674500717473763,0.080622361202117,1.46519589378592e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRADD,Death domain-containing protein CRADD,29163,0.116287441174407,0.00528788323334303,0.105923190037054,0.126651692311759,2.55762760585794e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPACT,Protein IMPACT,24845,0.0855582565943423,0.00388906660761023,0.0779356860434263,0.0931808271452584,3.00353721847327e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.117051098631761,0.00532693417609546,0.106610307646614,0.127491889616908,3.86124473479571e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APPL2,DCC-interacting protein 13-beta,24381,0.171911302878146,0.00782895808492786,0.156566545031687,0.187256060724604,7.65735749093047e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.0592004183765089,0.00270055894872902,0.053907322837,0.0644935139160178,1.12620479530694e-105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F11,Coagulation factor XI,24606,0.0474966752617559,0.00216545586636939,0.0432523817636719,0.0517409687598399,1.27390366082661e-105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.12520982757661,0.00571774524456701,-0.136416608255962,-0.114003046897259,1.8597010548253e-105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,24381,0.191843047163087,0.00877107733266363,0.174651735591066,0.209034358735108,4.8966348524085e-105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.119493684092131,0.00548030836510142,0.108752279696532,0.13023508848773,1.48915947355427e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRAP2,GRB2-related adapter protein 2,29478,0.194355470752131,0.00891638960403776,0.176879347128217,0.211831594376045,1.64156403232745e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0881110341320976,0.00403987858115864,0.0801928721130267,0.0960291961511685,1.87637480067324e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0478287647862988,0.00219441798574159,0.0435277055342453,0.0521298240383523,2.42801445815018e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MGLL,Monoglyceride lipase,29536,0.131717358777594,0.00605059311159288,0.119858196278872,0.143576521276317,2.998991094531e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.121330206217626,0.0055744209594965,0.110404341137013,0.132256071298239,4.9055340046124e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL4,C-C motif chemokine 4,29498,0.0988898931895187,0.00455425402508408,0.0899635553003539,0.107816231078684,9.90172806146521e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.0926662210022137,0.00427042283963666,0.0842961922365258,0.101036249767902,1.33625917472479e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.0803324291304724,0.00370011144152881,0.0730802107050759,0.0875846475558689,1.49597339069303e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEXN,Nexilin,24951,0.104383295596033,0.00481006263311807,0.0949555728351216,0.113811018356944,1.82006036827795e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18,Interleukin-18,29335,0.069580489965526,0.00320977597946087,0.0632893290457827,0.0758716508852693,2.16432992802281e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.145219722451689,0.00670282972139053,0.132082176197764,0.158357268705615,2.79431504519608e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0726602860838891,0.00335653380630093,0.0660814798235393,0.0792390923442389,5.74906208961148e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLG,Plasminogen,24421,0.0334943139736666,0.00154791386761536,0.0304604027931405,0.0365282251541927,7.25251617786133e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMOT,Angiomotin,24381,0.0609109412328972,0.00281552340002056,0.0553925153688569,0.0664293670969375,7.99132539840476e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,29725,0.0556787019417091,0.00257838670035274,0.0506250640090177,0.0607323398744005,1.24975801662367e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0533863092099525,0.00247362532971385,0.0485380035637134,0.0582346148561917,1.65169157079962e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.084886399719185,0.00393666419068183,0.0771705379054487,0.0926022615329214,2.49361988708836e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.116107905391249,0.00538492085597324,0.105553460513542,0.126662350268957,2.55169633064158e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0616033147625604,0.00285889257823501,0.0559998853092198,0.067206744215901,3.48173019911412e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.0858298123443695,0.00398102089521614,0.0780270113897459,0.0936326132989932,3.72772243343115e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIFBP,KIF-binding protein,29349,0.123824910532566,0.00574870008029475,0.112557458375189,0.135092362689944,4.10028243297757e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSNL1,Visinin-like protein 1,24845,0.0574686217603509,0.00266735259745488,0.0522406106693393,0.0626966328513625,5.05301634226344e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESYT2,Extended synaptotagmin-2,24845,0.123660184861626,0.00574720885677735,0.112395655502342,0.134924714220909,9.26613447800826e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.0433011626879201,0.00201342955144064,0.0393548407670965,0.0472474846087438,1.20186661621001e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUB1,NEDD8 ultimate buster 1,29434,0.125549087935513,0.00584417448364673,0.114094505947566,0.137003669923461,1.36350780678103e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXJ3,Forkhead box protein J3,24229,0.0666109941566962,0.00309937245990434,0.0605362241352837,0.0726857641781087,1.65185162173382e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOC1,Apolipoprotein C-I,24914,0.0562093013496643,0.00261611508196806,0.0510817157890069,0.0613368869103217,1.76634311802847e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.0873863742231772,0.00407168389168693,0.0794058737954709,0.0953668746508836,2.21164739472719e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.045695490466514,0.00213215373416612,0.0415164691475484,0.0498745117854796,4.01303410257888e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.0741362969023644,0.00345837168639183,0.0673578883970364,0.0809147054076924,5.17636152385576e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.127783783468448,0.00596099867660141,0.116100226062309,0.139467340874587,5.21881207049741e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,24396,0.0973327590390766,0.00454140742183519,0.0884316004922796,0.106233917585874,5.71268523193058e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRAS,Ras-related protein R-Ras,24195,0.195733666810715,0.00913526039756504,0.177828556431488,0.213638777189943,6.61421859023269e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.0807238343096031,0.00377521326377941,0.0733244163125954,0.0881232523066107,1.14039002051748e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RFC4,Replication factor C subunit 4,24793,0.03177356136678,0.00148580751811515,0.0288613786312743,0.0346857441022857,1.50447426942346e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD226,CD226 antigen,24229,0.0629124682397772,0.00294513832601544,0.0571399971207869,0.0686849393587674,2.57349925664128e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS2,Trypsin-2,29594,0.079708699089438,0.00373515655573632,0.0723877922401948,0.0870296059386811,2.75154211586086e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.146412422386248,0.00686180095853814,0.132963292507513,0.159861552264983,3.06172540691465e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD69,Early activation antigen CD69,29344,0.13018315723691,0.00612114849442107,0.118185706187845,0.142180608285975,1.27837448025138e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2,Microtubule-associated protein 2,24845,0.0686849845659895,0.00322959591157175,0.0623549765793089,0.0750149925526701,1.75847303501397e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.14498212872574,0.00681880272904856,0.131617275376805,0.158346982074675,1.96282025953885e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UROD,Uroporphyrinogen decarboxylase,24381,0.102769531352504,0.00483566469858609,0.0932916285432751,0.112247434161733,2.49841038341168e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.0831390334364192,0.00392633999189324,0.0754434070523084,0.0908346598205299,9.04751057085975e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FMNL1,Formin-like protein 1,28774,0.090700910409669,0.00428875743051177,0.082294945845866,0.0991068749734721,1.60382664214802e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YWHAQ,14-3-3 protein theta,24381,0.10924513538205,0.00516527233842857,0.09912120159873,0.11936906916537,2.11954317885166e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,29349,0.0480599754160483,0.00227460068325145,0.0436017580768755,0.0525181927552212,2.33251501637541e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSZ,Cathepsin Z,29487,0.0465602928784982,0.0022046547426589,0.0422391695828867,0.0508814161741096,2.84427391291555e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF19,Fibroblast growth factor 19,29581,0.113470521311741,0.00537945119660248,0.1029267969664,0.124014245657082,4.83960351148801e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.0620255718775038,0.00293976834910532,0.0562636259132574,0.0677875178417502,5.93646497885843e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED8,Protein TMED8,24805,0.151558849390778,0.00718634969083363,0.137473603996744,0.165644094784812,7.14560947594403e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATOX1,Copper transport protein ATOX1,29566,0.104915673991649,0.00498532212228372,0.0951444426319731,0.114686905351325,1.32612392262728e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CETN2,Centrin-2,28774,0.0991721315871532,0.00471732024403742,0.0899261839088398,0.108418079265467,2.18720423382561e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.0978016969658451,0.00464904926658386,0.0886895604033408,0.106913833528349,2.20245593906155e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK24,Serine/threonine-protein kinase 24,28774,0.090872213813864,0.00432366705576922,0.0823978263845563,0.0993466012431716,2.45601124972749e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.0441745548826113,0.00210192842228176,0.040054775174939,0.0482943345902835,2.46629217436716e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.124597593793629,0.00593096022399802,0.112972911754593,0.136222275832665,2.98057936556113e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGF,Pro-epidermal growth factor,29379,0.151333325580462,0.00720705100233734,0.137207505615881,0.165459145545044,3.55154300533922e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,23906,0.0784175654812814,0.00373201810330564,0.0711028099988024,0.0857323209637605,3.84717759380642e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.13702297069364,0.00652714746191885,0.124229761668279,0.149816179719001,5.31074683249358e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,29786,0.0986289512203046,0.00470204303652475,0.0894129468687161,0.107844955571893,5.50148189256204e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.124930685819274,0.00595851398484045,0.113251998408986,0.136609373229561,9.09297303740856e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17RB,Interleukin-17 receptor B,29034,-0.0785971659066115,0.00375124267328587,-0.0859496015462518,-0.0712447302669712,9.32003656698477e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.0751010438091727,0.00358610237567217,0.0680722831528552,0.0821298044654901,1.51633703076419e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F12,Coagulation factor XII,24966,0.0607762846977091,0.00290480258531765,0.0550828716304865,0.0664696977649316,2.23966206795692e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PF4,Platelet factor 4,24822,0.142173972232966,0.00679595475008273,0.128853900922803,0.155494043543128,2.37457269050341e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2,Complement C2,29545,0.0340642068963263,0.00163058659498473,0.0308682571701562,0.0372601566224963,3.23079931658132e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0835486437433976,0.00399907247007417,0.0757104617020523,0.091386825784743,3.28210036880419e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.0694704166730039,0.00332434505095653,0.0629547003731291,0.0759861329728787,3.77725080477671e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.111776472788149,0.00535412309608935,0.101282391519814,0.122270554056484,6.10370688064864e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EHD3,EH domain-containing protein 3,24240,0.171122981505479,0.00821038290513789,0.155030631011409,0.187215331999549,1.23828993052081e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPARC,SPARC,29566,0.102274042988757,0.0049116110833413,0.0926472852654076,0.111900800712105,1.30598335131253e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,24805,0.0850429811209864,0.00408220761464391,0.0770418541962843,0.0930441080456885,1.44579508339507e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD244,Natural killer cell receptor 2B4,29786,0.0393375466860278,0.00188979994288428,0.0356335387979746,0.043041554574081,1.4967350986121e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.0792994510908933,0.00382163857565608,0.0718090394826073,0.0867898626991792,6.02335152162046e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6AP2,Renin receptor,28797,0.0588116127635568,0.00283650198630236,0.0532520688704042,0.0643711566567094,8.46701975351944e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FIS1,Mitochondrial fission 1 protein,29453,0.111553466884393,0.00538310187046684,0.101002587218278,0.122104346550508,1.02294204900995e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP5,Microfibrillar-associated protein 5,29820,0.0591046430570192,0.00285242818976921,0.0535138838050715,0.0646954023089669,1.04735379171038e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0920124303140427,0.00443854195940844,0.0833128880736021,0.100711972554483,1.21117206376405e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0890628901106772,0.00429734864035645,0.0806400867755786,0.0974856934457758,1.36282758462374e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKD2,Polycystin-2,24111,0.0855158366942422,0.00412781794466831,0.0774253135226923,0.0936063598657921,1.62457861004254e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,24951,0.105066042499627,0.00507306843986514,0.095122828357491,0.115009256641762,1.73820469006461e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPON2,Spondin-2,29311,-0.0503623458438128,0.00243444633733123,-0.055133860664982,-0.0455908310226436,2.1305549840906e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,29820,0.10370427309073,0.00501372645443894,0.0938773692400298,0.11353117694143,2.22101426836905e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNM3,Dynamin-3,24867,0.0793962487727977,0.00383619596589853,0.0718773046796365,0.0869151928659588,2.32421911848767e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.0826281025501812,0.00400419681782218,0.0747798767872498,0.0904763283131127,6.11853741709961e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINE2,Glia-derived nexin,24922,0.0929297417822578,0.00450216116677927,0.0841055058953704,0.101753977669145,7.16457719748598e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.0659951042408543,0.003202582464292,-0.0722721658708666,-0.0597180426108419,1.08043822604319e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCB,Tubulin-folding cofactor B,29218,0.144724574076898,0.0070229913439081,0.130959511042839,0.158489637110958,1.09781006445546e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP10,Caspase-10,28774,0.102930541075604,0.00499603311465198,0.093138316170886,0.112722765980322,1.23927058899146e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP7,Caspase-7,24845,0.121035782021487,0.00587220836914138,0.10952625361797,0.132545310425004,1.31254973034879e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.149906893445183,0.00728169299103733,0.13563477518275,0.164179011707616,2.24669922770226e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.0771142129543039,0.00374636123576445,0.0697713449322055,0.0844570809764022,2.39032258040845e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTF1,Cardiotrophin-1,28916,0.121333320358487,0.00590086172203997,0.109767631383288,0.132899009333685,2.80149159914613e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGL1,Fibrinogen-like protein 1,24951,-0.0917020180467687,0.00445959556231755,-0.100442825348911,-0.0829612107446263,3.50448798736005e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0558700111247094,0.00271812253029374,0.0505424909653336,0.0611975312840851,4.31360544372093e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",24867,0.0898405957932059,0.00437121959842339,0.0812730053802961,0.0984081862061157,4.32619666727574e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.0885554203015484,0.00431234518759054,0.0801032237338709,0.0970076168692259,6.13277926402453e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,24793,0.0791274866737177,0.00385407646829876,0.0715734967958522,0.0866814765515833,6.77526169207979e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,24381,0.170652892366705,0.00831481618134316,0.154355852651272,0.186949932082137,8.02584929213062e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACYBP,Calcyclin-binding protein,24329,0.147707350506654,0.00719716008982429,0.133600916730598,0.161813784282709,8.21249239793119e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.105318981412136,0.00513521352997946,0.0952539628933765,0.115383999930896,1.09334593771419e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0516045824297872,0.00252044249237238,0.0466645151447373,0.056544649714837,1.60608439181106e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK13,Kallikrein-13,28845,0.0630682716952574,0.00308173059717261,0.057028079724799,0.0691084636657157,1.9980301860417e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.093493634239587,0.00457021593527983,0.0845360110064385,0.102451257472735,2.25273098078196e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.105513304461081,0.00516375626282899,0.0953923421859358,0.115634266736225,3.8106499179023e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSC22D1,TSC22 domain family protein 1,24867,0.0952488344256278,0.00465928865075694,0.0861166286701442,0.104381040181111,3.9907612544654e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.14189395479572,0.00694243974137026,0.128286772902635,0.155501136688806,4.58388080731115e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOD,Apolipoprotein D,23787,-0.0622265599629509,0.00304636119762278,-0.0681974279102916,-0.0562556920156103,5.9880296395721e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.0629073250506675,0.00308020022714244,0.0568701326054683,0.0689445174958667,6.11514585427993e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPBP,Platelet basic protein,24816,0.120763411053686,0.0059134981071126,0.109172954763745,0.132353867343627,6.12970685720068e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPI,Mannose-6-phosphate isomerase,29349,0.121867532540037,0.00597265800613057,0.110161122848021,0.133573942232053,6.67152150016605e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.0655690505066489,0.00321263878795572,0.0592722784822557,0.0718658225310421,8.11921635180616e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD72,B-cell differentiation antigen CD72,24381,0.0610667060377666,0.00299575890992993,0.0551950185743039,0.0669383935012292,1.33736610871126e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.0501296509984256,0.00246328481887552,0.0453016127534295,0.0549576892434216,2.55365820679265e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.0959282021976043,0.004718996705563,0.0866789686547008,0.105177435740508,3.07039116290595e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TADA3,Transcriptional adapter 3,24793,0.0562829882042401,0.00276745605521486,0.0508587743360189,0.0617072020724612,3.33352751328111e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPB1,Carboxypeptidase B,29820,0.0837809784708335,0.00412420278358932,0.0756975410149985,0.0918644159266686,3.97165931212029e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMVK,Phosphomevalonate kinase,28757,0.155745880857996,0.00766898909982513,0.140714662222339,0.170777099493653,4.71372790675873e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNMT,Histamine N-methyltransferase,29082,0.066817226768877,0.003292202588799,0.060364509694831,0.073269943842923,6.01100046176712e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL8,C-C motif chemokine 8,29683,0.0857409743638658,0.00422620926173486,0.0774576042108654,0.0940243445168661,6.81150042111514e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL18,C-C motif chemokine 18,29166,0.0996000448454693,0.00491012694944967,0.0899761960245479,0.109223893666391,7.46120538860868e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,28797,0.084904182260016,0.0041912974929346,0.0766892391738642,0.0931191253461678,1.31476586659904e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.0661957249667156,0.00326851143286365,0.0597894425583028,0.0726020073751283,1.38275762374547e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.122140774594047,0.00604024542964053,0.110301893551951,0.133979655636142,2.73408306285484e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.0622731837430095,0.00308021549488582,0.0562359613730333,0.0683104061129857,2.87245169549805e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,24195,0.113271302368427,0.00560860021437694,0.102278445948249,0.124264158788606,5.86464355948631e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMT,Catechol O-methyltransferase,28591,0.118770070785922,0.00588799486583456,0.107229600848886,0.130310540722958,7.35933023194632e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.0964545746445731,0.00478179225841859,0.0870822618180727,0.105826887471074,9.65959481330127e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BIN2,Bridging integrator 2,29443,0.12673318626232,0.00628928704059208,0.11440618366276,0.139060188861881,1.07151750389544e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPI,Glucose-6-phosphate isomerase,24951,0.0665814193992143,0.00330431488427057,0.060104962226044,0.0730578765723846,1.39597147620896e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRG1,Scrapie-responsive protein 1,24922,0.0387309838743651,0.0019240282603607,0.0349598884840581,0.0425020792646721,2.06802810474026e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",29395,0.153831628285964,0.0076473728365254,0.138842777526374,0.168820479045554,2.15683267312215e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.157285795416715,0.0078214871769945,0.141955680549806,0.172615910283624,2.51173318598233e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDT,D-dopachrome decarboxylase,24938,0.0574444288939228,0.00285588050789778,0.0518469030984431,0.0630419546894024,2.82218168495358e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OCLN,Occludin,24867,0.0617139767223709,0.00307107246823362,0.055694674684633,0.0677332787601087,4.14784572744201e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THTPA,Thiamine-triphosphatase,24755,0.123728161107059,0.00616520625260696,0.111644356851949,0.135811965362169,7.05897495172914e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX8,Syntaxin-8,29434,0.0677318361315348,0.00337850109703873,0.0611099739813389,0.0743536982817307,8.2624713830114e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB6,Serpin B6,29623,0.0828847403408125,0.00413619189450941,0.074777804227574,0.0909916764540509,9.79014227855097e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.0456575061909762,0.00228046763436084,0.0411877896276289,0.0501272227543234,1.38548699396238e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIAPIN1,Anamorsin,29566,0.0876462136570261,0.00437837252090613,0.07906460351605,0.0962278237980021,1.48532368349725e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.0661700324820492,0.00330652791867525,0.0596892377614457,0.0726508272026527,2.15592246408282e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX4,Syntaxin-4,29349,0.0828362371247833,0.00414485457925213,0.0747123221494492,0.0909601521001175,2.86290907159942e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.123751166043409,0.00619131993441043,0.111616178971964,0.135886153114853,3.45584504003175e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPT1,Angiopoietin-1,29322,0.117255108526195,0.0058796043083238,0.10573108408188,0.128779132970509,6.6514733753629e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.132198736134105,0.00663269154945789,0.119198660697167,0.145198811571042,8.25768571520857e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.102628359672904,0.00514775950228046,0.0925387510484348,0.112717968297374,9.79365584438141e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LACTB2,Endoribonuclease LACTB2,29478,0.0916609871760758,0.00460688459385178,0.0826314933721263,0.100690480980025,1.64019982944682e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPSE,Heparanase,24688,0.130770793984048,0.00657017697545424,0.117893247112158,0.143648340855938,1.8375810295298e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL7,Interleukin-7,29434,0.0895548159361332,0.00450323903019081,0.0807284674369592,0.0983811644353072,1.99167200330944e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RILP,Rab-interacting lysosomal protein,29632,0.0825887001914813,0.00415448174007145,0.0744459159809413,0.0907314844020214,2.28061407515032e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA1,Carboxypeptidase A1,29820,0.0844392669991504,0.0042490550750639,0.0761111190520252,0.0927674149462757,2.59282692403127e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MIF,Macrophage migration inhibitory factor,29386,0.0944126432773404,0.0047536062249692,0.0850955750764008,0.10372971147828,3.29439398249157e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.0528444431614219,0.00266119659998678,0.0476284978254478,0.058060388497396,3.56035307661914e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.0798903386303865,0.00402395962356651,0.0720033777681962,0.0877772994925769,3.85398163553987e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.0667095550405384,0.00335987732887014,0.0601241954759529,0.0732949146051238,4.93803288433459e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JAM3,Junctional adhesion molecule C,24381,0.0703440829712212,0.00354513465229317,0.0633956190527266,0.0772925468897158,6.22943854019957e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.138497883043559,0.00698604610474072,0.124805232678268,0.152190533408851,6.70855300459737e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.154798759349145,0.00781192614511451,0.139487384104721,0.170110134593569,7.99146271950325e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARA5,Scavenger receptor class A member 5,29694,0.0416741183527327,0.00210386369004983,0.037550545520235,0.0457976911852304,9.17676913921443e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFB2,BPI fold-containing family B member 2,24852,0.0899206245973135,0.00454019735869662,0.0810218377742682,0.0988194114203589,1.2468503490652e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL32,Interleukin-32,29434,-0.0602450634847295,0.00304571378900409,-0.0662146625111776,-0.0542754644582815,1.60904717113465e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.064597825141631,0.00326449432139465,0.0581994162716975,0.0709962340115645,1.75384948496697e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0784182204877236,0.00396646010386075,0.0706439586841566,0.0861924822912907,1.93297117924177e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,29354,0.12323805263023,0.00623395080097049,0.111019509060328,0.135456596200132,2.01912896709948e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARK7,Parkinson disease protein 7,29443,0.0720976585755662,0.00364944478038868,0.0649447468060044,0.079250570345128,2.59664875027402e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG6,Large proline-rich protein BAG6,28916,0.0502463024329004,0.00254479586086959,0.045258502545596,0.0552341023202048,3.29894806766408e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.105221754189521,0.00533306211667865,0.0947689524408305,0.115674555938211,4.27324705350425e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPB1,Heat shock protein beta-1,29039,0.0948076170112742,0.00480631786920068,0.0853872339876409,0.104228000034908,4.76402501558183e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP2,Caspase-2,29434,0.0935178744944214,0.00474434368972909,0.0842189608625524,0.10281678812629,6.17446418296571e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,24904,0.0660712072832773,0.0033542990472154,0.0594967811507351,0.0726456334158194,1.02012417908616e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTNB,Dystrobrevin beta,24752,0.0599003235495109,0.00304098922021361,0.0539399846778922,0.0658606624211295,1.02603253163067e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOM,Apolipoprotein M,29545,0.0381367891960276,0.00193804218224776,0.034338226518822,0.0419353518732332,1.17934679458859e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,28797,0.0622518174695918,0.00316869613905594,0.0560411730370422,0.0684624619021415,2.27574534566791e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.088301159951231,0.00449249527245692,0.0794958692172155,0.0971064506852466,2.32975875527894e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.124705573820554,0.00634742793342295,0.112264615071045,0.137146532570063,2.85289772619934e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.052113595034517,0.00265532026759929,0.0469091673100224,0.0573180227590116,4.10319675571144e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MESD,LRP chaperone MESD,29443,0.166205894569859,0.00848149317201785,0.149582167952704,0.182829621187014,5.79459240036482e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.085794799104959,0.00437924676984174,0.0772114754360692,0.0943781227738488,6.31966707539192e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.12554333104222,0.00641232490793855,0.11297517422266,0.138111487861779,8.19489073498879e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,24805,0.113965048287865,0.00582168952481615,0.102554536819226,0.125375559756505,1.08247216940625e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0913506901684213,0.0046661722266974,0.0822049926040944,0.100496387732748,1.10128981165953e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CERT,Ceramide transfer protein,28774,0.0840109740243134,0.00429479251380587,0.0755931806972539,0.0924287673513729,1.17883947083987e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.0547263481768433,0.00280249710523481,0.0492334538505831,0.0602192425031035,2.73908679132136e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM106A,Transmembrane protein 106A,24793,0.0966143364103244,0.00494848386543244,0.0869153080340768,0.106313364786572,2.95067393499341e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REEP4,Receptor expression-enhancing protein 4,24867,0.0848670208738573,0.00434875090374563,0.0763434691025158,0.0933905726451987,3.47870921226687e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA4,Protein disulfide-isomerase A4,24938,0.0829457220441447,0.00425204713928043,0.074611709651155,0.0912797344371343,4.0434023912733e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.12228499111338,0.00626935299797937,0.109997059237341,0.13457292298942,4.20957680906608e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.125636871395289,0.00644292262710258,0.113008743046168,0.13826499974441,4.84587746997296e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM2,Paralemmin-2,24845,0.0516201873194443,0.00265014312863401,0.0464259067873217,0.056814467851567,7.10141467373857e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIP,Gastric inhibitory polypeptide,24240,0.0697082519266767,0.00358070311418875,0.0626900738228667,0.0767264300304866,9.00653693455545e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.100202677295493,0.00514838662192123,0.0901118395165275,0.110293515074459,9.49512200073612e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D5,TBC1 domain family member 5,29434,0.106082826888948,0.00546055802659454,0.0953801331568226,0.116785520621073,1.52166503946246e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYO9B,Unconventional myosin-IXb,28931,0.0894826661018531,0.00462036117243229,0.0804267582038858,0.0985385739998204,4.92325245642467e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MENT,Protein MENT,24381,-0.0307221764999017,0.00158761307906405,-0.0338338981348673,-0.0276104548649362,8.34061227870006e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0783796448393756,0.00405404117759346,0.0704337241312924,0.0863255655474588,9.37226213691781e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.127187718602997,0.00657951199233203,0.114291875098027,0.140083562107968,9.67365653052187e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL16,C-X-C motif chemokine 16,29786,0.0318265372112529,0.00164726228414885,0.0285979031343211,0.0350551712881846,1.15147345386621e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.0849595783880921,0.00440122758249505,0.0763331723264018,0.0935859844497824,1.60817633796667e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.0816295539663981,0.0042265328910307,0.073345549499978,0.0899135584328183,1.70902814544565e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.138100688600212,0.00715639338423352,0.124074157567114,0.152127219633309,2.3407834193323e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L1,Bcl-2-like protein 1,24845,0.134468116445387,0.00697194682684699,0.120803100664766,0.148133132226007,2.76281618445598e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB33A,Ras-related protein Rab-33A,24111,0.0897628702167537,0.00465391864762438,0.08064118966741,0.0988845507660975,2.85004220232902e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB9,Serpin B9,29218,0.0447332316767678,0.00232179099049867,0.0401825213353904,0.0492839420181451,3.31483118843326e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATG4A,Cysteine protease ATG4A,28797,0.0793573283194269,0.00411918559148646,0.0712837245601134,0.0874309320787404,3.46284290892831e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXO3,Forkhead box protein O3,28797,0.129906161120432,0.00674617016404209,0.116683667598909,0.143128654641954,4.11209885823727e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.0707023057973925,0.00366992199321168,0.0635092586906976,0.0778953529040873,4.32285750520034e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUGT1,Protein SGT1 homolog,28797,0.108585179452829,0.00564209310813489,0.0975266769608847,0.119643681944773,5.04547266488549e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STXBP1,Syntaxin-binding protein 1,24867,0.104389076130611,0.00542713851514109,0.0937518846409342,0.115026267620287,7.47659575424735e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.12681801091348,0.00660636126068813,0.113869542842531,0.139766478984429,1.55311702567091e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCG2,Secretogranin-2,29559,0.0437372304128077,0.00228104653853963,0.03926637919727,0.0482080816283453,1.90212295292762e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSTN,Growth/differentiation factor 8,28916,0.0703288048784562,0.0036801558228739,0.0631156994656233,0.077541910291289,6.55075723714712e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMPER,BMP-binding endothelial regulator protein,24381,0.0304921827856662,0.00159936960099066,0.0273574183677245,0.0336269472036079,1.89736067851277e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.0899038207408242,0.0047231083959817,0.0806465282847,0.0991611131969483,2.7336155860237e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.0416440316365964,0.00218815862032899,-0.0459328225324412,-0.0373552407407516,2.82775678766117e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.086148915469736,0.00452402993795237,0.0772818167913494,0.0950160141481227,2.83868971218869e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERMAP,Erythroid membrane-associated protein,24229,0.0595621003690707,0.00312891626061582,0.0534294244982637,0.0656947762398777,3.30923695137946e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WDR46,WD repeat-containing protein 46,24793,0.0480032185934717,0.00252206523946078,0.0430599707241285,0.0529464664628148,3.37849230148007e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MICALL2,MICAL-like protein 2,24195,0.0910740775367534,0.00478668032885286,0.0816921840922018,0.100455970981305,3.96031252103795e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMG3,Proteasome assembly chaperone 3,29434,0.0669631435515091,0.00352447273304917,0.0600551769947328,0.0738711101082855,5.19748385710475e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.0708091192444417,0.00372796735412779,0.0635023032303512,0.0781159352585322,7.04734537005806e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.143178824397605,0.00754599736708283,0.128388669558123,0.157968979237087,1.02626745592591e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.129133036713317,0.00680641150784606,0.115792470157939,0.142473603268695,1.09479664235395e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMFG,Glia maturation factor gamma,24922,0.0951837838070913,0.00502347370655935,0.085337775342235,0.105029792271948,1.67018966623262e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,24805,0.116227355902573,0.00613595800054887,0.104200878221497,0.128253833583649,1.87289442109256e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.0864840337311944,0.00457290541918568,0.0775211391095905,0.0954469283527984,2.73745400333347e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFB,Complement factor B,24538,0.0435017960457614,0.00229977536567508,0.0389942363290382,0.0480093557624846,3.10836312902466e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F2R,Proteinase-activated receptor 1,29536,0.075729896913813,0.00400858081935978,0.0678730785078678,0.0835867153197582,3.89683599646251e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LARP1,La-related protein 1,24793,0.083114412502751,0.00439801891171462,0.0744942954357904,0.0917345295697117,4.25614806917025e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.124417081424916,0.00658770250467699,0.111505184515749,0.137328978334083,4.38485984978699e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.136685359635383,0.00723564891020114,0.122503487771389,0.150867231499378,4.90246594485002e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APP,Amyloid-beta precursor protein,29395,0.0878859114970539,0.00465514294081605,0.0787618313330544,0.0970099916610533,4.96117777263095e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.0487244359621307,0.00258545122999165,0.0436569515513471,0.0537919203729143,1.15830885842609e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.0645030408048389,0.0034238938717122,0.057792208816283,0.0712138727933948,1.31867904337093e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.0400205933859908,0.00212609650864409,0.0358534442290483,0.0441877425429332,1.71974601171772e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEMIP2,Cell surface hyaluronidase,24229,0.0436397220997968,0.00232033810509206,0.0390918594138164,0.0481875847857773,2.37405886185642e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP3R1,Calcineurin subunit B type 1,29218,0.0537888104647808,0.00286447780484945,0.0481744339672759,0.0594031869622857,3.31307651603098e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.114702932135675,0.00611175984158498,0.102723882846169,0.126681981425182,4.94194371306165e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC3B,Tetranectin,24381,0.0281406342805966,0.00149965031992339,0.0252013196535468,0.0310799489076464,5.20360385647345e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASSF2,Ras association domain-containing protein 2,28797,0.0733442307350947,0.00391107959509088,0.0656785147287166,0.0810099467414728,5.34908265820186e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BGLAP,Osteocalcin,24938,0.116339881236312,0.00620560680046293,0.104176891907405,0.128502870565219,6.96792071723841e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBI,Acyl-CoA-binding protein,29329,0.102730808953049,0.00548391137075365,0.0919823426663718,0.113479275239726,7.5804879011525e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.043582790729928,0.00232663186167772,0.0390225922810397,0.0481429891788164,7.71539706797723e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL2,C-C motif chemokine 2,29169,0.0687532461273267,0.00367223295715598,0.061555669531301,0.0759508227233524,9.29225870917692e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLMH,Bleomycin hydrolase,29820,0.0415455701266925,0.00222473994818533,0.0371850798282492,0.0459060604251357,2.21570629993531e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIF1,Allograft inflammatory factor 1,28797,0.0685938692412134,0.00367333121502306,0.0613941400597682,0.0757935984226586,2.33399126014578e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCA,Calcitonin,29163,0.0811517050587915,0.0043483863401342,0.0726288678321285,0.0896745422854545,2.82294306257664e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,24240,0.0738687982045204,0.00395670101526084,0.0661136642146092,0.0816239321944316,3.06855446213581e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP3,Caspase-3,29820,0.114609142354546,0.00615211765836455,0.102550991744152,0.126667292964941,5.10390738798256e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.14079555292142,0.00756298588501642,0.125972100586788,0.155619005256052,8.39858207816152e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSS,Cathepsin S,23389,0.0318988372514021,0.00171356433099403,0.0285402511626538,0.0352574233401505,8.64815038705501e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.127655611402656,0.00686478520562485,0.114200632399631,0.141110590405681,1.15095629962635e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTD,Deoxycytidylate deaminase,24381,0.123571286224394,0.00665052500519082,0.11053625721422,0.136606315234568,1.55782984819219e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.044930228078889,0.00242678850115831,0.0401737226166187,0.0496867335411593,4.25432933329294e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYBB1,Beta-crystallin B1,24922,0.0847218649334748,0.00457414971038816,0.0757565315011141,0.0936871983658356,4.46424951765985e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,24769,0.113418860260596,0.00612615863138617,0.101411589343079,0.125426131178113,5.20813097443172e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.0414241198501712,0.00224110610337819,0.03703155188755,0.0458166878127925,7.49562693054626e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD164,Sialomucin core protein 24,29443,0.0346403258430025,0.00187429264783664,0.0309667122532427,0.0383139394327623,7.78030913410828e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.0791520495339843,0.00428137520492371,0.0707605541323338,0.0875435449356347,8.66951414825809e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.163663738950589,0.00885518654736319,0.146307573317758,0.181019904583421,9.24586867628716e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.103653629582279,0.00560939451700065,0.0926592163289579,0.1146480428356,1.01937400317713e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRB1,Chymotrypsinogen B,29443,0.0718775285079486,0.00389488544697104,0.0642435530318854,0.0795115039840118,1.28670563162108e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.0486642640007412,0.00263688935130545,0.0434959608721825,0.0538325671292999,1.2897937536273e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.105468911261635,0.00571920707167296,0.0942592654011558,0.116678557122114,1.63734542202229e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRGN,Neurogranin,24951,0.11791217164768,0.00639161288158022,0.105384610399783,0.130439732895577,1.72323410147372e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.0517485990054037,0.00280558043464771,0.0462496613534942,0.0572475366573132,1.82501300673234e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POSTN,Periostin,24938,-0.0489798574990218,0.00265571755465176,-0.0541850639061392,-0.0437746510919043,1.88143791504764e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTF2,Transcription termination factor 2,24195,0.0633842988129497,0.00343904847676362,0.056643763798493,0.0701248338274064,2.4436160090312e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.128145026683084,0.00695986810915774,0.114503685189135,0.141786368177033,3.33287443371937e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.0784578181957481,0.00427634061337355,0.070076190593536,0.0868394457979603,9.13013614133307e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPT,Dermatopontin,29820,0.0338240968027303,0.0018440562793646,0.0302097464951757,0.0374384471102849,9.82783346332097e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DXO,Decapping and exoribonuclease protein,24845,0.0584940069445565,0.00319109186099543,0.0522394668970055,0.0647485469921076,1.47011516655297e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.085513725767237,0.00466640502479812,0.0763675719186327,0.0946598796158413,1.66584806987637e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA3,Annexin A3,29640,0.0892338325354081,0.00487554670969087,0.0796777609844139,0.0987899040864022,2.04092467761712e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.152788240904639,0.00835268427899269,0.136416979717814,0.169159502091465,2.4609857308565e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL1,Growth-regulated alpha protein,29420,0.1218726691454,0.00666301604142665,0.108813157704203,0.134932180586596,2.52791847513264e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAP3,Cytosol aminopeptidase,28931,0.0622245085413138,0.00340328805323193,0.0555540639569792,0.0688949531256483,2.93056358141851e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,29566,0.106897943618818,0.00584982046763234,0.0954322955022588,0.118363591735378,3.4371821795593e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0539182916010712,0.0029523138273537,0.0481317564994579,0.0597048267026844,5.08242468585891e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GET3,ATPase GET3,24922,0.0704830460720419,0.00386122175023269,0.0629150514415859,0.078051040702498,5.83360812487887e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12A_IL12B,Interleukin-12,29349,0.0990504438476324,0.00543191970963356,0.0884038812167506,0.109697006478514,6.98973870423883e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1R,Complement C1r subcomponent,24966,0.0247779981357688,0.0013593093440119,0.0221137518215054,0.0274422444500321,9.26093578702203e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,29581,0.0370224083621607,0.00203217693680485,0.0330393415660232,0.0410054751582982,9.39844910969827e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,24867,0.0619451126258833,0.00341352204312657,0.0552546094213553,0.0686356158304114,4.02648666375115e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.0968631252853269,0.00534461172349393,0.0863876863072788,0.107338564263375,6.15274814500778e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.0729411586708281,0.00403526511278226,0.0650320390497749,0.0808502782918813,1.25034752659527e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RP2,Protein XRP2,29349,0.0528931952144715,0.00292934815289356,0.0471516728348001,0.0586347175941429,1.73935110173357e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNRD2,Protein ZNRD2,24805,0.0869175441768536,0.00481392940023803,0.077482242552387,0.0963528458013201,2.082513425931e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCA,Tubulin-specific chaperone A,24381,0.108378354709904,0.00600342893381796,0.0966116339996207,0.120145075420187,2.22546282421787e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.0360218244370967,0.00199619402128341,0.0321092841553813,0.0399343647188122,2.48535170765796e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFP,Alpha-fetoprotein,29132,0.0858405832683022,0.00476374616275035,0.0765036407893115,0.0951775257472929,3.37952177198751e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARF1,Scavenger receptor class F member 1,29820,0.0534215509165155,0.00296520450094022,0.0476097500946726,0.0592333517383583,3.51834383198835e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEPR,Leptin receptor,29478,-0.0390568764000839,0.00217336311354934,-0.0433166681026406,-0.0347970846975273,7.9987453162839e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACYP1,Acylphosphatase-1,24297,0.0826997953313397,0.00459968184819736,0.0736844189088729,0.0917151717538065,8.25258472677807e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMSB10,Thymosin beta-10,29443,0.0953689089397991,0.00531014652387091,0.0849610217530121,0.105776796126586,9.73433669422804e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.0944441006959427,0.00525765221871858,0.0841391023472543,0.104749099044631,1.07373197602545e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.0399694735071116,0.00222810558903818,-0.0443365604616264,-0.0356023865525967,1.39892356545572e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.0359996481583965,0.00200933696449414,0.032061347707988,0.039937948608805,2.11390058414746e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSNAX,Translin-associated protein X,24111,0.0494652974208562,0.00275945476563973,0.0440567660802023,0.0548738287615101,2.16102599476986e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.0869259022533966,0.0048524706771091,0.0774150597262628,0.0964367447805305,2.67411478499725e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0685033699319619,0.0038274137387531,0.0610016390040058,0.0760051008599179,3.50977628660731e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.138982031745051,0.00777225939882343,0.123748403323358,0.154215660166745,3.95435964021344e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP7,Matrilysin,28870,0.0625258508867567,0.00349690066539859,0.0556719255825755,0.0693797761909379,4.06259078676642e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP5,Platelet glycoprotein V,24381,0.0453440905306398,0.00253544229199706,0.0403746236383256,0.050313557422954,4.46952862521858e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,29581,0.109336128677611,0.00612331793096533,0.0973344255329193,0.121337831822303,6.15962655196829e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP170,Centrosomal protein of 170 kDa,24240,0.0965678708215711,0.00540730255808382,0.0859695578077268,0.107166183835415,7.03639117214952e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.0566921442729961,0.00318324060525871,0.0504529926866891,0.0629312958593032,1.67802832977079e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP4,Dipeptidyl peptidase 4,28990,0.0372899909544094,0.00209922667506791,0.0331755066712762,0.0414044752375425,3.18674836289407e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C4BPB,C4b-binding protein beta chain,29566,0.0498635202874613,0.00280819323112114,0.0443594615544639,0.0553675790204588,3.56078240912765e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREH,Trehalase,24938,0.0932557866498569,0.00525024080145714,0.0829653146790009,0.103546258620713,3.75674632871077e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.0254432086810074,0.00143357981727574,-0.0282530251228678,-0.0226333922391469,4.12839951613216e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.0697124331574444,0.0039264732821583,0.0620165455244141,0.0774083207904746,4.42981785458826e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGH,Gamma-glutamyl hydrolase,28984,0.0422820874304218,0.00238643097777599,0.0376046827139809,0.0469594921468628,7.1601697254723e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMTN,Smoothelin,24776,0.117096942070935,0.00662219232812058,0.104117445107819,0.130076439034052,1.53176258340184e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0594563553021166,0.00337789484435644,0.052835681407178,0.0660770291970552,5.50414948277112e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.0839866931845888,0.00477269127406185,0.0746322182874276,0.09334116808175,6.9430443300217e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,29581,0.0501035384799534,0.00285575588219846,0.0445062569508444,0.0557008200090624,1.45297589792605e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.0777988931920913,0.00443475451212031,0.0691067743483355,0.0864910120358471,1.50229098422456e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.0936997364432103,0.00535136065472549,0.0832110695599484,0.104188403326472,3.12265658919808e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.086936597013173,0.00496668315893474,0.0772018980216609,0.096671296004685,3.42386008071537e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTX3,Pentraxin-related protein PTX3,29434,-0.0605749077932026,0.0034625387843672,-0.0673614838105623,-0.0537883317758429,3.5049144431809e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PQBP1,Polyglutamine-binding protein 1,28797,0.0682751752851488,0.00390406812874003,0.0606232017528183,0.0759271488174792,3.96863610785088e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NID1,Nidogen-1,29518,0.0463834424367554,0.00265486900561911,0.0411798991857419,0.0515869856877689,5.23831700017585e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,24195,0.0530351764345708,0.0030356408496912,0.0470853203691761,0.0589850324999656,6.25035335294894e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRD1,Natural killer cells antigen CD94,29786,0.0566580227929105,0.00324708468058951,0.0502937368189551,0.063022308766866,7.64304816666682e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MIA,Melanoma-derived growth regulatory protein,29566,0.0450908867623736,0.00258636165163018,0.0400216179251785,0.0501601555995688,9.93156928557833e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN9,Septin-9,29349,0.0346562232854239,0.0019883678830563,0.0307590222346336,0.0385534243362143,1.08198089459197e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBN1,Drebrin,24229,0.0626609766978875,0.00359909007501805,0.0556067601508522,0.0697151932449229,1.77893791983958e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLNK,B-cell linker protein,24229,0.0486790481971789,0.00279711173411885,0.043196709198306,0.0541613871960519,2.0038036843809e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.146428026357369,0.00842187171331936,0.129921157799263,0.162934894915475,2.26417563914836e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.0632562014904841,0.00364131198036605,0.0561192300089666,0.0703931729720016,2.92264305368459e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NBN,Nibrin,28931,0.0638446320440311,0.003675178635058,0.0566412819193174,0.0710479821687448,2.96205259490409e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL24,C-C motif chemokine 24,29536,0.10070062047056,0.00579720920325584,0.0893380904321783,0.112063150508941,2.98162517427028e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.0372004272914947,0.00214294817692819,0.0330002488647154,0.0414006057182739,3.59791501131864e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XCL1,Lymphotactin,29725,0.0674196105242694,0.00388423707961593,0.0598065058482222,0.0750327152003166,3.73213141620386e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSL,Cathepsin L1,29478,0.0295632392372336,0.00170383155445221,0.0262237293905073,0.03290274908396,4.17949397097077e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0602897752123234,0.00347278191515419,0.0534831226586212,0.0670964277660256,4.262647354644e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDCP1,CUB domain-containing protein 1,29218,0.0632338017797375,0.00364605043758701,0.056087542922067,0.070380060637408,4.82466071197592e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,24805,0.119187837142545,0.00688283583892586,0.105697478898251,0.13267819538684,8.70886099367465e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.0648289964057107,0.0037473247979032,0.0574842398018204,0.0721737530096009,1.00785322088929e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGXT,Serine--pyruvate aminotransferase,29478,0.0932063628324417,0.00539499561963217,0.0826321714179627,0.103780554246921,1.50710884597101e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.0964647383071171,0.00558296678634698,0.085522123405877,0.107407353208357,1.67641991499039e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,29169,0.0484867185142465,0.00280809003915754,0.0429828620374978,0.0539905749909953,1.79269087068072e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAP18,Chromatin complexes subunit BAP18,24845,0.0801960679212178,0.00464834494808737,0.0710853118229666,0.0893068240194691,2.60697604389264e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP6,Platelet glycoprotein VI,29400,0.105837762778628,0.00615986881385936,0.0937644199034639,0.117911105653793,7.62651080179832e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.145880844104049,0.00849488070484087,0.129230877922561,0.162530810285538,8.88886001376448e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARB2,Lysosome membrane protein 2,28762,0.0382771042639106,0.00222906091005286,0.033908144880207,0.0426460636476142,9.18928986035972e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD274,Programmed cell death 1 ligand 1,29218,0.0411778913065483,0.00239929983290589,0.0364752636340527,0.0458805189790438,1.06594455300691e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.108797951326566,0.00634644992077664,0.0963589094818434,0.121236993171288,1.72384023365277e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP1,Guanylate-binding protein 1,24816,0.0776309522198283,0.00452878335715668,0.0687545368398012,0.0865073675998554,1.73001080021537e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,24922,0.0330643273795263,0.00193083861719874,0.0292798836898168,0.0368487710692359,2.31439833462136e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAP,Prolyl endopeptidase FAP,29820,0.0329379995488657,0.00192471047591216,0.0291655670160779,0.0367104320816536,2.42879043087741e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TST,Thiosulfate sulfurtransferase,28706,0.0906849027130427,0.00529934805572009,0.0802981805238313,0.101071624902254,2.52955957159537e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABHD14B,Protein ABHD14B,29121,0.0687039176083346,0.00401541249682109,0.0608337091145652,0.0765741261021039,2.60767182351587e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0768127549043913,0.0044894378905469,0.0680134566389193,0.0856120531698632,2.6483870178014e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,29694,0.0550210160644489,0.00321623129216414,0.0487172027318072,0.0613248293970906,2.69450703442014e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF6,SLAM family member 6,28797,0.0458480352021163,0.00268093159968706,0.0405934092667296,0.0511026611375029,3.03883085706879e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.0643400664655366,0.0037690503629186,0.0569527277542161,0.071727405176857,5.13417260094718e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,28797,0.0472675466017828,0.00277599824095309,0.0418265900495148,0.0527085031540509,1.07085536151851e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.0452623055194218,0.00265928004211933,0.0400501166368679,0.0504744944019757,1.17109360134123e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.0428144808620212,0.00251622391737325,0.0378826819839697,0.0477462797400728,1.50169326717229e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",24240,0.103832434080745,0.00610556543031476,0.0918655258373281,0.115799342324162,1.74994928185118e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB10,Ras-related protein Rab-10,24922,0.063763694016829,0.00375214925144966,0.0564094814839877,0.0711179065496703,2.10281859716761e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCS,Copper chaperone for superoxide dismutase,29218,0.0563803818685773,0.0033232455766213,0.0498668205383996,0.0628939431987551,3.00750457940774e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.0709582649352403,0.00418781880762305,0.0627501400722991,0.0791663897981815,4.36415282544469e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRMD4B,FERM domain-containing protein 4B,24111,0.0834389425160015,0.00492829110974317,0.0737794919409049,0.0930983930910981,6.27174244278847e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.0802617104938751,0.00475169923517192,0.0709483799929382,0.0895750409948121,1.03576562075337e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.0627563603730389,0.00371346530500898,0.0554779683752213,0.0700347523708565,1.04896130736441e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL11,C-X-C motif chemokine 11,29694,0.0930746151417951,0.00551646996726404,0.0822623340059576,0.103886896277633,1.42832482529741e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.0830733201574127,0.00492434229093383,0.0734216092671824,0.092725031047643,1.6961471922057e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.051445515291376,0.00305624677735107,0.0454552716077679,0.0574357589749841,3.20519863493031e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREML2,Trem-like transcript 2 protein,29443,0.0399467607071183,0.00237693829717731,0.0352879616446508,0.0446055597695858,4.34747888761298e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,24111,0.0793890625879382,0.00473456534735565,0.0701093145071212,0.0886688106687553,9.49956182934559e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3BP1,SH3 domain-binding protein 1,24805,0.0563240206854011,0.00335978991545502,0.0497388324511092,0.0629092089196929,9.89546790440638e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS3BP,Galectin-3-binding protein,24966,0.0356677958258385,0.00212884029926579,0.0314952688392776,0.0398403228123995,1.1546266186639e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FADD,FAS-associated death domain protein,29478,0.0894312776254638,0.0053406214255917,0.0789636596313041,0.0998988956196236,1.19117827069977e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0267310801370103,0.0015973608141245,0.0236002529413262,0.0298619073326943,1.42831404483076e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BDNF,Brain-derived neurotrophic factor,24938,0.0974434548172449,0.00582886988445262,0.0860188698437177,0.108868039790772,2.14300284160648e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.02858787220093,0.00171128128165416,0.0252337608888878,0.0319419835129721,2.31844467764563e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0295556881529642,0.00177401213181739,0.0260786243746021,0.0330327519313263,5.51312813701733e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOF,Apolipoprotein F,24951,-0.0291939998153239,0.00175345778906555,-0.0326307770818923,-0.0257572225487554,6.6039994614359e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.0447764835546683,0.00268949817009794,0.0395050671412763,0.0500478999680603,6.70361378868426e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,29173,0.0330981248516443,0.00198942476213002,0.0291988523178694,0.0369973973854191,7.25208420162329e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.101979270509147,0.00614941937676594,0.089926408530686,0.114032132487609,1.74601076791198e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM1,Intercellular adhesion molecule 1,29391,0.0334577734815253,0.00201935804112587,0.0294998317209186,0.037415715242132,2.23635250452935e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPLAH,5-oxoprolinase,24240,0.0797556362758039,0.00481357607614066,0.0703210271665682,0.0891902453850396,2.54506703194926e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP25,Synaptosomal-associated protein 25,24101,0.0550139605462931,0.00332170963351055,0.0485034096646124,0.0615245114279738,2.86598406132337e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,24229,0.100318119184752,0.00606078285916648,0.0884389847807854,0.112197253588718,3.36037150273721e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPING1,Plasma protease C1 inhibitor,24914,0.0218058921402779,0.00131774752488447,0.0192231069915043,0.0243886772890514,3.5223881579045e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDHB,Succinate dehydrogenase,24805,0.0797821259701924,0.00482408978637443,0.0703269099888985,0.0892373419514862,4.13588885407018e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.138283127082786,0.00836751204431505,0.121882803475929,0.154683450689644,4.47454788447362e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFASC,Neurofascin,29786,0.0327814101308926,0.00198502049477284,0.0288907699611378,0.0366720503006474,5.40198896955138e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POMC,Pro-opiomelanocortin,24240,0.0818414452023283,0.00495913318426595,0.072121544161167,0.0915613462434896,7.48325833155052e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD83,CD83 antigen,29434,0.0392645874201517,0.00238284409530736,0.0345942129933493,0.0439349618469542,9.88149168144891e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.0697709823826533,0.00423943914991459,0.0614616816488207,0.0780802831164859,1.38344927284781e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP6,Bone morphogenetic protein 6,28884,0.0475698055171709,0.00289094498810575,0.0419035533404837,0.0532360576938582,1.46379030146262e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMMT,MICOS complex subunit MIC60,24793,0.0513344129104494,0.0031201695368123,0.0452188806182972,0.0574499452026015,1.68715081608976e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ING1,Inhibitor of growth protein 1,28719,0.0530060450537664,0.00322384496607832,0.0466873089202528,0.0593247811872799,1.81382976891713e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA13,Carbonic anhydrase 13,29114,0.119958908936964,0.00730251949213669,0.105645970732376,0.134271847141552,2.29091460023222e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.0345699110122001,0.00210846522498071,0.0304373191712379,0.0387025028531623,3.79120514716756e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLN4,Cerebellin-4,29725,0.036451396759258,0.00222535710109395,0.0320896968411139,0.0408130966774022,4.87249617574767e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.0641505702873774,0.00391462027130247,0.0564779145556246,0.0718232260191303,4.90814517035018e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB2B,Ras-related protein Rab-2B,24793,0.070931630373327,0.00433282683447872,0.0624392897777487,0.0794239709689052,6.3866652038693e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1RL,Complement C1r subcomponent-like protein,24925,0.0223990700259207,0.0013683057953698,0.0197171906669959,0.0250809493848455,6.44787072622997e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.075170627754919,0.00460009906440546,0.0661544335886843,0.0841868219211537,9.33354320716302e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNF,Tumor necrosis factor,28868,0.0437727808469009,0.00268031195393953,0.0385193694171794,0.0490261922766223,1.09702805566538e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.0537426191729716,0.00329182114179045,0.0472906497350623,0.0601945886108809,1.19395767626282e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPPK1,Epiplakin,24240,0.0844837597370845,0.00517353350410684,0.0743436340690351,0.0946238854051339,1.25816957412026e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALB2,Calretinin,28774,0.0348820428532598,0.00214129914590196,0.030685096527292,0.0390789891792276,2.14092986309175e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",24845,0.121242194975699,0.00744029758084742,0.106659211717239,0.13582517823416,2.16673732003543e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.0480190321158192,0.00294883788646109,0.0422393098583555,0.0537987543732829,2.32291874255583e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSR,"Glutathione reductase, mitochondrial",24867,0.025886016528665,0.00158948324545382,0.0227706293675755,0.0290014036897545,2.52659852502879e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,28797,0.0599951620008293,0.00368609193310779,0.052770421811938,0.0672199021897206,2.68625797601425e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLF4,Krueppel-like factor 4,24101,0.0453848221014556,0.00278992191982285,0.0399165751386028,0.0508530690643084,3.47780457108096e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX9,Sorting nexin-9,29478,0.0776454714548619,0.00478217765104846,0.0682724032588069,0.0870185396509169,5.03080177858072e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRN1,Secernin-1,29434,0.0635173879145369,0.00391265733945438,0.0558485795292063,0.0711861962998674,5.25136425427003e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.0274592222997914,0.00169400286332079,0.0241389766876827,0.0307794679119002,7.768127027854e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.0346057687317173,0.00213600728947729,0.0304191944443418,0.0387923430190928,8.92221693508368e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEP1B,Meprin A subunit beta,29478,0.132574393605759,0.00818482116435136,0.11653214412363,0.148616643087888,9.41334246530516e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAL,Integrin alpha-L,24229,0.0495745499720081,0.00306062532534845,0.0435757243343251,0.0555733756096911,1.06882141589709e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,29594,0.0520311739517926,0.00321803142399092,0.0457238323607704,0.0583385155428148,1.49710264038194e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.0994507930915259,0.00614940708055901,0.0873979552136302,0.111503630969422,1.57416888477459e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FEN1,Flap endonuclease 1,28797,0.0713402730278517,0.00441497437177009,0.0626869232591823,0.0799936227965211,1.78442947718062e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.0319280134871364,0.00197893049779865,0.0280493097114511,0.0358067172628218,2.96237977194313e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOL1,Apolipoprotein L1,24951,0.0679153021001476,0.00421153962753958,0.05966068443017,0.0761699197701252,3.30147259505788e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12B,Interleukin-12 subunit beta,29786,0.0614297913551185,0.00381464276205997,0.053953091541481,0.0689064911687561,4.23248874648308e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.0852750893405723,0.005296006570682,0.0748949164620356,0.095655262219109,4.4491163322091e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.0505090355859612,0.00313604059227228,0.0443623960251075,0.0566556751468148,4.64039882740165e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0470932010101722,0.00292577079633748,0.0413586902493508,0.0528277117709937,5.35209619523132e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,24793,0.049235587839266,0.0030601502406875,0.0432376933675185,0.0552334823110135,5.96815338666188e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARD3,Partitioning defective 3 homolog,24445,0.0836439926351872,0.00519959328088798,0.0734527898046468,0.0938351954657277,6.28418594976451e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDF2,Growth/differentiation factor 2,29478,0.0401016133336063,0.00249684141842032,0.0352078041535025,0.0449954225137101,8.43783885743503e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKN3,Serine/threonine-protein kinase N3,24445,0.0850534680322736,0.00529461163773121,0.0746760292223205,0.0954309068422268,8.99875604353204e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAEP,Glycodelin,29218,-0.148189835859058,0.00924035045899248,-0.166300922758683,-0.130078748959433,1.23786832504479e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS3,Galectin-3,29544,0.0332404904806175,0.00208796533568039,0.029148078422684,0.0373329025385511,7.93462134870807e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,24609,0.035627610779117,0.00223794431505164,0.0312412399216158,0.0400139816366182,8.87944773872918e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA1,Apolipoprotein A-I,24966,-0.0306788796756283,0.00192822390071616,-0.034458198521032,-0.0268995608302246,1.02009487939856e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPPB,Natriuretic peptides B,28916,-0.149337631707223,0.00939406238126717,-0.167749993974507,-0.130925269439939,1.15582689769879e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.0354359308126733,0.00223132662401006,0.0310625306296136,0.0398093309957331,1.62636197643698e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD40LG,CD40 ligand,29786,0.0863574722726573,0.00544361500797083,0.0756879868570344,0.0970269576882801,1.91728155716519e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNA4,Ephrin-A4,29169,0.034203074951455,0.00215630830330292,0.0299767106769813,0.0384294392259287,2.00511730546604e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,29478,0.0390791480797125,0.0024673459938173,0.0342431499318306,0.0439151462275944,2.88103573863093e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSTB,Cystatin-B,29030,0.0471940777978673,0.00298164015730528,0.041350063089549,0.0530380925061857,3.41722774739474e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.0426240123200623,0.00269354838453756,0.0373446574863687,0.047903367153756,3.9687680777893e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCOF1,Treacle protein,24922,0.0347374186907905,0.00219585573183131,0.0304335414564012,0.0390412959251799,4.28159238845089e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNC79,Protein unc-79 homolog,24016,0.0623278433814243,0.00393981634584288,0.0546058033435723,0.0700498834192764,4.35284662896896e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SWAP70,Switch-associated protein 70,24805,0.0397604762939985,0.00251373783920747,0.0348335501291518,0.0446874024588451,4.44981831778338e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STXBP3,Syntaxin-binding protein 3,28797,0.0484922579815087,0.00307229945837268,0.0424705510430983,0.0545139649199192,6.91488148410506e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA2,Integrin alpha-2,24381,0.0380104424958933,0.00240864216369409,0.0332895038550528,0.0427313811367337,7.96863831693841e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.0395931365970053,0.00251104349781267,0.0346714913412925,0.0445147818527181,8.90373924686092e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.0910957647461787,0.00578006840457672,0.0797668306732083,0.102424698819149,9.86590083554106e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.0409754147014678,0.00260103057462904,0.0358773947751949,0.0460734346277407,1.22283526863328e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPXM1,Probable carboxypeptidase X1,29566,0.0757233712501415,0.00481142787474254,0.0662929726156461,0.0851537698846369,1.3918165034545e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.0344636035205126,0.00218979604306539,-0.0387556037649208,-0.0301716032761044,1.49406769103814e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0309446990707146,0.00196642626422215,0.0270905035928392,0.03479889454859,1.60710707594813e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNAS,Neuroendocrine secretory protein 55,24867,0.0976158129726318,0.00620551168520644,0.0854530100696271,0.109778615875636,1.73196729905969e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN6,Dynactin subunit 6,28774,0.0785862539504933,0.00500196067361267,0.0687824110302124,0.0883900968707741,2.15917406711447e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.0519684717554912,0.00330702642204237,0.0454866999682882,0.0584502435426942,2.22537720510941e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTC,Probetacellulin,28797,0.081919618382263,0.00521696790666648,0.0716943612851967,0.0921448754793293,2.46718208289938e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.0484670452964245,0.00309287612062286,0.0424050081000037,0.0545290824928453,4.0278722270937e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,28967,0.0481650543247024,0.00307634336739536,0.0421354213246075,0.0541946873247973,5.03872900559675e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRK5,G protein-coupled receptor kinase 5,28916,0.0570976531619675,0.00364692189536493,0.0499496862470522,0.0642456200768827,5.0588014292375e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3C,Protein FAM3C,29433,0.0328383569342655,0.00210201234512273,0.028718412737825,0.0369583011307061,8.5194147959311e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF2,Fibroblast growth factor 2,29434,0.0738550853898152,0.00472878705288845,0.0645866627661539,0.0831235080134766,9.08798475099703e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFRP1,Secreted frizzled-related protein 1,29120,0.0474254932355562,0.00303809744667311,0.0414708222400769,0.0533801642310355,1.03360953050908e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCN1,Ficolin-1,24919,0.061369610794679,0.00393049337770697,0.0536658437743733,0.0690733778149847,1.06727153249171e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KITLG,Kit ligand,29478,-0.0407665928774782,0.00261347715065368,-0.0458890080927594,-0.035644177662197,1.23125210284566e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.0734878398755807,0.00471375320970387,0.0642488835845612,0.0827267961666003,1.42256643426727e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH7,Protocadherin-7,24805,0.0381098730616935,0.00244381385745599,0.0333199979010798,0.0428997482223073,1.44360959868086e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.0284956552564537,0.00182762610250508,-0.0320778024173637,-0.0249135080955438,1.50198413825905e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,24867,0.0390795864734988,0.00250782056095138,0.0341642581740341,0.0439949147729635,1.71844276628796e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLO1,Lactoylglutathione lyase,28916,0.0632238953828803,0.00405996100646586,0.0552663718102072,0.0711814189555534,1.86316540502191e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.0699898703832339,0.00449349404369199,0.0611826220575976,0.0787971187088702,1.95266245127529e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0556572085965061,0.00357693579800974,0.048646414432407,0.0626680027606052,2.23806438586702e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGS10,Regulator of G-protein signaling 10,24867,0.0651440256574406,0.00418676269114425,0.0569379707827978,0.0733500805320833,2.47515397241062e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF23,Fibroblast growth factor 23,29693,0.0618805453941147,0.00398134630480046,0.0540771066367058,0.0696839841515236,2.92296013674123e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLB,Beta-klotho,28774,-0.0807231345159768,0.00519658023671191,-0.0909084317799322,-0.0705378372520215,3.39811219702825e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARSA,Arylsulfatase A,29443,0.0486288148748238,0.00313962946835947,0.0424751411168393,0.0547824886328084,6.75168387796606e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACRBP,Acrosin-binding protein,24793,0.0421439661012254,0.00272078518409241,0.0368112271404043,0.0474767050620466,7.29368181624375e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.0643497128663998,0.00416233622718635,0.0561915338611146,0.0725078918716851,1.16603311373183e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1F,Protein phosphatase 1F,24922,0.0571955819819838,0.0036999985230755,0.0499435848767558,0.0644475790872117,1.17832791766955e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASS1,Argininosuccinate synthase,24111,0.0860127479539032,0.00556874792996238,0.075098002011177,0.0969274938966295,1.45895330828069e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.0484017994799786,0.00313400563921409,0.0422591484271189,0.0545444505328382,1.48978135504688e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0555461262272671,0.00359831865885159,0.048493421655918,0.0625988307986162,1.52140308510715e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLRX,Glutaredoxin-1,29291,0.06067574886189,0.00393119938050796,0.0529705980760944,0.0683808996476856,1.56198220799191e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL26,C-C motif chemokine 26,29434,0.0963718398387021,0.00624906272067489,0.0841236769061793,0.108620002771225,1.89138757569799e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD84,SLAM family member 5,29434,0.033739828327418,0.00219104020669757,0.0294453895222908,0.0380342671325452,2.6842936829656e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FST,Follistatin,29536,0.0544828487937366,0.00354070851230732,0.0475430601096143,0.061422637477859,3.19398264526049e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFRP4,Secreted frizzled-related protein 4,24381,0.0447158083382086,0.00290482121869789,0.0390223587495607,0.0504092579268565,3.21571155246906e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.0950381107987143,0.00618580150044146,0.082913939857849,0.10716228173958,4.63449039012033e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.0986806676001558,0.00642246275546331,0.0860926405994477,0.111268694600864,4.93468286837935e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.0930406284090354,0.00606346683188469,0.0811562334185414,0.104925023399529,6.74891401171778e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0342098993649871,0.00223237238430742,0.0298344494917445,0.0385853492382296,8.34865684479039e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARFIP1,Arfaptin-1,24867,0.0739346496675577,0.0048314649887546,0.0644649782895987,0.0834043210455167,1.2741959177142e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0624452757599039,0.00408497553118009,0.0544387237187909,0.0704518278010169,1.50188589270722e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSAP,Prosaposin,24761,0.0305349265216395,0.00199685274421126,0.0266210951429854,0.0344487579002935,1.51483756588993e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA6,Integrin alpha-6,29434,0.0558344942429155,0.00365295470314982,0.0486747030247418,0.0629942854610891,1.53891603781165e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MATN2,Matrilin-2,29497,0.0318725129138797,0.00208526162440722,0.0277854001300415,0.0359596256977178,1.53949298471053e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CORO1A,Coronin-1A,28847,0.0956284790059628,0.00626251348412262,0.0833539525770824,0.107903005434843,1.94489507266348e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MARCO,Macrophage receptor MARCO,29478,0.0281357445729584,0.00184456069841204,0.0245204056040708,0.031751083541846,2.47924011022972e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0769970589614917,0.00505130715078526,0.0670964969459526,0.0868976209770308,2.92711998963241e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0780240154148094,0.00513250093605117,0.0679643135801491,0.0880837172494697,5.43517629956819e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.0431635544335447,0.00284421742498793,0.0375888882805684,0.0487382205865211,8.86616874066447e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN4,CCN family member 4,29725,0.0426305955152891,0.00281046511524506,0.0371220838894088,0.0481391071411695,8.93633106852453e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.0299211649149142,0.00197368824799046,0.0260527359488529,0.0337895938809755,1.01714293010965e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.0873869768893365,0.00577253705741045,0.076072804256812,0.098701149521861,1.53708242294602e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.0735316617839062,0.00486037922670076,0.0640053184995727,0.0830580050682397,1.63719425370686e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO2,Gamma-enolase,29694,0.0694592101212027,0.00459146018877565,0.0604599481512024,0.078458472091203,1.65044062512155e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.0711633577546467,0.00470765791627577,0.0619363482387462,0.0803903672705473,2.13425023693913e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA2,Annexin A2,23907,0.0751912273201523,0.00498552769702136,0.0654195930339904,0.0849628616063141,3.66579005742319e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0515530645157823,0.00341921104073378,0.044851410875944,0.0582547181556205,3.84270783475627e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.0422644606205695,0.00280983923630992,0.036757175717402,0.0477717455237369,6.57235745878366e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0385299241278338,0.00256286694145001,0.0335067049225918,0.0435531433330758,7.48884931083315e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL1,Fc receptor-like protein 1,29478,0.0477584877466889,0.00318415588481061,0.0415175422124601,0.0539994332809177,1.15058214862883e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGR1,Prostaglandin reductase 1,24922,0.0858927849345098,0.00572996141491781,0.0746620605612709,0.0971235093077487,1.41640267732314e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.120504117359195,0.0080525410787095,-0.136287097873465,-0.104721136844924,1.92070695844163e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD46,Membrane cofactor protein,29331,0.0300426029939179,0.00200828500636153,0.0261063643814492,0.0339788416063865,2.07833872750217e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOE,Apolipoprotein E,24966,0.0762849475808929,0.00510317643590134,0.0662827217665263,0.0862871733952596,2.63014964933028e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX16,Syntaxin-16,28797,0.0608639969687601,0.00407515557517327,0.0528766920414205,0.0688513018960997,2.99314618524802e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.102664661785682,0.00687895807441668,0.0891819039598255,0.116147419611539,3.50127817798387e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NADK,NAD kinase,29478,0.0565005402475533,0.00378857314175978,0.0490749368897041,0.0639261436054025,4.10925616146546e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASAH1,Acid ceramidase,24732,0.048764396388872,0.00327104603907332,0.0423531461522883,0.0551756466254557,4.83353362620936e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGRN,Neugrin,24845,0.0231847589466378,0.00155620453544953,0.0201345980571568,0.0262349198361189,5.56232341701479e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.0706489533986623,0.00475032975518447,0.0613383070785007,0.0799595997188238,8.22362956656211e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDZD2,PDZ domain-containing protein 2,24111,0.062834221861774,0.0042278526227448,0.0545476307211942,0.0711208130023538,9.66709567922385e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.0406221987772992,0.00273337380840251,0.0352647861128303,0.0459796114417681,9.70192872124745e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DMD,Dystrophin,24240,0.053931056465854,0.00362978504475614,0.046816677778132,0.061045435153576,1.02364599092059e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.0534477511290492,0.00360038318681165,0.0463910000828983,0.0605045021752,1.12895989872347e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEPH,Hephaestin,24922,0.0275295843050525,0.00185548885728266,0.0238928261447785,0.0311663424653265,1.37896167681083e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,29361,0.0351155643896671,0.00237690092310616,0.0304568385803791,0.0397742901989552,3.25522373485919e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,28774,0.0396992337154283,0.00268710686630053,0.0344325042574792,0.0449659631733773,3.2681426435553e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMOTL2,Angiomotin-like protein 2,24711,0.0501406631729793,0.00339610378977077,0.0434842997450286,0.05679702660093,4.04021424333933e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA2,Carboxypeptidase A2,29577,0.0674989170311432,0.00457546312124535,0.0585310093135023,0.0764668247487841,4.44146257674929e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.0334893661195817,0.00226965635904308,0.0290408396558573,0.0379378925833062,4.5871527777732e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR3,Toll-like receptor 3,29786,0.0630941536380115,0.00428402500570804,0.0546974646268237,0.0714908426491993,6.35794267030322e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.0439058238432992,0.00298150049129577,0.0380620828803594,0.0497495648062389,6.59435542869383e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.0992191201253197,0.00673986499993888,0.0860089847254395,0.1124292555252,7.05822899683104e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100P,Protein S100-P,28916,0.055194361215205,0.00375738451036618,0.0478298875748873,0.0625588348555227,1.12673669549093e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0249285828032612,0.00170484537318049,0.0215870858718275,0.028270079734695,2.99488945577498e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FXN,"Frataxin, mitochondrial",29725,0.075111217438139,0.00514113167802617,0.0650345993492078,0.0851878355270703,3.57175102884778e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,29349,0.0222742490852697,0.00152584572969826,0.0192835914550611,0.0252649067154783,4.26813277749666e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRZB,Secreted frizzled-related protein 3,29123,0.0263784024301355,0.00180715343500393,0.0228363816975278,0.0299204231627432,4.36341989668167e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLTA,Clathrin light chain A,28916,0.0481169698409533,0.0033013493494753,0.0416463251159817,0.0545876145659249,6.00132758425195e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN2,Dynactin subunit 2,29349,0.0963210291968793,0.00661110933839458,0.0833632548936259,0.109278803500133,6.45115750140018e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UMOD,Uromodulin,29750,-0.0550605885579737,0.00378526719379958,-0.0624797122578209,-0.0476414648581265,9.03440945609879e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA9,Serpin A9,29227,0.0737489546790278,0.00507289363218217,0.0638060831599507,0.0836918261981049,1.02408139935139e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,24938,0.0335438293304287,0.00230918965060549,0.029017817615242,0.0380698410456155,1.29388150011697e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGR,Tyrosine-protein kinase Fgr,28774,0.0578388766765536,0.00398569188191411,0.0500269205880019,0.0656508327651052,1.50629845557039e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADM,Pro-adrenomedullin,29725,0.0270348664890608,0.00186348530542809,0.0233824352904218,0.0306872976876999,1.57510556198887e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMB1,Laminin subunit beta-1,24240,0.0310088025919158,0.00213719222753698,0.0268199058259433,0.0351976993578883,1.67832685456621e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0697857924193821,0.00481464485437989,0.0603490885047976,0.0792224963339667,2.0683352642454e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRG,Histidine-rich glycoprotein,24833,0.0319268838915191,0.00220410042628818,0.0276068470559942,0.0362469207270439,2.34484404399441e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPA1,Inositol monophosphatase 1,29218,0.061786827937871,0.00427800096933574,0.0534019460379729,0.070171709837769,4.03928744488366e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0902463307516839,0.00624866921392345,0.0779989390923939,0.102493722410974,4.37613741298518e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX6,Peroxiredoxin-6,29725,-0.0605703276151518,0.00419609663249962,-0.068794677014851,-0.0523459782154525,4.50388808266204e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNM1,Dynamin-1,24805,0.115733416439906,0.00802893242494038,0.0999967088870226,0.131470123992789,6.48993125076074e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADA,Adenosine deaminase,29786,0.0351278485875077,0.00244044150048395,0.0303445832465592,0.0399111139284563,8.1009309778717e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGMN,Legumain,29581,0.0361216198676495,0.0025132251545754,0.0311956985646817,0.0410475411706172,1.10470620729837e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0280126571486177,0.0019493014088981,0.0241920263871774,0.031833287910058,1.23228588072362e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SF3B4,Splicing factor 3B subunit 4,29349,0.0733934780118378,0.00510978601375577,0.0633782974248765,0.0834086585987992,1.26584329327562e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPAG1,Sperm-associated antigen 1,24867,0.058372301573152,0.00406508539930843,0.0504047341905075,0.0663398689557965,1.42871794923932e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NID2,Nidogen-2,29443,0.0738164776128399,0.00514251664271665,0.0637371449931152,0.0838958102325645,1.4417545677261e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERI1,3'-5' exoribonuclease 1,24445,0.0342027423325218,0.00238275140287475,0.0295325495828873,0.0388729350821563,1.548720673704e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.0358053415794123,0.00249599231823688,0.030913196635668,0.0406974865231565,1.64510858175022e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.0232942066338272,0.00162417199626755,0.0201108295211428,0.0264775837465116,1.70301714309117e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFA2,BPI fold-containing family A member 2,23405,-0.111760561342558,0.00778890038349494,-0.127026806094208,-0.096494316590908,1.71070472231762e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSHB,Follitropin subunit beta,24240,0.0652018343509333,0.00454719690159406,0.056289328423809,0.0741143402780577,1.93713615554209e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRIB,Protein scribble homolog,24240,0.0909031458593546,0.00635558283670303,0.0784462034994167,0.103360088219293,3.2390354817281e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.0228817294115901,0.00160125628412161,0.0197432670947118,0.0260201917284685,3.85249564658054e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0378612092285978,0.00265165802734912,0.0326639594949935,0.0430584589622021,4.29400723553009e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL19,C-C motif chemokine 19,29694,0.122918530395271,0.00862272161836685,0.106017996023272,0.13981906476727,5.90371325775602e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,29566,0.0242917280563091,0.00170537701946586,0.0209491890981561,0.0276342670144622,6.91299470585824e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRG2,Bone marrow proteoglycan,24938,-0.051866306204716,0.00364121708783732,-0.0590030916968772,-0.0447295207125549,7.37217769497002e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.0350818127088668,0.0024724792583014,-0.0399278720551375,-0.030235753362596,1.63317353908288e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPCAL1,Hippocalcin-like protein 1,29786,0.072936157193899,0.00514466064860956,0.0628526223226243,0.0830196920651738,1.78702289950907e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLIT2,Slit homolog 2 protein,28774,0.0516796881241496,0.00365346678542425,0.0445188932247181,0.0588404830235812,2.82965620651581e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPMT,Thiopurine S-methyltransferase,28797,0.0722262545559509,0.00510977445332986,0.0622110966274244,0.0822414124844775,3.27898144225169e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0583170059643394,0.00412818245295845,0.0502257683565408,0.066408243572138,3.89687295287536e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,29725,0.03875787709096,0.00274565251876414,0.0333763981541823,0.0441393560277377,4.23008822157108e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0501557587301765,0.00355607966999258,0.043185842576991,0.0571256748833619,5.05334400739924e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF22,Kinesin-like protein KIF22,24111,0.121253660158479,0.00863781731043522,0.104323538230026,0.138183782086932,1.37677313632524e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO2,Roundabout homolog 2,29694,0.0227960732249136,0.00162486880907608,0.0196113303591244,0.0259808160907027,1.42864211066648e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX7,Syntaxin-7,24229,0.0489953873595896,0.00349107460221701,0.0421528811392443,0.0558378935799349,1.43424951175268e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0700483029203028,0.00499298533261483,0.0602620516683778,0.0798345541722279,1.43914113274323e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.0559291353061919,0.00399484638302669,0.0480992363954596,0.0637590342169243,2.17038612479582e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGES2,Prostaglandin E synthase 2,24037,0.0541187725631207,0.00386943743476315,0.0465346751909849,0.0617028699352564,2.82321301084947e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPP1,Tripeptidyl-peptidase 1,29286,0.0449198243647616,0.0032186988595222,0.0386111746000981,0.0512284741294252,4.01216634433364e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOLA1,BolA-like protein 1,24101,0.0535629004892945,0.00383948357483119,0.0460375126826254,0.0610882882959637,4.63432052856193e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3B,Protein FAM3B,29349,0.0348217577564364,0.00250034580274881,0.0299210799830487,0.0397224355298241,6.01326950125625e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP3,Stromelysin-1,29443,-0.0479233356056476,0.00344280294459601,-0.0546712293770557,-0.0411754418342394,6.61343253613694e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PVR,Poliovirus receptor,29694,0.0361096963387829,0.00259819359695251,0.031017236888756,0.0412021557888099,8.93539622259198e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,28931,0.0652230850214279,0.00469917440606893,0.0560127031855328,0.074433466857323,1.16144179330555e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.0608311993093239,0.00438562724909956,0.0522353699010887,0.069427028717559,1.38703422961709e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSE,Cathepsin E,24381,0.0508852582013533,0.00367156623769496,0.0436889883754712,0.0580815280272354,1.63549263552313e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.0191354417608388,0.00138602010776222,-0.0218520411720527,-0.0164188423496248,3.20048014290643e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.0577006706076871,0.00417930040337311,0.0495092418170758,0.0658920993982984,3.36945026876116e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,28797,0.0446218143482342,0.00324129410181342,0.0382688779086799,0.0509747507877885,5.53583792343858e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAGED1,Melanoma-associated antigen D1,28797,0.0467261749939647,0.00339571904421214,0.0400705656673089,0.0533817843206205,6.04055392398114e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD302,CD302 antigen,29349,0.0294543281400301,0.00214146232326806,0.0252570619864247,0.0336515942936355,6.52237028859462e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,-0.0377342453666527,0.0027462102128468,-0.0431168173838324,-0.032351673349473,7.87905641509011e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DENR,Density-regulated protein,24229,0.055499729733539,0.00403795663687447,0.0475853347252651,0.063414124741813,7.95785939119721e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.0518842851823163,0.00377850360216867,0.0444784181220657,0.0592901522425669,8.89334988070327e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.0390914808509558,0.00284760789292204,0.0335101693808286,0.044672792321083,1.00007778346362e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK4,Serine/threonine-protein kinase 4,29478,0.0832418463424069,0.00606751025848233,0.0713495262357815,0.0951341664490322,1.05333750261668e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA4,Annexin A4,29341,0.0692743444853917,0.0050510500082917,0.05937428646914,0.0791744025016435,1.12091062641237e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK4,Dickkopf-related protein 4,29169,0.0441354698077659,0.00322084644835109,0.0378226107689978,0.050448328846534,1.31937224706092e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,24938,0.0254796897348693,0.00186044223913584,0.0218332229461631,0.0291261565235756,1.54023441823717e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDA,Cytidine deaminase,24890,0.0449070817805854,0.0032816820958128,0.0384749848727923,0.0513391786883785,1.79940318737426e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS27,Serine protease 27,29395,0.0386251857300339,0.00282454484237678,0.0330890778389754,0.0441612936210924,1.9364278106324e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AK1,Adenylate kinase isoenzyme 1,29478,0.0600270000572585,0.00440952688012189,0.0513843273722196,0.0686696727422974,4.49290576130442e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.112708296541182,0.00828076686411412,0.0964779934875179,0.128938599594845,4.88916626974544e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.0939414037264664,0.00690552234526067,0.0804065799297555,0.107476227523177,5.08826887788692e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP8,Caspase-8,29632,0.0586053887841123,0.00431866010179785,0.0501408149845885,0.0670699625836361,8.01702859320523e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,24445,0.0333407811246348,0.00245768065245466,0.0285237270458237,0.038157835203446,9.03315001118281e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,24805,0.024403081809321,0.0018010870672165,0.0208729511575766,0.0279332124610653,1.12920126940689e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.036358419111687,0.00268565739153131,0.0310945306242856,0.0416223075990883,1.24348110657589e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL25,C-C motif chemokine 25,29786,0.0466807608882567,0.00344834462334538,0.0399220054264998,0.0534395163500136,1.25364283659501e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBD,Thrombomodulin,29478,0.0272117110418174,0.00201022404301702,0.0232716719175041,0.0311517501661308,1.26579792823469e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDK,Midkine,29455,0.0482948768542767,0.00356824657199156,0.0413011135731732,0.0552886401353802,1.30134878548323e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C5,Complement C5,24966,0.014407796563766,0.00106518185555805,0.0123200401268722,0.0164955530006598,1.53628273291756e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTN,Pleiotrophin,28916,0.0473669539655338,0.00351178896578769,0.0404838475925899,0.0542500603384777,2.4555141131404e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPR,Nucleoprotein TPR,24111,0.0451379939529705,0.00335584128888288,0.03856054502676,0.0517154428791809,4.29890861808246e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C7orf50,Uncharacterized protein C7orf50,24845,0.0210471649761996,0.00156758485738267,0.0179746986557295,0.0241196312966696,5.87893572042092e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0818932718998652,0.00611696844760362,0.0699040137425621,0.0938825300571682,9.90846094314617e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP1,Interstitial collagenase,28424,0.0859468248819649,0.00642328653204928,0.0733571832791483,0.0985364664847814,1.04430982405213e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.0282939539145049,0.00211615299956359,0.0241462940353602,0.0324416137936495,1.24253919485269e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,28719,0.0619303982271405,0.00465548467507808,0.0528056482639875,0.0710551481902935,2.93932248609998e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,24240,0.0489848284310657,0.00368424247565676,0.0417637131787785,0.056205943683353,3.38865622368132e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COLEC12,Collectin-12,29454,0.0245862849832838,0.00185011312909533,0.0209600632502569,0.0282125067163106,3.4978417492211e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTA,Lymphotoxin-alpha,29434,0.0373972837828272,0.00281447250528943,0.03188091767246,0.0429136498931945,3.57258272996456e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BST2,Bone marrow stromal antigen 2,29694,0.0489265357464111,0.00368434027015116,0.0417052288169148,0.0561478426759074,3.95855096865693e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPL14,60S ribosomal protein L14,24240,0.0375151412494984,0.00283093964359055,0.0319664995480609,0.0430637829509359,6.06558250010204e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL14,C-C motif chemokine 14,29435,0.036787335790349,0.00277857546897344,0.0313413278711611,0.042233343709537,6.73804842412414e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.0458774181946726,0.00346975614285181,0.0390766961546831,0.0526781402346622,8.47949265497395e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C7,Complement component C7,24374,-0.0302006893559326,0.00228432209285043,-0.0346779606579194,-0.0257234180539457,9.11846302999955e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENAH,Protein enabled homolog,28931,0.0442325679356532,0.00334693061199157,0.0376725839361498,0.0507925519351567,9.26965434661072e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPOCK1,Testican-1,29218,0.0238776121789196,0.00180807408888433,0.0203337869647063,0.0274214373931328,1.05172281828731e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.0379491177691594,0.00288160024388024,0.0323011812911541,0.0435970542471646,1.78606302969821e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.0339749825253799,0.0025805911830037,0.0289170238066927,0.0390329412440672,1.87765691596996e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.0563334212612381,0.00427871830500786,-0.0647197091390535,-0.0479471333834227,1.88259754787588e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,0.0358278976580037,0.0027236551202984,0.0304895336222189,0.0411662616937886,2.06996761837669e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,24445,0.0651978089505125,0.00496244949798522,0.0554714079344614,0.0749242099665635,2.7025708061482e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.0642249646304149,0.00489907034273383,0.0546227867586565,0.0738271425021732,3.94272021298329e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL20,C-C motif chemokine 20,29786,0.0806627676446053,0.00615674229273332,0.068595552750848,0.0927299825383626,4.14039555094059e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK7,Kallikrein-7,23801,0.0360613052369061,0.00275305571369111,0.0306653160380715,0.0414572944357407,4.57674594628877e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDGF,Hepatoma-derived growth factor,29688,0.0857729298844389,0.00656175900624258,0.0729118822322034,0.0986339775366744,6.12797132277799e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_E,,29434,0.0266090704187838,0.00203673608352083,0.022617067695083,0.0306010731424847,6.73563065486019e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0514085505853177,0.00393840867973731,0.0436892695730326,0.0591278315976029,8.2134876567846e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.0401059815188893,0.0030771700247156,0.0340747282704467,0.0461372347673318,1.01712114771979e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFR,Epidermal growth factor receptor,29820,0.0149621163340288,0.00115084332547497,0.0127064634160979,0.0172177692519598,1.53742228967402e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.10381894662611,0.00799214528552387,0.0881543418664829,0.119483551385736,1.85892718191344e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.0435329799860084,0.00335572216140771,0.0369557645496493,0.0501101954223675,2.32731084117397e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.0299416469931295,0.00230926912189994,0.0254154795142056,0.0344678144720534,2.42856323505409e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL15,C-C motif chemokine 15,29820,0.0400212712826109,0.0030893639260744,0.0339661179875051,0.0460764245777167,2.810276867266e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APRT,Adenine phosphoribosyltransferase,29192,0.0433942432690279,0.00335347018284138,0.0368214417106588,0.049967044827397,3.40515135396276e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMIGO2,Amphoterin-induced protein 2,29349,0.020843045505069,0.00161093942267242,0.017685604236631,0.0240004867735069,3.47458984247386e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APLP1,Amyloid-like protein 1,29478,-0.0465603357094923,0.00360959320107899,-0.0536351383836071,-0.0394855330353774,5.7742057776895e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.0829902862296818,0.00643478882782876,0.0703781001271374,0.0956024723322261,6.22892083679284e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB8,Serpin B8,29786,0.0509103166171974,0.00395093520217079,0.0431664836209426,0.0586541496134521,6.84824643106494e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN2,Nectin-2,29433,0.0269418523944411,0.00209108518689805,0.0228433254281209,0.0310403793607613,7.00038652506447e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G15,Phospholipase A2 group XV,29566,0.0239940114511976,0.00186263821023669,0.0203432405591337,0.0276447823432615,7.21393613793965e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,24951,0.023565846010375,0.00183266218092692,0.0199738281357583,0.0271578638849918,1.01168364238833e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XRCC4,DNA repair protein XRCC4,28774,0.0334139678790338,0.0026013521237847,0.0283153177164158,0.0385126180416518,1.16705696005642e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMA4,Laminin subunit alpha-4,29581,0.0300542168241856,0.00234585828900745,0.025456334577731,0.0346520990706402,1.77636715866601e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMS,Spermine synthase,24101,0.0576213167849669,0.00449997545518613,0.0488013648928021,0.0664412686771317,2.04140692202111e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0473750256629856,0.00370145103193023,0.0401201816404023,0.0546298696855688,2.17880684441995e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0674365693750184,0.00527252649150181,0.0571024174516749,0.077770721298362,2.45161099803558e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.0337138584705057,0.00263777977222286,0.0285438101169489,0.0388839068240625,2.62649383635164e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VGF,Neurosecretory protein VGF,24867,0.0272586255088454,0.00213360423403148,0.0230767612101437,0.0314404898075472,2.93020795883029e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN3,Calsyntenin-3,24845,0.0273979506444199,0.00214584368941083,0.0231920970131747,0.0316038042756652,3.24367510712301e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX6,Syntaxin-6,28797,0.0603014785039612,0.00472566178297694,0.0510391814093264,0.069563775598596,3.43974676614819e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.0482459054968027,0.00378236971821467,0.040832460849102,0.0556593501445035,3.8291203662876e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXN,Thioredoxin,24647,0.0392649581507216,0.00307876671115571,0.0332305753968564,0.0452993409045867,3.90829686314506e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0378100986235014,0.00296921197358456,0.0319904431552757,0.0436297540917272,5.02756088708868e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,29434,0.0457895120216661,0.00360023673061851,0.0387330480296538,0.0528459760136784,5.84281230196621e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPB6,Heat shock protein beta-6,29725,0.0342912141758251,0.00269801528175948,0.0290031042235765,0.0395793241280737,6.51076839214576e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL8,Interleukin-8,29218,0.060398529940796,0.00476056156477752,0.051067829273832,0.0697292306077599,8.70121012990524e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM,Paralemmin-1,24657,0.0266249464104517,0.0021018393386488,0.0225053413067,0.0307445515142033,1.16563839591727e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMM2,Phosphomannomutase 2,24111,0.0533785657288934,0.00422896599047614,0.0450897923875601,0.0616673390702266,2.07923328082091e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0229581168905152,0.0018200892635051,0.0193907419340452,0.0265254918469852,2.29084002800135e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,28797,0.0295986978212128,0.00235194399456245,0.0249888875918704,0.0342085080505552,3.19001699574324e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BGN,Biglycan,28750,-0.10584173782036,0.00841546619310764,-0.122336051558851,-0.0893474240818693,3.5173505414768e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.0364815102532359,0.00290160129830288,0.0307943717085623,0.0421686487979095,3.70179361663228e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TF,Serotransferrin,24966,0.0190863030546675,0.00151922385297837,0.0161086243028299,0.0220639818065051,4.3277089754846e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPL,Periplakin,24229,0.028827877992787,0.00230091880881229,0.0243180771275149,0.033337678858059,6.70852993552658e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAA10,N-alpha-acetyltransferase 10,24111,0.0448801096052304,0.00358229630736828,0.0378588088427886,0.0519014103676722,6.7631452652344e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSME2,Proteasome activator complex subunit 2,29081,0.0318177829688089,0.00254359195128954,0.0268323427442814,0.0368032231933364,8.24448294431636e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL2A1,Collagen alpha-1(II) chain,24240,0.0710012431912395,0.00567823810065678,0.0598718965139522,0.0821305898685268,9.14391696522749e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNB2,Plexin-B2,29701,0.0209345781408848,0.00167570480995493,0.0176501967133731,0.0242189595683964,1.00273835272862e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0499142765721631,0.0040190987909239,0.0420368429419522,0.0577917102023739,2.52846399732986e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0476848470635169,0.00384359851319718,0.0401513939776504,0.0552183001493834,2.96154698175645e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0488029776140194,0.00394348539078148,-0.0565322089799511,-0.0410737462480877,4.33223745737514e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.057613243426724,0.0046550880539974,0.0484892708408891,0.0667372160125589,4.45003781176167e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.048826295529613,0.00394885529043106,0.0410865391603682,0.0565660518988579,5.16633483794918e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PER3,Period circadian protein homolog 3,24229,0.104296564378399,0.0084428608126648,0.0877485571855755,0.120844571571222,5.96422314274213e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCAM1,Vascular cell adhesion protein 1,29545,-0.0236756267313999,0.00191787377262402,-0.027434659325743,-0.0199165941370568,6.34305599206349e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QA,Complement C1q subcomponent subunit A,29646,-0.0196702210080891,0.00159399618362871,-0.0227944535280014,-0.0165459884881768,6.70403129404862e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP6,Gastrotropin,28872,0.048753801802659,0.00395141488688021,0.0410090286243738,0.0564985749809442,6.89772967214336e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHPS,Deoxyhypusine synthase,24793,0.0353474235538967,0.00286528215541838,0.0297314705292767,0.0409633765785167,7.29640671235589e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,29536,-0.0390735557447016,0.00317120115540722,-0.0452891100092998,-0.0328580014801035,8.46388184859119e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0437076775828031,0.00354972745827868,0.0367502117645769,0.0506651434010293,9.73385155264952e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAM2,Neural cell adhesion molecule 2,29443,-0.0233017634110982,0.00189339886196469,-0.027012825180549,-0.0195907016416474,1.01310185234128e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDF1,Endothelial differentiation-related factor 1,24867,0.0588409748758242,0.00478370528177686,0.0494649125235415,0.0682170372281068,1.13852400582719e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.0310264835748967,0.00252531061003039,0.0260768747792371,0.0359760923705562,1.36214904376315e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRSF1,G-rich sequence factor 1,23862,0.0697830370007336,0.00568110207658705,0.058648076930623,0.0809179970708442,1.41570147231496e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREML1,Trem-like transcript 1 protein,24951,0.045528466781284,0.00370973535060074,0.0382573854941065,0.0527995480684614,1.59702260064142e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.063017328944353,0.00513684999201812,0.0529491029599975,0.0730855549287085,1.63958059239779e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWC2,Brorin,29114,0.0343507324211794,0.00280231894330809,0.0288581872922956,0.0398432775500633,1.85219062010292e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGMB,RGM domain family member B,29694,0.0231837760159655,0.00189155325516014,0.0194763316358516,0.0268912203960794,1.87922792284272e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,24326,0.046828574694432,0.00382010774098228,0.0393411635221068,0.0543159858667573,1.91351041980621e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSNK1D,Casein kinase I isoform delta,24229,0.0549970793977711,0.00449478501525073,0.0461873007678796,0.0638068580276625,2.52912297196101e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY75,Lymphocyte antigen 75,29434,0.0333711809383426,0.00272897439498462,0.0280223911241728,0.0387199707525125,2.65360416877069e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELOB,Elongin-B,24111,0.0341083653741654,0.0027889588255169,0.0286420060761522,0.0395747246721785,2.72386372651561e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR5,Complement factor H-related protein 5,24623,0.035913035950282,0.00293902410701593,0.0301525487005307,0.0416735232000332,3.07875133705901e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP2,Retinol-binding protein 2,29349,-0.0658720306131865,0.00539491707009187,-0.0764460680705665,-0.0552979931558064,3.3277279541798e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.0370509275234067,0.00303540470284618,0.0311015343058282,0.0430003207409852,3.60857415826728e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.053164866575187,0.00435667279288069,0.0446257879011408,0.0617039452492331,3.77162416231575e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAPK2,Death-associated protein kinase 2,24229,0.0459917501604584,0.00377506876235201,0.0385926153862485,0.0533908849346684,4.81612360069333e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,24951,0.054073558971645,0.0044392640265827,0.0453726014795429,0.0627745164637471,4.91886057430075e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA2,Carbonic anhydrase 2,29368,0.0585347657643719,0.00482157654494446,0.0490844757362807,0.067985055792463,7.79830620377162e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD276,CD276 antigen,29454,-0.0306544815018123,0.00252512784357448,-0.0356037320752183,-0.0257052309284064,7.83181629568966e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.0135124736444678,0.00111324035395808,0.01133052255071,0.0156944247382257,7.98767257624783e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.0297069555033726,0.0024502682043977,0.0249044298227531,0.0345094811839921,9.49795900149629e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFA,Protransforming growth factor alpha,29434,0.0397164878256039,0.00328133717889987,0.0332850669549602,0.0461479086962476,1.21306188824831e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.028768794821948,0.00237908250918429,0.0241057931039468,0.0334317965399492,1.39157573141641e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LBP,Lipopolysaccharide-binding protein,29594,-0.0495111236057331,0.00409725492576608,-0.0575417432602346,-0.0414805039512316,1.53996145010292e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNGR2,Interferon gamma receptor 2,29218,0.0442105035166323,0.00365894956645636,0.0370389623663778,0.0513820446668867,1.56489810827577e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0525022406261715,0.00434530573300747,0.0439854413894769,0.0610190398628662,1.63331894283375e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.0253677239262717,0.0021092390555224,0.0212336153774478,0.0295018324750956,3.0698964120851e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRN,Progranulin,29313,0.020841533000762,0.00173335657651976,0.0174441541107832,0.0242389118907407,3.19042329494976e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0332227289431896,0.00277480076367655,0.0277841194463836,0.0386613384399957,5.88856729901833e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.050183380123838,0.00419415436421523,0.0419628375699761,0.0584039226776998,6.47659840348043e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.0816074819912761,0.00683133484973278,0.0682180656857999,0.0949968982967523,8.11007816868418e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CR1,Complement receptor type 1,24903,0.0301830710184928,0.00252719517589679,0.0252297684737351,0.0351363735632505,8.65030603658307e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.0347053554787118,0.00290591946411813,0.0290097533290403,0.0404009576283834,8.74274047070812e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRR3,Small proline-rich protein 3,24845,0.0568522936093042,0.00477801974551643,0.047487374908092,0.0662172123105164,1.47363811249163e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIT,Citron Rho-interacting kinase,24195,0.0379204110399183,0.00318874505692215,0.0316704707283509,0.0441703513514857,1.60592133851944e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.0408295021370979,0.00343988859398303,0.0340873204928911,0.0475716837813046,2.02305328918126e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEK,Angiopoietin-1 receptor,29566,0.0181787465451155,0.00153464652295499,0.0151708393601237,0.0211866537301073,2.68513961667438e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD101,Immunoglobulin superfamily member 2,24805,0.035562518046018,0.0030127128291067,0.0296576009009689,0.0414674351910671,4.52801618797696e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0607296449724014,0.00514819889215323,0.0506391751437811,0.0708201148010217,4.83578777368383e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP9,Caspase-9,24229,0.0522207910369589,0.00443192526291084,0.0435342175216536,0.0609073645522641,5.84923565372877e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPME1,Protein phosphatase methylesterase 1,29349,0.049372212869697,0.00419724607979387,0.041145610553301,0.057598815186093,7.14037375517373e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0392749118145979,0.00333990381155265,0.0327287003439547,0.0458211232852411,7.68355915398191e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO1,Roundabout homolog 1,29497,0.0198758122997004,0.00169204971099035,0.0165593948661593,0.0231922297332415,8.6567507684849e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.0551019263366348,0.00469196545513592,0.0459056740445684,0.0642981786287012,8.92758012205219e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.0353680085774783,0.00301250499101341,0.029463498795092,0.0412725183598645,9.60168896529228e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,29433,0.0613693990522871,0.00522854955206679,0.0511214419302362,0.071617356174338,9.65287140869405e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX5,Sorting nexin-5,24240,0.0245801544337678,0.00210055408838016,0.0204630684205427,0.0286972404469929,1.51824569888145e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,29349,0.0297330273089229,0.00254440203740637,0.0247459993156064,0.0347200553022393,1.77208538379194e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0495522760229168,0.00425367304259064,0.0412150768594391,0.0578894751863945,2.79426643696213e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,29820,0.0285803802086845,0.00245759619599184,0.0237634916645405,0.0333972687528285,3.41176910619333e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYM,Ketimine reductase mu-crystallin,24101,0.0623921468078575,0.0053704782708584,0.0518660093969751,0.07291828421874,4.06012882964119e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.0441958933325386,0.00381699211339523,0.0367145887902839,0.0516771978747932,6.34598161445123e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRDT,Bromodomain testis-specific protein,24111,0.0300015775371114,0.00259380989970447,0.0249177101336907,0.0350854449405322,7.34092571163632e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPCAM,Epithelial cell adhesion molecule,29457,-0.0786593048445701,0.00680726926836774,-0.0920015526105709,-0.0653170570785693,8.09949418518611e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0237148210073756,0.00205238397228299,-0.0277374935930502,-0.0196921484217009,8.14201311217383e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGKZ,Diacylglycerol kinase zeta,28931,0.0288041524086559,0.00249470900823385,0.0239145227525175,0.0336937820647942,9.02432699302568e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBS,Cystathionine beta-synthase,24240,0.0416250548396901,0.00360480658607106,0.0345596339309908,0.0486904757483893,9.1920599996536e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA6,Carbonic anhydrase 6,29372,-0.0511934311563056,0.00444005654391578,-0.0598959419823805,-0.0424909203302306,1.08585262495454e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.0388163695444147,0.00336999720961063,0.0322111750135779,0.0454215640752516,1.24714143179505e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHCHD6,MICOS complex subunit MIC25,24793,0.0235025487860789,0.00204032036328509,0.0195035208740402,0.0275015766981177,1.26590207912797e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD80,T-lymphocyte activation antigen CD80,24922,0.027701065623078,0.00240588249792109,0.0229855359271526,0.0324165953190033,1.34230903964467e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.0400959883163373,0.00348766448553661,0.0332601659246855,0.0469318107079891,1.64820103194881e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIMAP8,GTPase IMAP family member 8,24016,0.0412280842538352,0.003587730453407,0.0341961325651575,0.0482600359425129,1.75096336355604e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,0.0314140719162377,0.00273452292158298,0.0260544069899351,0.0367737368425404,1.76364440557583e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAT,Catalase,24587,0.0431406151650142,0.00376436501284367,0.0357624597398406,0.0505187705901878,2.49454714032847e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCF2,Neutrophil cytosol factor 2,29395,0.066786715854739,0.00583021669012103,0.0553594911421017,0.0782139405673762,2.5664187064965e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0631073536377133,0.00550927985542301,-0.0739055421543424,-0.0523091651210842,2.58114704176035e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.0272844394607435,0.00238461815356258,0.0226105878797609,0.0319582910417262,2.98835274610638e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0351288830186437,0.0030707452591089,0.0291102223107903,0.0411475437264972,3.16097458779166e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.0549230940210379,0.00481055632342645,0.045494403627122,0.0643517844149537,4.0808542478489e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSDE1,Cold shock domain-containing protein E1,24111,0.094873930833438,0.00833269335092155,0.0785418518656317,0.111206009801244,5.87450627690628e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2orf69,UPF0565 protein C2orf69,24195,0.0477004847904101,0.00419389300080628,0.0394804545088298,0.0559205150719904,6.72815962790721e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0291544774692201,0.00256639874072053,0.0241243359374079,0.0341846190010323,7.65127452421524e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.040452352184139,0.00356475900145488,0.0334654245412875,0.0474392798269906,8.76610933869498e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.0378020502257635,0.00333208729459377,0.0312711591283597,0.0443329413231673,9.09904984698366e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA4,Carbonic anhydrase 4,29820,-0.0189037231346642,0.00167038641879762,-0.0221776805155075,-0.0156297657538208,1.24304188659767e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.0255688904876515,0.00226420471054738,0.0211310492549787,0.0300067317203244,1.63860274851009e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS7_LGALS7B,Galectin-7,29320,0.0332075703308599,0.00294784083871641,0.0274298022869757,0.0389853383747441,2.24390005002906e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANSC1,MANSC domain-containing protein 1,29566,-0.0217413192737876,0.00193750033105662,-0.0255388199226586,-0.0179438186249166,3.67069838116232e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA3,Protein disulfide-isomerase A3,24381,0.019772978793697,0.00176473453957647,0.0163140990961272,0.0232318584912669,4.56434893388952e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17D,Interleukin-17D,28931,0.026874982701406,0.00240066681731299,0.0221696757394726,0.0315802896633395,4.96138909063185e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTRK3,NT-3 growth factor receptor,29694,-0.0170203498500201,0.00152204124108963,-0.0200035506825558,-0.0140371490174844,5.67095557935482e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRH,Corticoliberin,28751,0.0681829977748483,0.00610644618824535,0.0562143632458874,0.0801516323038092,6.87960118759745e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0298898440553414,0.0026801561225803,0.024636738055084,0.0351429500555988,8.19306710419376e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.0516758316187866,0.00466148209737924,0.0425393267079233,0.0608123365296499,1.72491815927892e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0497428308434865,0.0044883940066416,0.040945578590469,0.058540083096504,1.74144041936929e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.0294388118185779,0.00265862715850793,0.0242279025879024,0.0346497210492534,1.93640037948502e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK4,Kallikrein-4,29725,-0.0489532345541138,0.00442166459030407,-0.0576196971511098,-0.0402867719571178,1.96673644903794e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL5,Insulin-like peptide INSL5,24805,0.076082554366596,0.00687405388506002,0.0626094087518783,0.0895556999813136,2.0889390966034e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,29478,0.0518605367865324,0.00469623880319861,0.0426559087322632,0.0610651648408017,2.693361891257e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A12,Protein S100-A12,29023,0.0579947596956144,0.00527066816773443,0.0476642500868549,0.0683252693043739,4.18711515789749e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,29378,0.0314194225135969,0.00286146223107962,0.0258109565406809,0.0370278884865129,5.39488393993675e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK6,Kallikrein-6,29519,0.0236066541655448,0.00215196251963715,0.019388807627056,0.0278245007040336,6.0445254949668e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300A,CMRF35-like molecule 8,24381,0.0230490708042332,0.00211080399277032,0.0189118949784033,0.027186246630063,1.07740823292922e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPG,Macrophage-capping protein,29174,0.0446320008974544,0.00409694245444593,0.0366019936867404,0.0526620081081684,1.39181907738396e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPQ,Carboxypeptidase Q,24920,0.0282699368887964,0.00259547767156582,0.0231828006525274,0.0333570731250654,1.45223963421615e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BSG,Basigin,29760,0.015688614695295,0.00144267317430455,0.012860975273658,0.0185162541169319,1.71448551528428e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.0406728733130956,0.0037556023497944,0.0333118927074986,0.0480338539186927,2.85689648697862e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR2,Complement factor H-related protein 2,24789,0.0433446816755222,0.00401383417933828,0.0354775666840191,0.0512117966670252,4.00692368193117e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIT,Vitrin,24922,0.0285901306969319,0.00264948873116602,0.0233971327838465,0.0337831286100173,4.36707024418356e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.0436326166962432,0.00404448794072202,0.035705420332428,0.0515598130600584,4.39396283637748e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.0494870552357857,0.00459051773587081,0.0404896404734789,0.0584844699980925,4.79378002464168e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.023408327539673,0.00217211695744305,0.0191509783030846,0.0276656767762614,5.10545654625189e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.018845347437212,0.00175004613996465,0.0154152570028813,0.0222754378715427,5.45082742334189e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0282143080331829,0.00262058037368386,0.0230779705007625,0.0333506455656033,5.70680124204891e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.0258674250767013,0.0024094074938329,-0.0305898637646138,-0.0211449863887888,7.89959580411126e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINI2,Serpin I2,24805,0.0428681751166492,0.00399496019468321,0.0350380531350701,0.0506982970982282,8.37711285328114e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIPF,Gastric triacylglycerol lipase,24240,0.046082287086683,0.00429931060631927,0.0376556382982973,0.0545089358750688,9.56592488431102e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS22,Brain-specific serine protease 4,24229,0.0263964621332762,0.00246389908216361,0.0215672199322355,0.0312257043343168,1.01213027589575e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0326218568974429,0.00304644234316364,0.0266508299048421,0.0385928838900436,1.04359996208644e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX1,Peroxiredoxin-1,28669,-0.0678335652936904,0.00634506667441989,-0.0802698959755534,-0.0553972346118274,1.26235583792526e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0297043817113667,0.00278327600288729,0.0242491607457076,0.0351596026770258,1.53164864141096e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAM,Signal transducing adapter molecule 1,24793,0.0275939800622312,0.00259403904128211,0.0225096635413183,0.0326782965831441,2.27436009032808e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN4B,Sodium channel subunit beta-4,24240,0.0318812069358934,0.00300607084790954,0.0259893080739907,0.0377731057977961,3.2038230757715e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHCY,Adenosylhomocysteinase,29478,0.0502838832064816,0.00474275272251547,0.0409880878703513,0.0595796785426119,3.24318760567051e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASET2,Ribonuclease T2,29697,0.019773973604741,0.00186637617374968,0.0161158763041916,0.0234320709052903,3.50664186499961e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.040271530957268,0.00380481486249486,0.0328140938267781,0.0477289680877579,3.9257290592061e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.0190299766650458,0.00179797515715424,-0.0225540079730681,-0.0155059453570235,4.02378960323146e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALCAM,CD166 antigen,29820,0.0145431674613848,0.00137499084687036,0.0118481854015189,0.0172381495212507,4.24169102355184e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA12,Serpin A12,28628,0.0829285782537003,0.00785956644218156,0.0675238280270244,0.0983333284803761,5.59261875215623e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.0333362650589908,0.00316143296838711,0.027139856440952,0.0395326736770295,6.12353759660764e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LACRT,Extracellular glycoprotein lacritin,24732,0.0369366726872093,0.00350457546186867,0.0300677047819467,0.0438056405924719,6.44308370651491e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.0411669355651887,0.00392343901842568,0.0334769950890743,0.048856876041303,1.06180355771675e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST5,Cystatin-D,28890,0.0409858595217035,0.00390820955813038,0.0333257687877679,0.048645950255639,1.10109599026533e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,28797,0.0349573873172973,0.00333632024632916,0.0284181996344921,0.0414965750001024,1.21476210491852e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SBSN,Suprabasin,24905,-0.0254204687342403,0.00242681333638208,-0.0301770228735492,-0.0206639145949314,1.27457888017385e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLU,Clusterin,24966,0.0233917239223756,0.0022343936756412,0.0190123123181188,0.0277711355266323,1.35577174093677e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBP1,Z-DNA-binding protein 1,24229,0.0299766169970163,0.00286539047064292,0.0243604516745562,0.0355927823194764,1.46963352009905e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIGR,Polymeric immunoglobulin receptor,29115,0.0265857517725087,0.00254203162457693,0.0216033697883379,0.0315681337566795,1.48752589987101e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX2,Sorting nexin-2,24793,0.0597799201794843,0.00572455644328409,0.0485597895506475,0.0710000508083211,1.78713529583802e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCT,Secretin,24195,0.0344784962555393,0.0033030887189164,0.0280044423664631,0.0409525501446154,1.87829167448183e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.0252022455479701,0.00241620105028622,0.0204664914894091,0.0299379996065311,1.99302167833055e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD2,Sushi domain-containing protein 2,29443,-0.0209232544660067,0.00200830142028772,-0.0248595252497706,-0.0169869836822428,2.26272115430202e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.0359134119739511,0.00344894422203445,0.0291534812987636,0.0426733426491386,2.44297394688878e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A13,Protein S100-A13,24229,0.0257539730949788,0.0024765858167664,0.0208998648941166,0.0306080812958409,2.83277168373749e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL2,Fc receptor-like protein 2,29645,0.0359946631007622,0.00346381068119612,0.0292055941656178,0.0427837320359066,2.99120941432742e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.0374804700468089,0.00360709674997852,0.030410560416851,0.0445503796767667,3.08665253994409e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.0189006122707375,0.00181965239544719,0.015334093575661,0.022467130965814,3.14093018922371e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0187685616103628,0.00180812248124928,0.0152246415471143,0.0223124816736114,3.37472393841111e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAS2,Growth arrest-specific protein 2,24445,0.0385465541349514,0.00372025706136647,0.0312548502946731,0.0458382579752297,4.19362676635178e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XG,Glycoprotein Xg,29693,0.0234121881482802,0.0022627752123451,0.0189771487320838,0.0278472275644766,4.77955647871316e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.0174050229677888,0.00168307112207196,-0.0207038423670499,-0.0141062035685278,5.05999741065035e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECE1,Endothelin-converting enzyme 1,28774,0.025642640191424,0.00248129712187999,0.0207792978325392,0.0305059825503088,5.44863103940111e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.0248334349760247,0.00241121852839898,-0.0295594232916867,-0.0201074466603627,7.84996269309833e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.0432104259551625,0.00419776282588555,0.0349828108164268,0.0514380410938982,8.46475923240418e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPHS1,Nephrin,24229,0.0246986954727199,0.00240037861145402,0.0199939533942701,0.0294034375511698,8.83868427140139e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.0191118446489704,0.00185865126552966,0.0154688881685323,0.0227548011294085,9.28922307033777e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD1,Programmed cell death protein 1,29661,0.0309763923261343,0.00301536204900919,0.0250662827100763,0.0368865019421923,1.02748775788852e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP12,Macrophage metalloelastase,29466,0.038314465209641,0.00373134481999005,0.0310010293624605,0.0456279010568215,1.07802792659802e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD59,CD59 glycoprotein,28277,0.0166370827136741,0.0016204704645011,0.013460960603252,0.0198132048240963,1.09870075769283e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.041928855030242,0.00408485625363471,0.033922536773118,0.049935173287366,1.12129160561816e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.0187930843387118,0.00183336474310496,0.015199689442226,0.0223864792351975,1.31701489168591e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,24240,0.0173152965071747,0.00169151390309544,0.0139999292571077,0.0206306637572418,1.52567212197675e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH5,Cadherin-5,29820,-0.0218284465142198,0.00213445553656121,-0.0260119793658798,-0.0176449136625598,1.65273994022486e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAST,Gastrin,24845,0.0936537233609453,0.0091662873899049,0.0756878000767317,0.111619646645159,1.85670841370519e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.0237073216438138,0.00232547921696657,-0.0282652609090683,-0.0191493823785593,2.34013986617138e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GC,Vitamin D-binding protein,24966,0.0185667122177835,0.00182161652581794,0.0149963438271803,0.0221370806083867,2.39219246343231e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,28797,0.0421714486737193,0.00414596070875746,0.0340453656845546,0.0502975316628839,2.91552334187849e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.0265469062660495,0.00261092675148345,0.0214294898331419,0.031664322698957,3.08627710796567e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR2,Folate receptor beta,29694,-0.0209232436767278,0.00205867656834657,-0.0249582497506871,-0.0168882376027685,3.16324247536763e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300LF,CMRF35-like molecule 1,29725,0.0430928026971809,0.00424009380937192,0.0347822188308119,0.0514033865635498,3.1717444929854e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYGD,Gamma-crystallin D,24845,0.0691886054028571,0.00681133802850848,0.0558383828669805,0.0825388279387338,3.409116177716e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.0410744769032486,0.00404433040023893,0.0331475893187802,0.0490013644877169,3.41943941685365e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COPB2,Coatomer subunit beta',24111,0.0307600021040694,0.0030306400845899,0.0248199475382732,0.0367000566698656,3.71849405823258e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,0.0233175499278726,0.00230805635916789,0.0187937594639035,0.0278413403918417,5.88576005442558e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RCOR1,REST corepressor 1,28916,0.0316755002459488,0.00313999054575558,0.0255211187762678,0.0378298817156297,6.8544766524406e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JAM2,Junctional adhesion molecule B,29694,0.0189311302264564,0.00187772303534138,0.0152507930771873,0.0226114673757255,7.25331839232921e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.0300274309835608,0.00298137838337795,0.02418392935214,0.0358709326149816,8.07592571870945e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.0300496947735675,0.00299136425742214,0.0241866208290201,0.0359127687181149,1.05014160626852e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM3,Myomesin-3,24381,-0.0660353817593357,0.00657674278554227,-0.0789257976189986,-0.0531449658996729,1.12201056705975e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM4,Intercellular adhesion molecule 4,29434,-0.037107528613652,0.00369880641486389,-0.0443571891867853,-0.0298578680405188,1.19989785058091e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.0258746370936972,0.00258121472226085,0.0208154562380659,0.0309338179493285,1.30061023984174e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMNB2,Lamin-B2,24845,0.0196902153538937,0.00197077717661802,0.0158274920877224,0.023552938620065,1.84649334722985e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEL1L,Protein sel-1 homolog 1,24240,0.0224676883669653,0.00224963939007317,0.0180583951624219,0.0268769815715087,1.92422623233894e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.0355169740235254,0.00355757331981973,0.0285441303166787,0.0424898177303721,1.96555920385803e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0229579132304183,0.00230439733449666,0.0184412944548048,0.0274745320060317,2.45554285510342e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,29443,-0.0365736482539436,0.00368712607035242,-0.0438004153518343,-0.0293468811560529,3.73181760430902e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSB,Cathepsin B,29480,-0.0365594524053209,0.00368744170498785,-0.0437868381470971,-0.0293320666635448,3.91062305816757e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.0716830236465892,0.00722981070910779,0.0575125946567379,0.0858534526364405,3.95906343060844e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG4,Regenerating islet-derived protein 4,29497,0.0345576603138568,0.00349304876866627,0.0277112847272709,0.0414040359004427,4.8364934592687e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA12,Carbonic anhydrase 12,29349,-0.0226205614565323,0.00229145887926009,-0.0271118208598821,-0.0181293020531826,5.99724455838894e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB6,Integrin beta-6,28931,0.0210906663198566,0.00213798801683451,0.016900209806861,0.0252811228328523,6.43417527308297e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMOX1,Heme oxygenase 1,29165,-0.0332492098932935,0.0033779040003572,-0.0398699017339936,-0.0266285180525934,7.96468125904726e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.0582163557052721,0.00592325062506341,0.0466067844801478,0.0698259269303964,9.2230116448137e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.0248175811384812,0.00252852175055597,0.0198616785073915,0.029773483769571,1.05092987372508e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHAD,Chondroadherin,24381,0.0358060630988703,0.00365035088225814,0.0286513753696443,0.0429607508280962,1.13509330426901e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFC1,Cryptic protein,28797,0.0324410684064765,0.00330979833588776,0.0259538636681365,0.0389282731448165,1.20333574150495e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRL,Prolactin,29694,-0.052224054896097,0.00532841630187601,-0.062667750847774,-0.04178035894442,1.20605124030773e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFAP1,Actin filament-associated protein 1,24381,0.0580413076941287,0.00592367111085402,0.0464309123168549,0.0696517030714026,1.26193446217199e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA7,Thyroxine-binding globulin,24966,0.0127729018392795,0.00130377859701943,0.0102174957891214,0.0153283078894376,1.27616138481224e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.0581028386115901,0.00593695182011892,0.046466413044157,0.0697392641790232,1.39119863362847e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD248,Endosialin,24938,-0.0275854170212961,0.00283244944750616,-0.0331370179384082,-0.0220338161041841,2.25204041214202e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.0269688877792,0.00277243160685036,0.0215349218297733,0.0324028537286267,2.52240700457955e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.0321283576202518,0.00330334705321493,0.0256537973959506,0.0386029178445531,2.5289921777726e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0293324390381796,0.00301604778199451,0.0234209853854704,0.0352438926908889,2.53659146401215e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGA,Fibrinogen alpha chain,24407,0.0211684372674464,0.00217695759706039,0.016901600377208,0.0254352741576847,2.61888827050643e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PVALB,Parvalbumin alpha,29599,0.0766345258484461,0.00789047885594344,0.061169187290797,0.0920998644060953,2.88577939500082e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.0202996458467095,0.00209300842974561,0.0161973493244081,0.0244019423690109,3.29581925650545e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.0297671218313941,0.00307022109531086,-0.0357847551782034,-0.0237494884845849,3.4022995593068e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR2,TGF-beta receptor type-2,29566,0.0223017601047636,0.00230352277756058,0.0177868554607448,0.0268166647487823,3.89471849586047e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,-0.028697380186725,0.00296762165554875,-0.0345139186316005,-0.0228808417418494,4.3559897948962e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA1,Carbonic anhydrase 1,28867,0.040577714644003,0.00419794154622667,0.0323497492133988,0.0488056800746073,4.53754284454262e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.0386035234123471,0.0039939854215987,0.0307753119860137,0.0464317348386806,4.562085447357e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.0262536078836703,0.00271795870994183,0.0209264088121843,0.0315808069551563,4.91911946692757e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.014215052354722,0.00147401448126054,0.0113259839714514,0.0171041207379927,5.63107945500605e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CENPF,Centromere protein F,24445,0.0368194029380642,0.00381994213615315,0.029332316351204,0.0443064895249244,6.00266335433972e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL3,Insulin-like 3,24845,0.0511394500581143,0.00531543602546544,0.040721195448202,0.0615577046680266,7.12309737869941e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK3,Dickkopf-related protein 3,29820,-0.0198866453147174,0.00206926547034552,-0.0239424056365946,-0.0158308849928402,7.76717897025466e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC16A1,Monocarboxylate transporter 1,28774,0.0390092051436831,0.00406445326565501,0.0310428767429993,0.0469755335443669,8.81736569894416e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSC,Dipeptidyl peptidase 1,29446,0.0289981931821934,0.00304849785472679,0.0230231373869289,0.0349732489774579,2.00221754520438e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE3,Eosinophil cationic protein,29343,0.072392011058158,0.00763166842707869,0.0574339409410837,0.0873500811752322,2.58225601998006e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300C,CMRF35-like molecule 6,29694,0.0230187519786833,0.00243127921124168,0.0182534447246496,0.027784059232717,3.06366178605672e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ULBP2,UL16-binding protein 2,29218,0.0253720483779181,0.00268566861398158,0.0201081378945142,0.030635958861322,3.73088187962803e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.0188946854331288,0.00200197458557352,-0.022818555620853,-0.0149708152454047,4.06883889560759e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0262645963448614,0.00278668154004005,0.0208027005263829,0.0317264921633399,4.67326535340582e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPO,Myeloperoxidase,29443,0.0303889594341662,0.00322800680832829,0.0240620660898427,0.0367158527784896,5.10500267894849e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSR,Insulin receptor,24229,0.0112515702328783,0.00119627250520458,0.00890687612267736,0.0135962643430793,5.62187853605827e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRDL1,Chordin-like protein 1,29536,0.0208250020460399,0.00221458749948545,0.0164844105470484,0.0251655935450314,5.64359844157008e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EBI3_IL27,Interleukin-27,29674,-0.0204448960597162,0.00217464763025972,-0.0247072054150253,-0.0161825867044072,5.75430633671334e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA11,Integrin alpha-11,29434,-0.0226189244559099,0.00240950189268444,-0.0273415481655714,-0.0178963007462484,6.57926872075661e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH1,Protocadherin-1,29713,0.0139722558568506,0.00149246936514884,0.0110470159011589,0.0168974958125423,8.37080947306549e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CABP2,Calcium-binding protein 2,24195,0.0430322347812685,0.0046002540371399,0.0340157368684743,0.0520487326940627,9.12194337349331e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD14,Monocyte differentiation antigen CD14,28954,0.0272047728793608,0.00291090539337219,0.0214993983083513,0.0329101474503703,9.75327941538399e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CX3CL1,Fractalkine,29218,-0.0221874469076935,0.00237630725310871,-0.0268450091237866,-0.0175298846916004,1.05963861996983e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD93,Complement component C1q receptor,28353,-0.0206567884259256,0.00221357264262138,-0.0249953908054635,-0.0163181860463877,1.11363129011775e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.0475397811676598,0.00509681091289675,0.0375500317783821,0.0575295305569374,1.17469482092514e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENSA,Alpha-endosulfine,24793,0.0346848218239212,0.00371892416105683,0.0273957304682498,0.0419739131795926,1.18207412232262e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTB,Lymphotoxin-beta,24793,0.0228972343873286,0.00245962041218807,0.01807637837944,0.0277180903952172,1.39082060576197e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1A,Protein phosphatase 1A,28797,0.0203835533216027,0.00219099669188672,0.0160891998055047,0.0246779068377007,1.45471022375267e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.0518644050123147,0.00558118619930899,0.0409252800616691,0.0628035299629603,1.6067565430474e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL3,Fc receptor-like protein 3,28931,0.0353238442371638,0.00380852812908069,0.0278591291041657,0.042788559370162,1.8972879450858e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.0183730285432069,0.00198139982952565,0.0144894848773366,0.0222565722090771,1.96096221569115e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFIC,Nuclear factor 1 C-type,24867,0.0290385844851602,0.00313447305086519,0.0228950173054644,0.035182151664856,2.11862743293283e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH1,Cadherin-1,28477,0.0261218920099189,0.0028204490193342,0.0205938119320239,0.0316499720878139,2.15114798568589e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.0188521714564892,0.00203910869483911,0.0148555184146046,0.0228488244983739,2.49827766311016e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CILP,Cartilage intermediate layer protein 1,24938,0.0353885736343882,0.00383511646592079,0.0278717453611835,0.0429054019075929,2.98347698512291e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDM1,Nuclear protein MDM1,24195,0.0203294648225076,0.00220589395368849,0.0160059126732782,0.024653016971737,3.32867452892367e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.0288968797339098,0.00314278909212597,0.0227370131133429,0.0350567463544767,4.05620667111105e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18BP,Interleukin-18-binding protein,29594,0.0199296521557678,0.00216996806724873,0.0156765147439603,0.0241827895675754,4.40431245094611e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.037832980001721,0.00412076697229347,0.0297562767360258,0.0459096832674162,4.60178427223413e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.0450935093522171,0.00491784078622516,0.0354545414112158,0.0547324772932184,5.12585968434418e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR15L,Protein GPR15L,24805,0.0392922494818877,0.00430613335462593,0.0308522281068208,0.0477322708569545,7.72482958608986e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAX,Apoptosis regulator BAX,28722,0.0579562922319418,0.00635244119164324,0.045505507496321,0.0704070769675625,7.73855887232295e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.0192039105120214,0.00210680259094187,0.0150745774337753,0.0233332435902674,8.33416070263118e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LUZP2,Leucine zipper protein 2,24793,0.028733818881666,0.00315411136573589,0.0225517606048237,0.0349158771585084,8.84786069149774e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.0234252129579192,0.00257270813777633,0.0183827050078776,0.0284677209079609,9.25518757564213e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGT,Angiotensinogen,24951,0.0147663231379739,0.00162635028059058,0.0115786765880164,0.0179539696879315,1.17021192124956e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,24845,0.023696099969355,0.00261315017222615,0.0185743256317918,0.0288178743069183,1.29930517610803e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.0266915610235784,0.00294565339605271,0.0209180803673151,0.0324650416798417,1.38080471474798e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE6,Ribonuclease K6,24828,0.0195749863740532,0.00216377175133304,0.0153339937414404,0.023815979006666,1.57881462952181e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,24111,0.0291396932184345,0.00322123341336726,0.0228260757282347,0.0354533107086343,1.59026252117164e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR4,Complement factor H-related protein 4,24892,0.0464571415174932,0.00515748038156938,0.0363484799696172,0.0565658030653692,2.25105087880117e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0161192611118615,0.00179336725713544,0.012604261287876,0.0196342609358469,2.65848242099891e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.0159199224294538,0.00177197896689381,0.0124468436543419,0.0193930012045657,2.7564220354614e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA14,Carbonic anhydrase 14,29725,-0.022425908130323,0.00250150930165696,-0.0273288663615707,-0.0175229498990754,3.28166233631688e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSHB,Thyrotropin subunit beta,29478,0.0484427028040692,0.00540616752607562,0.037846614452961,0.0590387911551774,3.41387163398242e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPM3,Tropomyosin alpha-3 chain,24111,-0.0278714685149417,0.00311160177041629,-0.0339702079849576,-0.0217727290449258,3.56326260101453e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.0212824308861772,0.00237729716392768,0.0166229284448789,0.0259419333274754,3.72360706912636e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAM,Integrin alpha-M,29443,-0.0199196483365206,0.00222548499993293,-0.0242815989363891,-0.015557697736652,3.7349793090324e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.0193589174412082,0.0021717397033734,0.0151023076225963,0.0236155272598201,5.26110302167751e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL9,C-X-C motif chemokine 9,29581,0.0416155905426206,0.00467165283692964,0.0324591509822385,0.0507720301030027,5.48172096063672e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN3,CCN family member 3,29795,0.0212009906460259,0.00238031294924158,0.0165355772655124,0.0258664040265394,5.54403915977382e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.0341375625698973,0.00383789933154852,0.0266152798800622,0.0416598452597324,6.24984609586625e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.0240677934867472,0.00270705335117928,0.0187619689184358,0.0293736180550585,6.48464512330271e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF1C,Kinesin-like protein KIF1C,24111,0.0227490932856254,0.00255933947972908,0.0177327879053564,0.0277653986658944,6.60877239033328e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF7,SLAM family member 7,29434,-0.0365640017166423,0.0041209715299696,-0.0446411059153827,-0.0284868975179019,7.53704598503491e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRK1,Protein BRICK1,28774,0.027771304828678,0.00314878325124248,0.0215996896562427,0.0339429200011132,1.21122325181702e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RALY,RNA-binding protein Raly,24793,0.0298348693826845,0.003389328841081,0.0231917848541657,0.0364779539112033,1.42246932790942e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGA,Glycoprotein hormones alpha chain,29443,0.0496218735971412,0.00564138566552578,0.0385647576927107,0.0606789895015717,1.49299634108992e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.0344056048955358,0.00391277870802342,0.0267365586278099,0.0420746511632617,1.54696753313597e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,24922,-0.0218828609311116,0.00249795287025237,-0.0267788485568062,-0.0169868733054169,2.06847988817875e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.0189900299404466,0.0021680939754572,-0.0232394941323427,-0.0147405657485505,2.07792462118787e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0210076504703872,0.00239928509876132,0.016305051676815,0.0257102492639594,2.15353717296004e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACAN,Aggrecan core protein,29192,0.0174031185115722,0.00198829728095561,0.0135060558408992,0.0213001811822452,2.19172113621542e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,28916,0.0332934526375103,0.00380426777917608,0.0258370877903252,0.0407498174846954,2.21557403301054e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFD,Vascular endothelial growth factor D,29732,-0.0220017619803491,0.00251667047346652,-0.0269344361083435,-0.0170690878523548,2.39971876834477e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PZP,Pregnancy zone protein,24966,0.0328057015046678,0.0037569105859716,0.0254421567561635,0.0401692462531721,2.65363324843382e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CR2,Complement receptor type 2,29594,0.0284878375384208,0.00327419661959922,0.0220704121640063,0.0349052629128352,3.46591246920283e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYZL2,Lysozyme-like protein 2,24016,0.0220979348984422,0.00253990445932773,0.0171197221581599,0.0270761476387246,3.51865127625903e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.0473218387684542,0.00544083808900066,0.0366577961140129,0.0579858814228955,3.6034104569325e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGR2,Anterior gradient protein 2 homolog,28553,0.0616938373042659,0.00709660168509559,0.0477844980014786,0.0756031766070533,3.70141980067967e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.0202229294870504,0.00232614441001037,0.01566368644343,0.0247821725306707,3.72476916844689e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGFAC,Hepatocyte growth factor activator,24720,0.0171849432996017,0.00197732517301156,0.013309385960499,0.0210605006387043,3.81130267000612e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAA4,Serum amyloid A-4 protein,24966,0.0200148711816142,0.00230589289720221,0.0154953211030978,0.0245344212601305,4.19955882127901e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCP1,Plastin-2,24938,0.0289705396258849,0.00334141529978866,0.0224213656382991,0.0355197136134706,4.57388957876044e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.0606105532047705,0.00700886919604921,0.046873169580514,0.0743479368290269,5.5769033866142e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGCR6,Protein DGCR6,24101,0.0266846883683218,0.00308658161350577,0.0206349884058505,0.0327343883307931,5.69057715903003e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300E,CMRF35-like molecule 2,29642,0.024723475481363,0.00286441465302912,0.0191092227614259,0.0303377282013,6.36697193349871e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A11,Protein S100-A11,29208,0.0275960280996895,0.00319921003732104,0.0213255764265403,0.0338664797728388,6.67638643525022e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARF2,Scavenger receptor class F member 2,29694,-0.0176125383938177,0.0020516519493747,-0.0216337762145921,-0.0135913005730433,9.5559708972271e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,29089,0.0702973787742034,0.00819839526127289,0.0542285240621085,0.0863662334862982,1.04349290334679e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.0464940048947246,0.00542506923872948,0.0358608691868148,0.0571271406026343,1.09369968928452e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0247207906774716,0.0028973585205654,0.0190419679771634,0.0303996133777798,1.50560618814412e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.0268798505132014,0.00315849914094635,0.0206891921969465,0.0330705088294562,1.81586887469439e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPH1,Neurexophilin-1,28774,0.022839746086168,0.00268883812699019,0.0175696233572672,0.0281098688150688,2.08626058266274e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSF,Cathepsin F,29566,0.023944668084589,0.00281998595484471,0.0184174956130933,0.0294718405560846,2.14211115900584e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA9,Carbonic anhydrase 9,29725,-0.0273105184245868,0.00321649370109115,-0.0336148460787255,-0.0210061907704482,2.14686261914132e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.0268863992650949,0.00316991169336635,0.0206733723460968,0.0330994261840929,2.3403539915608e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1B,Interleukin-1 beta,28745,0.0335768213130937,0.00396079789965009,0.0258136574297796,0.0413399851964079,2.41381653024906e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0398406665562423,0.00470557542748881,0.0306177387183642,0.0490635943941203,2.66703690254522e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.020043567542635,0.00237665260788231,0.0153853284311857,0.0247018066540844,3.53331088699198e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRLF1,Cytokine receptor-like factor 1,29581,0.0152781521454493,0.00181435231568484,0.011722021606707,0.0188342826841916,3.90867915050181e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.0181516449831204,0.00215688321352478,-0.022379136081629,-0.0139241538846118,4.12123900252996e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSPN,Persephin,29434,0.0556069100443145,0.00660997569515006,0.0426513576818204,0.0685624624068087,4.19020957201798e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,24845,0.141822112151285,0.0168653873104641,0.108765953022775,0.174878271279794,4.3520958349045e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOBR,Apolipoprotein B receptor,24240,-0.0252220732393033,0.00300169544635647,-0.031105396314162,-0.0193387501644446,4.60336518380197e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6L2,Seizure 6-like protein 2,29349,-0.0141440941702646,0.00168621574471063,-0.0174490770298975,-0.0108391113106318,5.16066536169638e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOB,Apolipoprotein B-100,24951,0.0132978395055677,0.00158525777050581,0.0101907342753763,0.0164049447357591,5.18383719341114e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,29545,-0.0173059243642572,0.00206674185705852,-0.0213567384040919,-0.0132551103244226,5.83588222605075e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.016187941742189,0.00193567501789131,0.0123940187071221,0.019981864777256,6.38074210362345e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.0146984191700311,0.00175801971364258,-0.0181441378087706,-0.0112527005312917,6.5613749711592e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSH,Pro-cathepsin H,28852,0.043063385119122,0.00515725921412108,0.0329551570594447,0.0531716131787993,7.12502605630622e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,0.0161459520598395,0.0019390630099115,0.012345388560413,0.019946515559266,8.66873173875112e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,0.0221407515936514,0.00267698831440254,0.0168938544974224,0.0273876486898803,1.38586246662669e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,0.0242850679054098,0.00294023138259541,0.0185222143955228,0.0300479214152968,1.52298316164522e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICOSLG,ICOS ligand,29349,0.0110801193069891,0.00134329525995912,0.00844726059746917,0.0137129780165089,1.6708471916625e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.0236776358596249,0.00287516682116908,0.0180423088901335,0.0293129628291163,1.86736879560688e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.0299251482428266,0.00363383583275978,0.0228028300106175,0.0370474664750358,1.86863271546574e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNLY,Granulysin,29443,0.0301372523680665,0.00367155422542423,0.022941006086235,0.037333498649898,2.33395932896383e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.0229380978031288,0.00279600854646662,0.0174579210520543,0.0284182745542034,2.43952189030089e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.0224850333065224,0.00274373630344301,0.0171073101517741,0.0278627564612707,2.60603327215682e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,29434,0.0353967838950426,0.00432373875892234,0.0269222559275548,0.0438713118625304,2.79429178042231e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN5,CCN family member 5,29443,0.022379185952026,0.00273691081079699,0.0170148407628639,0.0277435311411881,3.03074618067323e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA7,Carbonic anhydrase 7,24445,-0.0197547291972196,0.002423520417348,-0.0245048292152217,-0.0150046291792175,3.7729286617077e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PODXL,Podocalyxin,29349,0.00867113675138999,0.00106583952355286,0.0065820912852264,0.0107601822175536,4.26301868901331e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YAP1,Transcriptional coactivator YAP1,24845,0.0154958036926824,0.0019045886511986,0.0117628099363332,0.0192287974490317,4.2737999041164e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.019234616169451,0.00236501338161361,0.0145991899414884,0.0238700423974137,4.3501335529565e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AZU1,Azurocidin,28534,0.0437931167323415,0.00538626715764721,0.033236033103353,0.0543502003613301,4.44653537599386e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRP2,Neuropilin-2,29443,-0.0163783265655529,0.00201624602061229,-0.020330168765953,-0.0124264843651528,4.71740804049195e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2,Apoptosis regulator Bcl-2,24805,0.030674512006548,0.00378136996870462,0.023263026867887,0.0380859971452091,5.20759343370597e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL21,C-C motif chemokine 21,29581,0.0231515811474474,0.00285465550343606,0.0175564563607127,0.028746705934182,5.25116020434525e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAM,Basal cell adhesion molecule,29443,-0.013718047713389,0.00169388915076223,-0.017038070448883,-0.0103980249778951,5.77482932573786e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMBS,Porphobilinogen deaminase,29725,0.0245307989885168,0.00303001727047598,0.0185919651383839,0.0304696328386497,5.89831155749801e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,29030,0.0165854387564663,0.00205160162688636,0.0125642995677691,0.0206065779451636,6.50190708710833e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.0203078500480038,0.00252685895050603,0.015355206505012,0.0252604935909956,9.64176359367415e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.0197472853349098,0.00246024317171225,0.0149252087183538,0.0245693619514658,1.03906956852704e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.0194884787806568,0.00243098208649841,0.0147237538911199,0.0242532036701937,1.1262285188648e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,29218,-0.0203565425096807,0.0025488990785749,-0.0253523847036875,-0.0153607003156739,1.44002001229427e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,28797,0.0296510387085385,0.00372003617400523,0.0223597678074883,0.0369423096095888,1.63668253908819e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D17,TBC1 domain family member 17,28774,0.0249834550247807,0.00314023365513437,0.0188285970607174,0.0311383129888441,1.8429495296982e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,0.0333222489778393,0.00419163222681994,0.0251066498132722,0.0415378481424064,1.94873074329278e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,24793,0.0332198886523133,0.00417970794329087,0.0250276610834632,0.0414121162211634,1.97733579032038e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB1A1,Uteroglobin,29523,0.030894866801007,0.00388834020244747,0.0232737200042099,0.038516013597804,2.00229055703058e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A14,Protein S100-A14,24867,0.0295106454048265,0.00372567347148942,0.0222083254007072,0.0368129654089458,2.4563458798595e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH15,Cadherin-15,29639,0.0321998113360316,0.00406695822771022,0.0242285732097195,0.0401710494623436,2.50919317513419e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNC,Tenascin,29594,-0.0265306507012075,0.00335426597136928,-0.0331050120050912,-0.0199562893973237,2.67329997869413e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMPD3,AMP deaminase 3,24845,0.0394440655499455,0.00499224190632489,0.0296592714135487,0.0492288596863423,2.87918492811692e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPC1,Glypican-1,29725,0.0163468218893592,0.00207169403423581,0.012286301582257,0.0204073421964614,3.11121881118776e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.0236123764860201,0.00299740976781881,0.0177374533410953,0.029487299630945,3.45395346668918e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C8B,Complement component C8 beta chain,24966,0.0168672521048641,0.00214211850680127,0.0126686998315336,0.0210658043781946,3.57102256357275e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIMAP7,GTPase IMAP family member 7,24381,-0.0178975961073545,0.0022781610745402,-0.0223627918134532,-0.0134324004012557,4.1236854332738e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B2M,Beta-2-microglobulin,24966,0.0171852295619875,0.00219102610144031,0.0128908184031645,0.0214796407208105,4.55759982871768e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.0198735253722113,0.00254721368611845,0.0148809865474192,0.0248660641970035,6.33523686776858e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECM1,Extracellular matrix protein 1,24349,0.0202019034848969,0.00259125332873429,0.0151230469605777,0.0252807600092161,6.63502396014089e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB6A,Ras-related protein Rab-6A,29434,0.0253403634987504,0.00325701162215906,0.0189566207193186,0.0317241062781821,7.47437767488015e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,24801,0.0210585948677359,0.00270729960636129,0.0157522876392678,0.026364902096204,7.62675630475904e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB37,Ras-related protein Rab-37,28931,0.0449405873924001,0.00578780362882129,0.0335964922799104,0.0562846825048898,8.453175578571e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,24951,-0.0144309424464793,0.00186278188394672,-0.0180819949390149,-0.0107798899539437,9.7671281820135e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKD1,Polycystin-1,24922,0.0144920750305862,0.00187218437420898,0.0108225936571367,0.0181615564040358,1.02590384363766e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,24845,0.0252727651041191,0.00327434242593482,0.0188550539492869,0.0316904762589514,1.22199089725473e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG3,Desmoglein-3,29589,0.0185128525728843,0.00240553453787364,0.013798004878652,0.0232277002671167,1.44821548163268e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.02336127029631,0.00303690486181493,0.0174089367671527,0.0293136038254672,1.48913157041242e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,24240,0.021530101054389,0.00280034265587366,0.0160414294488766,0.0270187726599013,1.54657446406328e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTN2,Alpha-actinin-2,24111,-0.0320673840716548,0.00417843704506148,-0.0402571206799753,-0.0238776474633343,1.72359150426252e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,0.018285875760503,0.00238376280367648,0.0136137006652971,0.0229580508557089,1.75898246268774e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MST1,Hepatocyte growth factor-like protein,24615,0.0347101048784995,0.00452464171407049,0.0258418071189214,0.0435784026380777,1.76492909755344e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN8,Septin-8,24801,0.0173661081253911,0.00226638864887572,0.0129239863735947,0.0218082298771875,1.89072735575996e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFB,Vascular endothelial growth factor B,24229,0.0156267874126221,0.00203965637199872,0.0116290609235046,0.0196245139017396,1.90675740472752e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,29473,0.0210346157378531,0.00274666356329315,0.0156511551537986,0.0264180763219077,1.9426209911777e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNA1,Ephrin-A1,29390,0.0151899072078643,0.00198861070400697,0.0112922302280106,0.019087584187718,2.26525807408127e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OBP2B,Odorant-binding protein 2b,29137,-0.0335341323505078,0.00440763901725591,-0.0421731048243294,-0.0248951598766862,2.86354514700773e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL34,Interleukin-34,28722,0.0193222511535289,0.00254430193692752,0.014335419357151,0.0243090829499069,3.18803722257633e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP4,Guanylate-binding protein 4,28774,0.0261970279831261,0.00345711673587088,0.0194210791808191,0.032972976785433,3.62278500698818e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.0283234579046736,0.0037529014127405,0.0209677711357022,0.035679144673645,4.58213992293571e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.0193398618178921,0.00256366267835016,0.0143150829683258,0.0243646406674584,4.69728457138805e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPA,Apolipoprotein(a),24484,-0.0948727167499293,0.0125815748797216,-0.119532603514184,-0.0702128299856748,4.84029654383595e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.047170301396953,0.00626471010846018,0.0348914695843711,0.059449133209535,5.23777533577655e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRUNE2,Protein prune homolog 2,24445,0.0153710769570484,0.00206067247439029,0.0113321589072434,0.0194099950068533,8.99123162447567e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM2,Myomesin-2,24111,-0.026839809607376,0.00359874226101412,-0.0338933444389637,-0.0197862747757883,9.07358989692342e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.014097490995377,0.00189428364149688,0.0103846950580431,0.0178102869327109,1.01774855217143e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMB,Granzyme B,29434,0.0341405053753324,0.00458830014891039,0.0251474370834681,0.0431335736671968,1.02830972236966e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.0328757605967871,0.00442447060156323,0.0242037982177232,0.041547722975851,1.11817334154903e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,0.0156000121587837,0.00210062858141003,0.01148278013922,0.0197172441783473,1.14656434937293e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINI1,Neuroserpin,24329,0.0160201065431427,0.00215703448710079,0.0117923189484251,0.0202478941378602,1.14817710721234e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.0136426294821212,0.00183762718007219,0.0100408802091797,0.0172443787550627,1.16687416241841e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.0252763857336526,0.00340721895747355,0.0185982365770044,0.0319545348903008,1.22386381466209e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.0220276810286207,0.00297729231413222,0.0161921880929215,0.0278631739643198,1.42028540484431e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN2,Calsyntenin-2,29786,-0.020596365352923,0.0027844499874503,-0.0260538873283256,-0.0151388433775204,1.43049000025309e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG4,Desmoglein-4,29242,0.0257579344951396,0.00348717104956648,0.0189230792379893,0.0325927897522899,1.54788054118716e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTPN,Myotrophin,28916,0.0170409506189243,0.00230740973187061,0.0125184275444579,0.0215634736933907,1.56196929089136e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.0170773004089436,0.00234359874668285,0.0124838468654452,0.0216707539524419,3.25505750088809e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA1,Annexin A1,24281,0.0219671957407767,0.00301649922013664,0.0160548572693089,0.0278795342122445,3.38056372479089e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MATN3,Matrilin-3,29169,-0.0163594543648058,0.00226334559091812,-0.0207956117230053,-0.0119232970066063,5.0220989996812e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.0190608269671552,0.00264114275983038,0.0138841871578877,0.0242374667764228,5.4758279472589e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.0153433196057839,0.00212672713369036,0.0111749344237508,0.019511704787817,5.54616158726991e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF16,Fibroblast growth factor 16,24229,0.0243410934717579,0.00337747778311264,0.0177212370168572,0.0309609499266587,5.89233949337471e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNG,Interferon gamma,28931,0.0576766138662197,0.00800612382433664,0.0419846111705199,0.0733686165619196,5.98731538063151e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.0178343526277308,0.00247810226765001,0.0129772721831368,0.0226914330723248,6.34065030165324e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.0202793174065655,0.00282305233806483,0.0147461348239585,0.0258124999891726,6.98706901559386e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRELP,Prolargin,29454,0.0117413511142734,0.00163635958466654,0.00853408632832703,0.0149486159002199,7.38597785134924e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMD,Osteomodulin,29581,-0.0216963659095812,0.00303400010975568,-0.0276430061247023,-0.0157497256944601,8.8098401120408e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.0430652819191015,0.00603576102875708,0.0312351903027376,0.0548953735354653,9.95099665052889e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYTL1,Cytokine-like protein 1,24938,0.0121255310106021,0.00170184997022107,0.00878990506896879,0.0154611569522354,1.06978610203664e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MILR1,Allergin-1,28931,-0.0252995470442932,0.00355177953537711,-0.0322610349336323,-0.018338059154954,1.08021687013181e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRCAM,Neuronal cell adhesion molecule,29478,0.0141801678278496,0.00199248411490639,0.0102748989626331,0.0180854366930662,1.12962303566742e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.01383072206134,0.00194588792591874,0.0100167817265393,0.0176446623961407,1.20770938514335e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMOD1,Leiomodin-1,24867,-0.017677191804485,0.00250105137323018,-0.0225792524960162,-0.0127751311129539,1.61444562332256e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD1,Bromodomain-containing protein 1,24445,-0.0152657893447532,0.00216408431841695,-0.0195073946088504,-0.0110241840806559,1.78280771124595e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN2,Prefoldin subunit 2,28774,0.0276206147458594,0.00391611034619458,0.0199450384673181,0.0352961910244008,1.78962365723388e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.0148974120493735,0.00211265308633158,0.0107566120001636,0.0190382120985834,1.80967821801922e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,-0.0167216216398294,0.00237219369853024,-0.0213711212889487,-0.0120721219907101,1.84154218003608e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAP,Cartilage-associated protein,24195,0.0242313545523991,0.00343827178418191,0.0174923418554026,0.0309703672493957,1.86997689858666e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBS4,Thrombospondin-4,29518,0.0223603862374139,0.00318038648507627,0.0161268287266644,0.0285939437481634,2.09947929443049e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLVRB,Flavin reductase,29443,0.032090673489599,0.00458073363970753,0.0231124355557723,0.0410689114234258,2.51259930066828e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLGN,Calmegin,24195,0.0221847529565821,0.00316818066308738,0.0159751188569309,0.0283943870562334,2.58264718645406e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMH,Granzyme H,28916,0.0376685714848066,0.00537986517416136,0.0271240357434503,0.0482131072261628,2.58271499401889e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,0.0166622203243251,0.00239104474832102,0.0119757726176159,0.0213486680310343,3.26863386271732e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGBL1,Integrin beta-like protein 1,24938,0.018232094273011,0.00262566545595661,0.013085789979336,0.0233783985666859,3.91060260188774e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA5,Protein disulfide-isomerase A5,24016,0.0300304482067986,0.00432895583523641,0.0215456947697352,0.0385152016438619,4.10363427441171e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEPD,Xaa-Pro dipeptidase,24951,0.0127827573391127,0.00184485932359621,0.00916683306486416,0.0163986816133613,4.34587986895846e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.023574150376453,0.00340765424485659,0.016895148056534,0.0302531526963719,4.69487631571721e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.030668910955068,0.00443637858442021,0.0219736089296044,0.0393642129805316,4.85821608380338e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.0198797968040262,0.00287887134713206,0.0142372089636474,0.0255223846444051,5.12663932410053e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHISA5,Protein shisa-5,24938,0.0123210606449243,0.00178455646606286,0.00882332997144112,0.0158187913184075,5.16728187996534e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SATB1,DNA-binding protein SATB1,24867,0.0144188054120662,0.00209267348523813,0.0103171653809994,0.0185204454431329,5.70693726659902e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,24738,-0.0131547094621966,0.0019102207826261,-0.0168987421961438,-0.00941067672824944,5.85564965271051e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN10,Ataxin-10,28774,0.0352396757826719,0.00512094137335093,0.0252026306909041,0.0452767208744398,6.04461629172981e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,29517,0.0129957823239221,0.0018933084998413,0.00928489766423314,0.016706666983611,6.82541852201763e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST1,Cystatin-SN,21656,0.0508423678503044,0.00742020081839455,0.0362987742462511,0.0653859614543577,7.48398695690939e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,24867,0.014526926800022,0.00212158900973044,0.0103686123409503,0.0186852412590936,7.70673420124234e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.0186628850160304,0.00273576982397111,0.013300776161047,0.0240249938710137,9.16492851843189e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.0187523917612035,0.00274882425570353,0.0133646962200246,0.0241400873023824,9.19199820957173e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.0235862761847683,0.00346630878009059,-0.0303802413937459,-0.0167923109757908,1.03382979713036e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.0276753567296064,0.00406800734301905,0.019702062337289,0.0356486511219237,1.0434268725201e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.0230543187888768,0.00339707196233974,-0.0297125798350626,-0.0163960577426909,1.170432592541e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PADI4,Protein-arginine deiminase type-4,28722,0.0339047647136804,0.00500129242289619,0.0241022315648039,0.043707297862557,1.23180995143237e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD209,CD209 antigen,29527,-0.0185509636864347,0.00273716958545163,-0.0239158160739199,-0.0131861112989495,1.24635748963904e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0332925434701899,0.00491676266353393,0.0236556886496634,0.0429293982907164,1.30107106271453e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP3,"Fatty acid-binding protein, heart",24922,0.0241290131920164,0.00357044473127687,0.0171309415187138,0.0311270848653191,1.430098913192e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UROS,Uroporphyrinogen-III synthase,24195,0.0324774538858525,0.00481275892637533,0.0230444463901569,0.0419104613815481,1.53074250174164e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RSPO3,R-spondin-3,29725,0.0134505780888696,0.00199545738866511,0.00953948160708602,0.0173616745706532,1.606175632571e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MET,Hepatocyte growth factor receptor,29507,-0.00937376209426715,0.00139093141394343,-0.0120999876655963,-0.00664753652293802,1.62193131657097e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGA4,Pepsin A-4,24951,0.0337340404811583,0.00501172889261727,0.0239110518516285,0.0435570291106882,1.7213283237809e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.020878724211963,0.00310208862001173,0.01479863051674,0.026958817907186,1.72812140738676e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,28774,0.0402949627474468,0.00599707671533236,0.0285406923853953,0.0520492331094982,1.86259088547753e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHB4,Ephrin type-B receptor 4,29820,-0.0117867004328113,0.00175532284005504,-0.0152271331993192,-0.00834626766630345,1.91659478127804e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,0.0266044691451991,0.00396256095823309,0.0188378496670622,0.0343710886233359,1.93623926361822e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.0109531328869441,0.00164053012359821,0.00773769384469164,0.0141685719291966,2.48889157898416e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLC,Galectin-10,29426,-0.0311079591713945,0.00466405942827407,-0.0402495156508117,-0.0219664026919773,2.60834437335788e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB2A2,Mammaglobin-A,24111,-0.0148549152318333,0.00222804296685779,-0.0192218794468745,-0.010487951016792,2.66278988723798e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,-0.0100599489913437,0.00150976628502086,-0.0130190909099846,-0.00710080707270285,2.72647511921227e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,29478,0.00825144813502936,0.00123961819465204,0.00582179647351137,0.0106810997965474,2.85453213904589e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHGA,Chromogranin-A,24938,-0.0411362528396305,0.00618969046193249,-0.0532680461450182,-0.0290044595342428,3.07523803473251e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDK2,Protein sidekick-2,24381,0.0181164665486765,0.00273278445033518,0.0127602090260196,0.0234727240713334,3.44315699842645e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,-0.012362824313104,0.00186535742051323,-0.0160189248573099,-0.00870672376889804,3.48174722195367e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNU13,NHP2-like protein 1,24111,0.0292045073507765,0.00441273342346882,0.0205555498407776,0.0378534648607754,3.71145127305588e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.0236291600171164,0.00357186410244616,0.016628306376322,0.0306300136579109,3.7820319929032e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLPS,Colipase,29400,0.0329954806551177,0.00499169228210863,0.0232117637821848,0.0427791975280506,3.9068539731362e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN2,Ataxin-2,24101,0.0515531212766649,0.00782395666965947,0.0362181662041324,0.0668880763491975,4.51523130437874e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLASP1,CLIP-associating protein 1,24016,0.0338928480313656,0.00514921457652207,0.0238003874613824,0.0439853086013489,4.73293219867922e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA7A,Semaphorin-7A,29736,0.0127847196535554,0.00194532169502693,0.00897188913130258,0.0165975501758082,5.04530825400442e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPE,Carboxypeptidase E,29468,-0.0177842563447491,0.00271759014749611,-0.0231107330338414,-0.0124577796556567,6.0825429644098e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROCR,Endothelial protein C receptor,24111,-0.0165505440665499,0.00252912085285708,-0.0215076209381498,-0.0115934671949501,6.11012600846769e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTG,Protogenin,29725,0.0114577621475805,0.00175369379753692,0.00802052230440813,0.0148950019907529,6.52873927359793e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.0320160441474188,0.00490641395894207,0.0223994727878923,0.0416326155069452,6.91737493066762e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALB1,Calbindin,29349,0.0200422343363053,0.00307204804711857,0.0140210201639529,0.0260634485086577,6.95415804325269e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GM2A,Ganglioside GM2 activator,24421,0.0176428815030785,0.00270796101114833,0.0123352779212278,0.0229504850849293,7.40118750890824e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.0183242182036621,0.00281825172935055,0.012800444814135,0.0238479915931892,8.07781158290621e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD6,Programmed cell death protein 6,29478,-0.0320123717707458,0.00492658731456537,-0.041668482907294,-0.0223562606341977,8.27589026875504e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL3,Myosin light chain 3,24240,-0.0334369719294406,0.00515677462035344,-0.0435442501853333,-0.0233296936735478,9.09905895542764e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,29349,-0.0185398729626765,0.002874354499001,-0.0241736077807184,-0.0129061381446345,1.13515677640716e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.0133506428845438,0.00207039727016953,0.00929266423501157,0.0174086215340761,1.15226700867472e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.0119082678953746,0.00184945958395296,-0.0155332086799225,-0.00828332711082684,1.22713414123464e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LXN,Latexin,29117,-0.0303991258677046,0.00473574983349048,-0.039681195541346,-0.0211170561940633,1.39216094122622e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK8,Kallikrein-8,28443,0.0162717839410412,0.00253556363989284,0.0113020792068512,0.0212414886752311,1.40782105588271e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1R1,Interleukin-1 receptor type 1,29390,-0.0103769951170829,0.00162017689127756,-0.013552541823987,-0.00720144841017892,1.527886733971e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,28722,0.0241771524368131,0.00377762939308412,0.0167729988263683,0.031581306047258,1.57684242917272e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TK1,"Thymidine kinase, cytosolic",24445,0.0206638309090646,0.00322880734370003,0.0143353685154126,0.0269922933027167,1.58367379174259e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.0124094661537868,0.00194003666857554,0.00860699428337873,0.0162119380241948,1.61789250003338e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.0100176187730077,0.00156685835549859,0.00694657639623047,0.013088661149785,1.64622965995375e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIL1,Nucleotide exchange factor SIL1,24240,0.0145537799031678,0.00227877486115011,0.0100873811753136,0.0190201786310221,1.72614810052844e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOSB,Protein fosB,28774,0.0174227237358925,0.00272860098447047,0.0120746658063304,0.0227707816654546,1.73759093581626e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.0236336661579419,0.00370339128425893,0.0163750192407944,0.0308923130750894,1.77879322135936e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD7,T-cell antigen CD7,24177,0.019641987870274,0.0030801882615292,0.0136048188776767,0.0256791568628712,1.84001396947492e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN1,Nectin-1,24229,0.0145110548460272,0.00228330040773738,0.010035786046862,0.0189863236451925,2.11726562773223e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFHD1,EF-hand domain-containing protein D1,24867,0.0157536798571121,0.00248545331577093,0.0108821913582011,0.0206251683560231,2.36220463821829e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,24888,-0.0218564654152022,0.00345194892064624,-0.0286222852996688,-0.0150906455307356,2.46726263326008e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.016648486029104,0.00263229426868951,0.0114891892624726,0.0218077827957355,2.58045284230884e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIF,Leukemia inhibitory factor,28774,0.0228294293501044,0.00361932499106201,0.0157355523676229,0.0299233063325859,2.87425124167941e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LHB,Lutropin subunit beta,28797,0.0385997722537706,0.00612390014227298,0.0265969279749155,0.0506026165326256,2.95908322324028e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,-0.0109176046035134,0.001732778181597,-0.0143138498394435,-0.00752135936758329,3.00565367530681e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP9,Fatty acid-binding protein 9,29434,0.0247937231558218,0.0039418016181286,0.0170677919842897,0.0325196543273538,3.22036927388247e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.0176069083712772,0.00279939735047562,-0.0230937271782094,-0.012120089564345,3.23703679301695e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD86,T-lymphocyte activation antigen CD86,24805,0.0132696189877341,0.00211059290585902,0.00913285689225042,0.0174063810832178,3.28730819761456e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANPEP,Aminopeptidase N,29531,0.0124010124203791,0.00197423515918936,0.00853151150836793,0.0162705133323902,3.40154642502236e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PREB,Prolactin regulatory element-binding protein,28931,0.0128282289438661,0.00204284257305795,0.00882425750067254,0.0168322003870597,3.44272914201845e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNPEP,Aspartyl aminopeptidase,24845,0.0257456859555091,0.00410787598620379,0.0176942490225496,0.0337971228884685,3.73168761974616e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.0457230270138163,0.00730536711202494,0.0314045074742474,0.0600415465533852,3.94396287808745e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,29581,0.0118874606078569,0.00190006153203875,0.00816334000506098,0.0156115812106529,3.99472697006303e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDC1,Syndecan-1,29478,0.017691546685175,0.00282781805270924,0.0121490233018649,0.0232340700684851,3.99752728336928e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.017508362752397,0.00280590421495566,0.0120087904910839,0.0230079350137101,4.44146917256375e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0271461089103002,0.00435048666601065,0.0186191550449193,0.0356730627756811,4.44241826389402e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM5,Intercellular adhesion molecule 5,29478,0.0197148034687364,0.00316413494471518,0.0135130989770947,0.0259165079603782,4.70606537666563e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,28862,0.0229819374273486,0.00369217033406324,0.0157452835725846,0.0302185912821125,4.89719499713009e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSBP1,Heat shock factor-binding protein 1,24240,0.041986210930594,0.00674671922754439,0.028762641244607,0.0552097806165811,4.95083860621278e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REN,Renin,29478,-0.0331944284692501,0.0053476156122608,-0.0436757550692813,-0.0227131018692189,5.4609337864927e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEO1,Neogenin,24867,0.0095945930316754,0.00154582417876185,0.00656477764130216,0.0126244084220486,5.49353259824186e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSAB1,Tryptase alpha/beta-1,29753,0.0228284128711086,0.0036842994701029,0.0156071859097069,0.0300496398325103,5.86251480757444e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA1,Alpha-1-antitrypsin,24548,-0.00355542555592449,0.000573873261266413,-0.00468021714800666,-0.00243063396384232,5.90279164955672e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,24867,0.0167920461574005,0.00271322186423549,0.011474131303499,0.0221099610113021,6.15052396428454e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMS1,PMS1 protein homolog 1,24195,0.0221110659898218,0.00358090235752518,0.0150924973690725,0.0291296346105712,6.73362905061541e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,0.0211464428758711,0.00342537292115399,0.0144327119504093,0.0278601738013329,6.76945174117392e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.016461860814855,0.00266750577701917,-0.0216901721378125,-0.0112335494918974,6.87964280887662e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP7,Dipeptidyl peptidase 2,29279,0.0260961351218427,0.00423284676019957,0.0177997554718516,0.0343925147718339,7.13358069694378e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC16,Mucin-16,29349,0.0816954679508998,0.0132968710955116,0.0556336006036971,0.107757335298103,8.15225692012911e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,28733,0.0123837982958719,0.0020171856853346,0.00843011435261614,0.0163374822391278,8.40519178942998e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,0.011645475523758,0.00189699611516071,0.00792736313804305,0.015363587909473,8.4149707258716e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNPY2,Protein canopy homolog 2,28916,0.026159880142679,0.00428834879238142,0.0177547165096114,0.0345650437757466,1.07264682116467e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB44,Ras-related protein Rab-44,24793,0.0181065269643758,0.00296967769432026,0.0122859586835081,0.0239270952452435,1.09581939880196e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,24111,0.0189436458841101,0.00310913381281791,0.012849743610987,0.0250375481572332,1.12563112412406e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSC2,Desmocollin-2,29135,-0.0147201188273984,0.00241927997014911,-0.0194619075688907,-0.00997833008590616,1.18308576725897e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.0365579085451576,0.00602233703462539,-0.0483616891330234,-0.0247541279572919,1.29214542524115e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,29623,0.0350186905431285,0.00578646901819041,0.0236772112674753,0.0463601698187818,1.44933545353302e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDI2,Protein DDI1 homolog 2,24381,0.0327053513433761,0.00540476350409141,0.0221120148753569,0.0432986878113953,1.45860729824241e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE1,Ribonuclease pancreatic,24951,0.0103867833853136,0.00171834362433267,0.00701882988162154,0.0137547368890056,1.5186140423665e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.0223172773892915,0.00369642047746781,0.0150722932534546,0.0295622615251284,1.58708911297439e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTX2,Neuronal pentraxin-2,24938,-0.0141640600332665,0.00235136408862877,-0.0187727336469789,-0.00955538641955413,1.72795294322597e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR1,Cadherin-related family member 1,28774,0.0180667244676504,0.00301228876883928,0.0121626384807254,0.0239708104545754,2.02551898427804e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX3,Syntaxin-3,24845,0.0162114159389221,0.00270536390176251,0.0109089026914675,0.0215139291863766,2.09713826575875e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.0102277323703406,0.00170801097499873,0.0068800308593431,0.0135754338813381,2.1475923149775e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARG1,Arginase-1,29216,0.0218193893161722,0.00364530673226824,0.0146745881209264,0.0289641905114179,2.18090849404508e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OLFM4,Olfactomedin-4,23498,0.0518134108982934,0.00869604566445709,0.0347691613959576,0.0688576604006293,2.5855070303552e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,29443,-0.0183850411148813,0.00308597307312622,-0.0244335483382087,-0.0123365338915539,2.58850470018177e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRC1,Macrophage mannose receptor 1,24951,0.0118753412722023,0.00199606587601199,0.00796305215521881,0.0157876303891858,2.72760851694635e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,29409,0.019272146640788,0.00324800504146679,0.0129060567595131,0.0256382365220629,2.99800340436187e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L15,Bcl-2-like protein 15,24229,0.0235470304318357,0.0039800085469228,0.015746213679867,0.0313478471838044,3.33635930141395e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHB6,Ephrin type-B receptor 6,29163,0.0132489605590631,0.00224639902441287,0.00884601847121388,0.0176519026469123,3.7229022739124e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,29678,0.011266287705543,0.00191214460028512,0.00751848428898419,0.0150140911221018,3.85747338874647e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS53,Serine protease 53,24845,0.0155140032526985,0.00263352850955442,0.0103522873739719,0.0206757191314252,3.88913351295539e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP1,Caspase-1,28774,0.0281022891792687,0.00478266759227015,0.0187282606984192,0.0374763176601182,4.2528152610565e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0432374357275011,0.00736340024661091,0.0288051712441437,0.0576697002108585,4.35383949570516e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPS10,40S ribosomal protein S10,24111,-0.0173802977223672,0.0029603497450067,-0.0231825832225803,-0.0115780122221541,4.38776018941449e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN8,Tetraspanin-8,24805,0.0411771666848149,0.00705956236413636,0.0273404244511076,0.0550139089185222,5.51745129703901e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,24381,0.0216876926416999,0.00373417410670014,0.0143687113925677,0.0290066738908322,6.40489310465485e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.0291806552830969,0.00502729761748925,0.019327151952818,0.0390341586133758,6.53655652566321e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPA2,Replication protein A 32 kDa subunit,24229,0.0130190495684128,0.00224502551553635,0.00861879955796159,0.0174192995788641,6.75142769056679e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOC,Brother of CDO,28916,-0.00956139596423565,0.0016499085839928,-0.0127952167888615,-0.00632757513960977,6.89862382618163e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QL2,Complement C1q-like protein 2,24229,0.017540290450512,0.00303009486388858,0.0116013045172904,0.0234792763837336,7.18113817916423e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.0153722969526476,0.00265793844325136,-0.0205818563014202,-0.0101627376038749,7.40449541743119e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLL4,Delta-like protein 4,24240,0.0350347218381186,0.00606234680450506,0.0231525221012887,0.0469169215749485,7.60355386948855e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSTL1,Follistatin-related protein 1,24240,-0.00930067964562192,0.00161139310983568,-0.0124590101408999,-0.00614234915034398,7.93736460416212e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.00946967466961322,0.00164094222055856,0.00625342791731844,0.012685921421908,7.96568718881236e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.058866159190382,0.0102182579492016,0.038838373609947,0.0788939447708171,8.45289584999134e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.0109209771245473,0.00190014970762778,0.00719668369759683,0.0146452705514977,9.16694507946457e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.0126370966482688,0.00220191262801652,0.00832134789735644,0.0169528453991812,9.6290965326274e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.0114340935544187,0.00199242425640533,-0.0153392450969732,-0.00752894201186428,9.64859133550214e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,24445,0.0184157964833904,0.00320998840478439,0.0121242192100129,0.0247073737567678,9.74896415845207e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL5,Fc receptor-like protein 5,29443,-0.0232122878965765,0.00404910239880693,-0.0311485285982381,-0.0152760471949149,9.98099633650589e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPARCL1,SPARC-like protein 1,29489,-0.0110792659300376,0.00193304741984471,-0.0148680388729332,-0.00729049298714197,1.00514848493071e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,24016,0.0309628957435011,0.00540849455046676,0.0203622464245863,0.041563545062416,1.04750786490801e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSM,Oncostatin-M,29293,0.0285533443722335,0.00499868024055556,0.0187559311007446,0.0383507576437224,1.1261999402725e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPH3,Neurexophilin-3,24229,0.0121901253416399,0.00213479793804699,0.00800592138306777,0.016374329300212,1.1416296783537e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHNAK2,Protein AHNAK2,24240,0.0119569831004819,0.00209846285572732,0.00784399590325633,0.0160699702977074,1.22646711532543e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.015721724628508,0.00276085315539901,0.0103104524439259,0.0211329968130901,1.24926546039977e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH3,Cadherin-3,29694,0.0144926747616842,0.00254846431450487,0.00949768470525461,0.0194876648181137,1.30636304491678e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.0133167047862189,0.00234274457145846,-0.0179084841462775,-0.00872492542616027,1.32919630506014e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSTL3,Follistatin-related protein 3,29351,0.0127025918372967,0.00224429856485287,0.0083037666501851,0.0171014170244083,1.52838698296551e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERC2,ERC protein 2,24195,0.0300705973349036,0.00531846212954915,0.0196464115609873,0.04049478310882,1.58520936210368e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITM2A,Integral membrane protein 2A,29434,-0.0240201721960751,0.004249564093436,-0.0323493178192097,-0.0156910265729405,1.59699787693605e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.0174743869265375,0.00309637371047827,0.011405494454,0.0235432793990749,1.68472327964683e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,0.0167702609581959,0.00297673262140504,0.010935865020242,0.0226046568961497,1.77909231389119e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EXTL1,Exostosin-like 1,24111,0.0188728274840768,0.00335895071212877,0.0122892840883044,0.0254563708798491,1.94559708567367e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.0124759580051166,0.00222512695868117,-0.0168372068441317,-0.00811470916610155,2.08295017831095e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALPP,"Alkaline phosphatase, placental type",29349,0.0407534162519012,0.00728221485604625,0.0264802751340506,0.0550265573697519,2.20935256394173e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,29542,-0.0121607593727862,0.00217539283389012,-0.0164245293272108,-0.00789698941836153,2.2888304348272e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.0218548090752176,0.00391775406525357,-0.0295336070431146,-0.0141760111073206,2.44871808253968e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWF,von Willebrand factor,29820,-0.0284384444757383,0.00510490776941985,-0.0384440637038012,-0.0184328252476754,2.55751882836347e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBA,Lysosomal acid glucosylceramidase,24195,0.0211779639270103,0.0038040650846777,0.013721996361042,0.0286339314929786,2.61622799081281e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF3,Granulocyte colony-stimulating factor,28931,0.0189730399294661,0.00340941692024042,0.0122905827657948,0.0256554970931373,2.64635632867043e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP1,"Fatty acid-binding protein, liver",29454,0.0367908853717984,0.00661246637480922,0.0238304512771723,0.0497513194664245,2.66153171866959e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFLAM,Pikachurin,24805,0.0120829989787056,0.00217172986763268,0.00782640843814552,0.0163395895192656,2.66738079474033e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.016190549691793,0.00291489580182908,-0.021903745463378,-0.010477353920208,2.81477727368729e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,29116,0.0115011000640056,0.00207271043276697,0.00743858761578231,0.0155636125122288,2.90103141027629e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHI3L1,Chitinase-3-like protein 1,28935,0.0306205776664012,0.00553951991491809,0.0197631186331617,0.0414780366996406,3.27330237882531e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN1,Contactin-1,29820,-0.0105852825916839,0.00191842760360406,-0.0143454006947478,-0.0068251644886199,3.46344419506066e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLIC5,Chloride intracellular channel protein 5,24195,-0.0123716283372169,0.00224874836625465,-0.016779175135076,-0.00796408153935777,3.8025538598497e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL1A1,Collagen alpha-1(I) chain,29820,-0.00967734143801303,0.00175987880339682,-0.0131267038926708,-0.00622797898335525,3.85370242519321e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAFB2,Scaffold attachment factor B2,24867,0.0106087260050662,0.00193483257623863,0.00681645415563851,0.014400997854494,4.22192819752644e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.0257964383812282,0.00471470926527414,0.0165556082212909,0.0350372685411655,4.50611101921629e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH12,Protocadherin-12,24867,0.00982675395567173,0.00180146119537006,0.00629589001274642,0.013357617898597,4.94732984590886e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDS,Iduronate 2-sulfatase,29786,0.00341142698266809,0.000625494414964721,0.00218545792933724,0.00463739603599894,4.96494214729015e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFAP,Glial fibrillary acidic protein,28753,0.0177182080928668,0.00325702814283295,0.0113344329329142,0.0241019832528194,5.37173341510598e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0146772494735965,0.00270203367980955,-0.0199732354860232,-0.00938126346116977,5.61858792227036e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,29434,0.0178889911404315,0.00329615167232718,0.0114285338626702,0.0243494484181927,5.76853120672282e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.0130569708309957,0.00242034500785214,0.00831309461560551,0.0178008470463859,6.91792601986194e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEPACAM2,HEPACAM family member 2,24845,-0.0159758460578313,0.00296219442459691,-0.0217817471300412,-0.0101699449856213,6.98275362648804e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYT1,Synaptotagmin-1,24845,0.0150189506442928,0.0027869772128773,0.00955647530705325,0.0204814259815323,7.15056428058947e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.0125926563061952,0.00234380631271226,0.0079987959332792,0.0171865166791113,7.82477927774112e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.0232213795463807,0.00432528080958177,0.0147438291596004,0.031698929933161,7.99898752556046e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.0143661381093037,0.00267673330978542,-0.0196125353964831,-0.0091197408221243,8.07780617279833e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX18,Sorting nexin-18,24805,0.016806687360892,0.00314608277440424,0.0106403651230597,0.0229730095987243,9.26858372117233e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F3,Tissue factor,29541,-0.0102628984913322,0.00192350712973758,-0.0140329724656179,-0.00649282451704659,9.59756375580971e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,24229,0.0242591915921773,0.00454715377242765,0.0153467701982192,0.0331716129861355,9.63874766965749e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASPN,Asporin,24922,0.0103490820413694,0.00194148426983346,0.00654377287249585,0.014154391210243,9.87945215570734e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.0107223320695169,0.00201244539582643,-0.0146667250453367,-0.00677793909369706,1.00028698611893e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.0255226610260923,0.00479983173894866,-0.0349303312344317,-0.0161149908177529,1.06165742525216e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP2,Guanylate-binding protein 2,28931,0.0224455915749689,0.00422146976399542,0.0141715108375379,0.0307196723123999,1.0626913080566e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMNB1,Lamin-B1,24756,0.0220398903380864,0.00414617076660416,0.0139133956355423,0.0301663850406306,1.07155543703457e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA4,Carboxypeptidase A4,23902,0.0164129385551254,0.00309646641011136,0.0103438643913072,0.0224820127189437,1.16486330341005e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0137361944213843,0.002603048470313,0.00863421941957085,0.0188381694231978,1.32470703014986e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.0172390553687314,0.00327220753539434,-0.0236525821381043,-0.0108255285993585,1.38631804529245e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.00722037900747527,0.00137083970572462,-0.00990722483069554,-0.00453353318425501,1.39728140907914e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.018914484703922,0.00362794513275956,0.0118037122437133,0.0260252571641308,1.86785582708983e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA2,GDNF family receptor alpha-2,29349,0.00771232598080278,0.00148106927129924,0.00480943020905627,0.0106152217525493,1.92931961176613e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,24922,-0.0144577823577166,0.00277962369956381,-0.0199058448088617,-0.00900971990657153,1.99415660463412e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.0200912943558708,0.00387121449519613,0.0125037139452864,0.0276788747664552,2.12038732632028e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.0164398920885344,0.00316816243758149,0.0102302937108747,0.0226494904661941,2.12984278275111e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,0.0142100614840599,0.00273931206199286,0.00884100984255388,0.0195791131255659,2.14596756358803e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QSOX1,Sulfhydryl oxidase 1,24502,0.015584142925451,0.00300740821454069,0.00968962282495128,0.0214786630259508,2.21356644780701e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.0177619974258014,0.00344140369126046,0.0110168461909309,0.0245071486606719,2.47172635436124e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RCC1,Regulator of chromosome condensation,24793,0.0187400534408476,0.00363096252677854,0.0116233668883617,0.0258567399933336,2.47290000632937e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,29375,0.0134533888971728,0.00260764556132536,0.00834240359697512,0.0185643741973705,2.4960621794619e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST7,Cystatin-F,29498,0.0337485856260486,0.00654457076119513,0.0209212269341061,0.046575944317991,2.52922208702922e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RLN1,Prorelaxin H1,24867,-0.0249771466285791,0.00485740954726482,-0.0344976693412182,-0.0154566239159401,2.73785547616065e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM26,Tripartite motif-containing protein 26,24016,0.0203010048824189,0.00395382375763463,0.0125515103174551,0.0280504994473828,2.85066033388027e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.0133640648937095,0.0026060341460208,-0.0184718918199103,-0.00825623796750872,2.94900729292578e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCAN,Versican core protein,29694,-0.0108391180070633,0.00211555389216409,-0.0149856036357049,-0.00669263237842165,3.01733168506755e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDN1,Endothelin-1,24240,0.0104949316632754,0.00205922430080804,0.00645885203369165,0.0145310112928592,3.48505253621031e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTF4,Neurotrophin-4,28797,0.0141664402261579,0.00278017577712021,0.00871729570300226,0.0196155847493135,3.49982602224777e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.012449433215292,0.00244695630848198,0.0076533988506673,0.0172454675799167,3.64587271726507e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.0232714148950049,0.00457622156353772,0.014302020630471,0.0322408091595389,3.69775700864104e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.0252302608710108,0.00497007224807105,-0.03497160247723,-0.0154889192647915,3.87357905449319e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.0254282170435005,0.00500940911023762,0.0156097751874348,0.0352466588995662,3.87603657429077e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPEP1,Dipeptidase 1,29163,-0.0173549865308924,0.00342039067855446,-0.0240589522608591,-0.0106510208009256,3.91974547223537e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRLB,Fc receptor-like B,28797,0.021878330458855,0.00431341861498461,0.0134240299734852,0.0303326309442248,3.95775012857274e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO4,Roundabout homolog 4,24240,-0.00644026865992597,0.00127035268411535,-0.00893015992079205,-0.00395037739905988,4.01439928599586e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,27939,0.0142735633350393,0.00281763885079354,0.00875099118748394,0.0197961354825946,4.09301264972459e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLIN3,Perilipin-3,29478,0.0151609056865933,0.00299394526234663,0.00929277297239393,0.0210290384007927,4.13335919475929e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.0114746804914202,0.00226612950768181,-0.0159162943264766,-0.00703306665636387,4.14037422946964e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC2,Mucin-2,24938,0.0326571421554533,0.00645326530762136,0.0200087421525155,0.0453055421583912,4.20994887745905e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD55,Complement decay-accelerating factor,28490,0.00932190650962717,0.00185011166064639,0.00569568765476025,0.0129481253644941,4.71903905490525e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEDD9,Enhancer of filamentation 1,24229,0.0118337172787265,0.00235309458482298,0.0072216518924735,0.0164457826649796,4.96558926261046e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX5,Syntaxin-5,24229,0.0144944145650448,0.00288350836816826,0.00884273816343501,0.0201460909666546,5.02653940899284e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIM,Vimentin,28916,0.0411820392438275,0.00821147381396304,0.02508755056846,0.0572765279191951,5.3296553541876e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.0123910948395846,0.00248615824264473,0.00751822468400088,0.0172639649951682,6.2632001795047e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNGR1,Interferon gamma receptor 1,29581,0.00736420092357295,0.00148055597998704,0.00446231120279834,0.0102660906443475,6.59720138022265e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,29443,-0.0110910870778063,0.00223535297430757,-0.0154723789074491,-0.00670979524816345,7.02786089531521e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCN,Decorin,28916,-0.00798821651180558,0.00161196942571987,-0.0111476765862165,-0.00482875643739463,7.25283559855759e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.0193985010286764,0.00391521233119686,0.0117246848595305,0.0270723171978222,7.28717858810043e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.0112033088503936,0.0022718004691534,-0.0156560377699343,-0.00675057993085294,8.21511329829849e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,29581,0.00991391791005594,0.00201069683913106,0.00597295210535907,0.0138548837147528,8.24262595138128e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC13A1,Solute carrier family 13 member 1,24793,0.021213477071956,0.00430716094351486,0.0127714416226669,0.0296555125212451,8.48317304691501e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KEL,Kell blood group glycoprotein,28774,0.0124342093221574,0.00252842360009357,0.00747849906597398,0.0173899195783408,8.80173811579014e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM171B,Protein FAM171B,24793,0.00941600308172045,0.00191486416812031,0.00566286931220463,0.0131691368512363,8.82974387539766e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSLN,Mesothelin,29293,0.0193582600065344,0.00394089730375509,0.0116341012911744,0.0270824187218944,9.0570698241114e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FMR1,Synaptic functional regulator FMR1,28797,0.0122809849392298,0.00250316856179194,0.00737477455811764,0.017187195320342,9.33759947279165e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JCHAIN,Immunoglobulin J chain,28931,-0.0212689164746961,0.00433918461234971,-0.0297737183149016,-0.0127641146344907,9.55770638037189e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEG1,Protein LEG1 homolog,23603,-0.0242012401406642,0.00494311771373068,-0.0338897508595764,-0.0145127294217521,9.84800379933025e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.0200347715827677,0.00410778614552539,0.011983510737538,0.0280860324279975,1.08241631648007e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPP1,Osteopontin,29757,-0.0157987907245758,0.00324538766636526,-0.0221597505506517,-0.00943783089849984,1.13267850396179e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.00979763016796665,0.00201854301731949,0.00584128585402045,0.0137539744819128,1.21846654965896e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIFR,Leukemia inhibitory factor receptor,29434,-0.00829056723585884,0.00171122254749164,-0.0116445634289425,-0.00493657104277522,1.27370114305435e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX2,Peroxiredoxin-2,24556,0.0210568361225995,0.00434642890515943,0.0125378354684871,0.029575836776712,1.2762175180494e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD48,CD48 antigen,29536,0.0102131773920504,0.00210850475634775,0.00608050806960881,0.014345846714492,1.28023432029082e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTX1,Neuronal pentraxin-1,29443,0.0138406974615173,0.0028632951793586,0.00822863890997441,0.0194527560130601,1.34602193242547e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDK1,Cyclin-dependent kinase 1,24016,0.0124200348703161,0.0025758816671753,0.00737130680265247,0.0174687629379797,1.43237313901814e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,-0.0090099311900265,0.00186921561490469,-0.0126735937952397,-0.0053462685848133,1.44155384597544e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD160,CD160 antigen,29786,0.0159061918236557,0.00330030455994686,0.0094375948861598,0.0223747887611515,1.44545032588592e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.0197478537039258,0.00410265628666112,0.01170664738207,0.0277890600257816,1.49109215166432e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EP300,Histone acetyltransferase p300,24229,0.0102219810490416,0.00213178828563408,0.00604367600919875,0.0144002860888844,1.63619404840084e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDHB15,Protocadherin beta-15,24793,-0.0134647496972128,0.00282340008587372,-0.0189986138655253,-0.00793088552890031,1.86209630232591e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTF3,Neurotrophin-3,29434,0.0116501776589247,0.00244381451899541,0.00686030120169369,0.0164400541161557,1.87686812640784e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA4,Apolipoprotein A-IV,24966,0.0119486989453907,0.00252097249880179,0.00700759284773919,0.0168898050430422,2.15195248544081e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD3,Bromodomain-containing protein 3,24111,0.0160016405020978,0.00338060938860936,0.00937564610042345,0.0226276349037721,2.22087371503598e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MBL2,Mannose-binding protein C,24610,-0.0360393871351446,0.00762349643107657,-0.0509814401400547,-0.0210973341302345,2.28661466225053e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INHBB,Inhibin beta B chain,24381,0.0172930509142685,0.00365888275680814,0.0101216407109245,0.0244644611176124,2.29901534414659e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.0174122269070039,0.00368855363274076,0.010182661786832,0.0246417920271758,2.36453881910767e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,29478,0.0104760844382597,0.00223559444657847,0.00609431932296591,0.0148578495535535,2.79786056418674e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.00934392780077262,0.00199545450854674,0.00543283696402102,0.0132550186375242,2.84511582105158e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPON1,Spondin-1,29497,0.0108128695967567,0.00231122826787789,0.00628286219171602,0.0153428770017974,2.90392527281365e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.0168095866826376,0.00361061349884857,-0.0238863891403808,-0.00973278422489444,3.24436081636233e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PI3,Elafin,29014,0.017997171153471,0.0038783220777286,0.010395659881123,0.0255986824258191,3.49165487230645e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN4,Contactin-4,29443,-0.00784421160907589,0.00169504491930209,-0.011166499650908,-0.0045219235672438,3.71269328671367e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCB,Calcitonin gene-related peptide 2,24845,0.0130654232878302,0.00283248654457758,0.00751374966045812,0.0186170969152023,3.99446103837784e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK11,Kallikrein-11,29296,0.0100196897095807,0.00217282560408749,0.0057609515255692,0.0142784278935922,4.01725324200922e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.0282696729759024,0.00613812259175168,0.0162389526960691,0.0403003932557357,4.13390747995681e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH6,Cadherin-6,29478,-0.0123726615344742,0.0026996241032157,-0.0176639247767769,-0.00708139829217138,4.59999675495285e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.0199555567587312,0.0043597826854333,0.0114103826952819,0.0285007308221804,4.73614699141118e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,28774,0.0158920486661578,0.0034741489204449,0.0090827167820858,0.0227013805502298,4.79643040534378e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD109,CD109 antigen,29443,-0.0108521840109955,0.00237641474398535,-0.0155099569092068,-0.00619441111278422,4.97657285157159e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CENPJ,Centromere protein J,24445,0.0230832954499559,0.00506847506675044,0.0131490843191251,0.0330175065807868,5.2817086978426e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,24845,0.00955794326278875,0.00209933875387777,0.00544323930518831,0.0136726472203892,5.31788728825273e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17RA,Interleukin-17 receptor A,29443,0.0140913298334331,0.00310301737752451,0.00800941577348509,0.0201732438933812,5.616456744591e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,0.0183577028476975,0.00404497962289643,0.0104295427868204,0.0262858629085745,5.69086865546126e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DRAXIN,Draxin,29218,0.0136797273971963,0.00302216237342131,0.00775628914529048,0.019603165649102,6.02136683852382e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,29349,0.00829980193161721,0.00183683293971095,0.00469960936978375,0.0118999944934507,6.25105647350898e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB39B,Ras-related protein Rab-39B,24111,0.0287632646059711,0.00637696810700184,0.0162644071162475,0.0412621220956948,6.4982499702538e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTP1,Glutathione S-transferase P,28604,-0.0221531822726212,0.0049139167316291,-0.0317844590666143,-0.0125219054786282,6.56227709206028e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00593511003801042,0.0013172120346913,0.00335337445001548,0.00851684562600536,6.64195567328983e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.00681282199692641,0.00151244482223762,0.00384843014534068,0.00977721384851215,6.68299165984185e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDRG1,Protein NDRG1,28774,0.0213686463736517,0.00475168109620549,0.012055351425089,0.0306819413222145,6.91651877300059e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AREG,Amphiregulin,29349,-0.0144265150074572,0.00321435809372012,-0.0207266568711487,-0.00812637314376579,7.21180613985551e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.0114708418711709,0.00255629425903458,0.00646050512346312,0.0164811786188787,7.24563012123809e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF8,SLAM family member 8,28797,0.0168870855010151,0.00377534780684818,0.00948740379959266,0.0242867672024375,7.74290531080373e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.0128227448275708,0.00286946477288804,0.00719859387271028,0.0184468957824314,7.90568971812636e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,29349,0.00977843636349656,0.00220194285379558,0.00546262837005722,0.0140942443569359,8.99429423403218e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA6,Corticosteroid-binding globulin,24966,0.00526955538261767,0.00118803492427653,0.00294100693103567,0.00759810383419968,9.22417203691378e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,24016,-0.0130069340641889,0.0029336268525857,-0.0187568426952568,-0.0072570254331209,9.30236945586677e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.0183886635545633,0.00419101845035659,0.0101742673918644,0.0266030597172622,1.15077568731036e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,24229,0.032686572717129,0.00748805308750451,0.0180099886656201,0.0473631567686378,1.27554009721339e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.0108071961678288,0.00247793288217851,0.00595044771875893,0.0156639446168987,1.29693842684281e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD99,CD99 antigen,29443,-0.0060090050117474,0.00138527436243487,-0.00872414276211974,-0.00329386726137506,1.44412700991528e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN2,Contactin-2,29725,0.0135815018953995,0.00314189472082452,0.00742338824258349,0.0197396155482156,1.54624766323897e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.0114376370183597,0.0026493673538974,0.00624487700472075,0.0166303970319986,1.5859437734823e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK14,Kallikrein-14,29725,-0.0139768729502324,0.00324604855550563,-0.0203391281190234,-0.00761461778144137,1.66907526158471e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMOD4,Tropomodulin-4,24016,-0.0124228845440264,0.00289443522259536,-0.0180959775803133,-0.00674979150773947,1.77773184044213e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA11,Serpin A11,29820,-0.0123638321550244,0.00288247458268356,-0.0180134823370842,-0.00671418197296466,1.79791423239375e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.0167990149493504,0.00393477743969653,0.00908685116754521,0.0245111787311556,1.9676638658113e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TERF1,Telomeric repeat-binding factor 1,24229,-0.00883979009588363,0.00207308066736831,-0.0129030282039255,-0.00477655198784174,2.01484034455688e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPO,Erythropoietin,29434,0.0227751003307849,0.0053425086713511,0.0123037833349368,0.0332464173266331,2.02330818026639e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.0161770098297827,0.00379874497787712,0.00873146967314358,0.0236225499864219,2.06442781686454e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKCQ,Protein kinase C theta type,28931,0.0130563064471964,0.00306976349046842,0.00703957000587826,0.0190730428885145,2.11402407311945e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1,Integrin beta-1,29474,0.00648572772922159,0.00152864914945986,0.00348957539628026,0.00948188006216292,2.21438162454282e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP152,Centrosomal protein of 152 kDa,24016,0.0124404383800655,0.00294496449414799,0.00666830797153546,0.0182125687885956,2.40559143983981e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.0112267488331352,0.00265859370087824,-0.0164375924868565,-0.00601590517941384,2.4215477186072e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,24445,0.0206838495192192,0.00491554663308552,0.0110493781183716,0.0303183209200669,2.58739566961266e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.0158168388592794,0.00376240255340978,-0.0231911478639626,-0.00844252985459626,2.63277875272209e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMMD9,COMM domain-containing protein 9,24793,0.0116746658562449,0.00278363151915592,0.00621874807869928,0.0171305836337905,2.7497994174794e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARTN,Artemin,28931,0.0131831812168439,0.00315394580261737,0.00700144744371389,0.019364914989974,2.92492987792722e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA4,Ephrin type-A receptor 4,24381,0.00844113909296273,0.00201967518175678,0.00448257573671945,0.012399702449206,2.93228853406778e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.0120376791465493,0.00288103004812144,-0.0176844980408673,-0.00639086025223127,2.94788287548036e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.0182338659437182,0.00437331933852692,0.00966216004020547,0.026805571847231,3.06541596085177e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NME1,Nucleoside diphosphate kinase A,24229,-0.00643949558095602,0.00154637920392439,-0.00947039882064783,-0.0034085923412642,3.13470966368095e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFD,Complement factor D,24966,0.00573603857462007,0.00137936625478906,0.00303248071523352,0.00843959643400663,3.21471283621795e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.018103892446603,0.00435906492761678,-0.0266476597047318,-0.00956012518847408,3.28828077670155e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.0204445875773972,0.00492914784628264,0.0107834577986833,0.0301057173561112,3.36773278700891e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6,Interleukin-6,29349,0.0215227634884039,0.00518962637211025,0.0113510957990678,0.03169443117774,3.37414329166549e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUP50,Nuclear pore complex protein Nup50,24111,-0.00986005107964449,0.00238628866685613,-0.0145371768666825,-0.00518292529260646,3.60895987961772e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTXR,Neuronal pentraxin receptor,29478,0.00989471644393917,0.00239590054970773,0.00519875136651202,0.0145906815213663,3.63995616726054e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.0538372996745382,0.0130438548566433,0.0282713441555173,0.0794032551935591,3.6788944391063e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPT2,Angiopoietin-2,29725,-0.0110541037019208,0.0026840076463827,-0.0163147586888309,-0.0057934487150107,3.82366233494136e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.0079405821047277,0.00193153455827974,0.0041547743704994,0.011726389838956,3.94964918340907e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUCA2A,Guanylin,29333,-0.00987546954919795,0.00241194434539455,-0.0146028804661713,-0.00514805863222463,4.2439351168483e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AOC3,Membrane primary amine oxidase,29594,-0.00869282278397614,0.00212485081437099,-0.0128575303801433,-0.004528115187809,4.30603356011877e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD3,Extracellular superoxide dismutase,24951,-0.017251639997178,0.00422369918901941,-0.0255300904076561,-0.0089731895867,4.43123927982913e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.00989417182562141,0.00242314857138335,-0.0146435430255328,-0.00514480062571005,4.45653974327257e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMG4,Proteasome assembly chaperone 4,24229,0.016169262341319,0.00396134438231743,0.00840502735197685,0.0239334973306612,4.48390039591265e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0141245894411454,0.00346175750503317,-0.0209096341510104,-0.00733954473128035,4.51193190995415e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCC,Netrin receptor DCC,24195,0.00657395674878924,0.00161446914680455,0.00340959722105233,0.00973831627652616,4.67795907224193e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSAP,Gamma-secretase-activating protein,28797,0.0249116613176863,0.0061248184518224,0.0129070171521144,0.0369163054832582,4.7681313635256e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMP,Cartilage oligomeric matrix protein,29214,0.00961139490194439,0.00236830340620317,0.00496952022578616,0.0142532695781026,4.95500426296001e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP290,Centrosomal protein of 290 kDa,24445,0.0151919118650224,0.00374670586175023,0.00784836837599198,0.0225354553540529,5.03460002285071e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.0104528902256923,0.00258223712461616,0.00539170546144462,0.01551407498994,5.18181346873413e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNN,Tenascin-N,24938,0.0123240014923139,0.00306775599421281,0.00631119974365677,0.018336803240971,5.90491296805538e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELAVL4,ELAV-like protein 4,24101,0.0239206499312663,0.00597964815026848,0.0122005395567401,0.0356407603057925,6.34393520674726e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO1,Alpha-enolase,29392,0.0221996271002913,0.00555305046094357,0.0113156481968419,0.0330836060037407,6.41075216978486e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,28797,0.0131890480772384,0.00331451866714204,0.00669259148964002,0.0196855046648368,6.93243424361007e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.00825784226209428,0.00207721148223624,0.00418650775691125,0.0123291767672773,7.0451259991329e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM3,Intercellular adhesion molecule 3,29820,-0.00726786280081923,0.00183635786163062,-0.0108671242096152,-0.00366860139202321,7.58313743297487e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAN,Neurocan core protein,29694,0.0103503384957841,0.00263124491093485,0.00519309847035179,0.0155075785212164,8.38635204656141e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,-0.00582446950285337,0.00148201478739221,-0.0087292184861421,-0.00291972051956465,8.51455491231447e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUK1,Guanylate kinase,24111,-0.0111232331314746,0.00283231095420511,-0.0166745626017166,-0.0055719036612326,8.61568125493372e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYMP,Thymidine phosphorylase,29301,0.0183686005399975,0.00468042756257199,0.00919496251735641,0.0275422385626386,8.70882872607293e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MELTF,Melanotransferrin,24922,0.00818802278861784,0.00208929261839051,0.00409300925657244,0.0122830363206633,8.91396487622286e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.00720884531276599,0.00184528997205866,-0.010825613658001,-0.00359207696753101,9.38505300616777e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.0116726283373213,0.00299794385042261,0.00579665839049301,0.0175485982841496,9.90069149692623e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00728391153803121,0.0018749814954439,-0.0109588752691013,-0.00360894780696117,0.000102682614589131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA2,Ephrin type-A receptor 2,28347,0.00860889206057861,0.00221632283355194,0.00426489930681682,0.0129528848143404,0.000102852600604518
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,0.00756185150466699,0.001949361024004,0.00374110389761915,0.0113825991117148,0.000105052862554695
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN2B,Sodium channel subunit beta-2,24195,-0.00792302427328623,0.00204445990251234,-0.0119301656822104,-0.00391588286436205,0.000106746745825491
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NINJ1,Ninjurin-1,28797,0.0150749367551228,0.00389960586506835,0.00743170925958881,0.0227181642506567,0.000110987351627151
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC1,Sialoadhesin,29581,0.0115513674867942,0.00298884171453335,0.00569323772630882,0.0174094972472795,0.000111403604722154
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD200,OX-2 membrane glycoprotein,29434,-0.00721659145159579,0.00186816462630421,-0.0108781941191521,-0.00355498878403953,0.000112274531649949
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,28774,0.0108755203628667,0.00281657800494864,0.00535502747316742,0.0163960132525661,0.000113053770755264
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN3,Neuronal-specific septin-3,24867,-0.0205766139658114,0.00534178023431307,-0.0310465032250651,-0.0101067247065578,0.000117444091501445
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.00857417451211881,0.00222909625648717,-0.0129432031748337,-0.00420514584940395,0.000120076118895373
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17C,Interleukin-17C,28931,-0.01907529864923,0.00496113402708296,-0.0287991213423126,-0.00935147595614738,0.000120836552420994
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00611419284174759,0.00160074522613644,0.00297673219852017,0.00925165348497502,0.000133943704791256
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRR4,Proline-rich protein 4,24203,-0.0188095421821334,0.00492438510786063,-0.0284613369935402,-0.00915774737072656,0.000133962253823378
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0189853685576772,0.0049727386399158,0.00923880082344218,0.0287319362919121,0.000134930168398432
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,0.0139021445455677,0.0036432845440008,0.0067613068393261,0.0210429822518093,0.000136011143439221
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN1,Calsyntenin-1,28774,0.0138584274845187,0.00364009295323194,0.0067238452961841,0.0209930096728533,0.000140861624496917
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,24016,0.0113410254746287,0.0029849066473301,0.00549060844586171,0.0171914425033957,0.000145370987654106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.00917734271949416,0.00242248537649516,-0.0139254140574247,-0.00442927138156365,0.000151920945887979
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAL,Galanin peptides,29581,-0.0171783159969633,0.00453962427848145,-0.0260759795827869,-0.00828065241113962,0.000154580415616436
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.00792186954255694,0.00209850807548377,0.00380879371460876,0.0120349453705051,0.000160389552049554
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC12A2,Solute carrier family 12 member 2,24111,-0.00730148602788843,0.00194695589512257,-0.0111175195823287,-0.00348545247344818,0.000177102552829842
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM1,Myomesin-1,24101,0.0126368202483528,0.00336976360629898,0.00603208358000676,0.0192415569166988,0.000177204986341272
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPS,Calcyphosin,24845,0.024996574818997,0.00668406590666956,0.0118958056419247,0.0380973439960694,0.000184634792143027
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANSC4,MANSC domain-containing protein 4,24111,0.0175535439919126,0.00470204514257612,0.00833753551246343,0.0267695524713618,0.000189518066392915
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.0113561488805699,0.00304300784174393,0.00539185351075184,0.017320444250388,0.000190475618340859
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR158,Probable G-protein coupled receptor 158,24867,0.00944117508068357,0.00253010494326456,0.00448216939188503,0.0144001807694821,0.000190740200459641
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSC1,Hamartin,24229,0.0197563215420397,0.0053003143909453,0.00936770533578689,0.0301449377482925,0.000193915623871107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",24111,0.0147837543036341,0.0039812641857,0.0069804764996621,0.0225870321076061,0.000205009588087042
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.012925798638876,0.00348248096817147,0.00610013594125994,0.0197514613364921,0.000206351876375615
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,24381,0.00737969796341202,0.00198829336508958,0.00348264296783645,0.0112767529589876,0.000206432716324831
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP1,Methionine aminopeptidase 1,28774,0.00781474205799146,0.00210755801578065,0.00368392834706139,0.0119455557689215,0.000209327547238713
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRTN,Neurturin,28931,0.0128809603806149,0.00348364643716251,0.00605301336377637,0.0197089073974534,0.000218091821000354
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR1,Folate receptor alpha,29383,0.00751892876136676,0.00203381206770213,0.00353265710867059,0.0115052004140629,0.000218590607562365
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP164,Centrosomal protein of 164 kDa,28931,0.0163875969959601,0.00444414919019155,0.00767706458318468,0.0250981294087356,0.000226923119190719
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYO6,Unconventional myosin-VI,24867,0.00971032984980494,0.00263605209610217,0.00454366774144468,0.0148769919581652,0.000230392873773233
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.00869236874909653,0.00236011142923143,-0.0133181871503901,-0.00406655034780293,0.000230888859562604
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA3G,Semaphorin-3G,24381,0.0114330085925313,0.00312257123520278,0.00531276897153388,0.0175532482135288,0.000251362821171757
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR101,Probable G-protein coupled receptor 101,24101,-0.0158163394068851,0.0043539821234088,-0.0243501443687664,-0.00728253444500388,0.000281146349983769
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACE,Angiotensin-converting enzyme,24951,-0.0067005846501192,0.00184705628238426,-0.0103208149635924,-0.00308035433664605,0.000286516681335761
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEFL,Neurofilament light polypeptide,28674,0.0114208751128383,0.00315779915030777,0.00523158877823505,0.0176101614474415,0.00029887192897111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS4,Galectin-4,29454,0.0138601130864067,0.00383839122581769,0.00633686628380397,0.0213833598890093,0.00030562276755791
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3GL3,Endophilin-A3,24307,0.0212650560169293,0.00591468428743476,0.00967227481355719,0.0328578372203014,0.000324661487923575
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,28774,0.00970728210977896,0.00270646471319137,0.00440261127192388,0.015011952947634,0.0003354419971164
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPESP1,Sperm equatorial segment protein 1,24922,0.00766447073122601,0.00214214019103392,0.00346587595679953,0.0118630655056525,0.000346956456153393
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,24229,0.00514264613692392,0.00143967298138471,0.0023208870934099,0.00796440518043795,0.00035482607461629
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.00732901042150013,0.0020583248448051,0.00329469372568213,0.0113633271173181,0.000370622086132296
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.00795784686633332,0.00223992531548799,-0.0123481004846898,-0.00356759324797685,0.000381983050599082
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY6D,Lymphocyte antigen 6D,29283,0.00960181883282252,0.00270471570751355,0.00430057604609595,0.0149030616195491,0.000385792732777398
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.0114739852038585,0.00323497931962707,0.00513342573738945,0.0178145446703276,0.000390606968566351
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.0100434193703681,0.0028347838403973,-0.0155995956975468,-0.00448724304318943,0.000396466945272586
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,24445,0.0133190898372679,0.00377052504075227,0.00592886075739346,0.0207093189171423,0.000412529082729524
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGMA,Repulsive guidance molecule A,29694,-0.00782006713460659,0.00221606999178161,-0.0121635643184986,-0.00347656995071462,0.000418079975725248
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNL1,Thioredoxin-like protein 1,24069,0.0243349918698756,0.00693116237145943,0.0107499136218151,0.0379200701179361,0.000447318986126157
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.072930301768477,0.020783118446697,0.0321953896129508,0.113665213924003,0.000450275608278792
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH7B,Myosin-7B,24016,-0.0109914876667956,0.00313360905061137,-0.0171333614059938,-0.00484961392759728,0.000452972832780494
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C9orf40,Uncharacterized protein C9orf40,24805,0.019829092007675,0.00565780407032512,0.00873979602983777,0.0309183879855122,0.000457871977861868
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL28,C-C motif chemokine 28,29327,0.0146067887515215,0.00417309739673174,0.00642751785392734,0.0227860596491157,0.000465552103388848
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.0117055764460418,0.00334734213277449,0.00514478586580376,0.0182663670262798,0.00047127312281034
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3D,Protein FAM3D,24805,0.0208489456803703,0.00596321441337273,0.00916104543015972,0.0325368459305808,0.000472654344776922
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP4,Bone morphogenetic protein 4,29169,-0.0113526113718696,0.0032577389818464,-0.0177377797762885,-0.00496744296745063,0.00049320416138912
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,29594,0.00676197530460874,0.00194342085396161,0.00295287043084398,0.0105710801783735,0.000503225497812798
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.0156382691784285,0.00450367852913773,0.00681105926131859,0.0244654790955385,0.000516724984630894
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.0180601522699948,0.00521156964880735,0.00784547575833239,0.0282748287816572,0.000530342745781004
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MKI67,Proliferation marker protein Ki-67,24229,0.0095467857113119,0.00275514895108733,0.00414669376718072,0.0149468776554431,0.000531009912861257
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAG,S-arrestin,24101,-0.0128890441712371,0.00372985286735185,-0.0201995557912468,-0.0055785325512275,0.000549925369477242
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLMP,CXADR-like membrane protein,29725,0.00514910109665161,0.00149116566438804,0.00222641639445106,0.00807178579885216,0.000555014722920515
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCP2,Non-specific lipid-transfer protein,28797,0.0184913104188314,0.00536845646752007,0.00796913574249207,0.0290134850951708,0.000573064871433628
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.0155557147713838,0.00452175426170498,-0.0244183531243256,-0.00669307641844209,0.000582269528283171
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.00774993914063251,0.00225663796864442,0.00332692872208946,0.0121729495591756,0.000594936816149758
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOX9,Transcription factor SOX-9,24195,0.00660309143521347,0.00192855453289235,0.00282312455074446,0.0103830583196825,0.000618418783821803
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.0135194131503761,0.00394993351089815,0.00577754346901577,0.0212612828317365,0.000621038539431278
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.0134109864536333,0.00392322183434158,0.00572147165832376,0.0211005012489428,0.000630864291064516
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,29288,0.00540598751968865,0.00158270880701528,0.00230387825793871,0.0085080967814386,0.000637151285865954
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.0125889224329842,0.00369033520852071,0.00535586542428357,0.0198219794416848,0.000647533029488912
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM19,Probable RNA-binding protein 19,24111,-0.011521099115548,0.00337934873329017,-0.0181446226327967,-0.0048975755982993,0.00065244575668985
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,0.0124434296984349,0.00366221015868485,0.00526549778741256,0.0196213616094572,0.000680387932677583
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NLGN2,Neuroligin-2,24101,-0.0114042703941499,0.00335709211216474,-0.0179841709339928,-0.004824369854307,0.000682221328747126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00615615063729488,0.00181297297551824,-0.00970957766931064,-0.00260272360527913,0.000685828569746273
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMBN,Ameloblastin,28931,-0.00681928639717065,0.00201459398776036,-0.0107678906131809,-0.00287068218116035,0.00071287555044573
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELENOP,Selenoprotein P,24966,0.00535823633475404,0.00159604863105461,0.00222998101788701,0.00848649165162108,0.000788569728372054
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.00696364080235871,0.00208003822109993,0.00288676588900285,0.0110405157157146,0.000815452482066812
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G1B,Phospholipase A2,29787,-0.0101465999989126,0.00303414474058263,-0.0160935236904545,-0.00419967630737064,0.000826403690699398
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.0144867905271244,0.00433604634817406,-0.0229854413695456,-0.00598813968470327,0.000835999423918491
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,24240,0.0134696206755008,0.00404492902610072,0.00554155978434344,0.0213976815666582,0.000869750710524887
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,24445,-0.0102742836517107,0.00309786851978685,-0.0163461059504929,-0.00420246135292852,0.000912641216832622
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,0.0103363326224446,0.00312380005490076,0.00421368451483907,0.01645898073005,0.000937996934845708
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.0136818447579956,0.00414102975031427,-0.0217982630686116,-0.00556542644737961,0.000954644311412395
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,29443,0.0099233325883559,0.00301243835920445,0.00401895340431517,0.0158277117723966,0.000988469718286598
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRC,Chymotrypsin-C,29456,0.0148040822330651,0.00449550292145631,0.00599289650701078,0.0236152679591195,0.000992105803705874
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.0088323016014595,0.00268571843351328,0.00356829347177347,0.0140963097311455,0.00100824365070663
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,24805,0.0127052643435897,0.00386661855938939,0.0051266919671865,0.0202838367199929,0.00101803604915928
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST6,Cystatin-M,28830,0.0112909372857776,0.0034398807643332,0.00454877098768454,0.0180331035838707,0.00103063456764855
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH23,Cadherin-23,24845,-0.00613942501000806,0.00187165961933959,-0.00980787786391367,-0.00247097215610246,0.00103874983044146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.00743963653743093,0.00226921159729752,0.00299198180672778,0.0118872912681341,0.00104503955549933
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.0140718206579339,0.00429392785283968,0.00565572206636817,0.0224879192494997,0.0010498517136959
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,24883,0.00341076207775281,0.00104530277061883,0.00136196864733991,0.00545955550816571,0.00110410863531441
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.0139903340043065,0.00428937370177773,-0.0223975064597908,-0.00558316154882212,0.00110928271073919
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.00793016062269498,0.00243427131318252,0.00315898884885724,0.0127013323965327,0.00112439633579094
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RALB,Ras-related protein Ral-B,24229,0.00678902347575877,0.00208770173601166,0.00269712807317592,0.0108809188783416,0.00114788071907026
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.0117066795725523,0.00360861225066366,0.00463379956125156,0.0187795595838531,0.00117985746852455
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSPN,Claspin,28719,0.00791630322992799,0.00244806011582933,0.00311810540290249,0.0127145010569535,0.00122333867380887
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCG3,Secretogranin-3,29497,-0.00756280147382559,0.00234193036853038,-0.0121529849961451,-0.00297261795150604,0.00124228427214368
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.0155294132460794,0.00481026995324929,0.00610128413771074,0.024957542354448,0.00124651917682294
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRXN3,Neurexin-3,24195,0.00801812731522191,0.00249160729258738,0.00313457702175066,0.0129016776086932,0.00129233500099009
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,24111,0.00903875162862325,0.00282152861251442,0.00350855554809497,0.0145689477091515,0.00135947151847834
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRAL,GDNF family receptor alpha-like,24025,-0.0140668139286472,0.00442370533432885,-0.0227372763839318,-0.00539635147336268,0.00147527557004946
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCND2,G1/S-specific cyclin-D2,24445,0.00820286153959088,0.00260151188120936,0.00310389825242054,0.0133018248267612,0.00161734577787674
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR4,Toll-like receptor 4,24229,0.00631261790861665,0.00200249417009153,0.00238772933523726,0.010237506481996,0.00162144178686745
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SULT1A1,Sulfotransferase 1A1,29694,-0.0284784191123344,0.00903823105321166,-0.0461933519766292,-0.0107634862480395,0.00162938714374911
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.0111169919704933,0.00352949536596534,0.00419918105320119,0.0180348028877853,0.00163583231138764
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPN1,Epsin-1,24445,0.00965154601892816,0.00308575151908899,0.00360347304151374,0.0156996189963426,0.00176339978454332
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.0124260100471514,0.00397575715610087,0.00463352602119368,0.0202184940731091,0.00177747230525961
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.0149719374184889,0.00479856347742384,0.00556675300273812,0.0243771218342396,0.0018097614659005
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP112,Centrosomal protein of 112 kDa,24111,0.0100931897885728,0.003238677461567,0.00374538196390153,0.0164409976132442,0.00183255230049905
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.0258615349242101,0.00831424685362839,0.00956561109109847,0.0421574587573217,0.00186947157412833
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA6C,Semaphorin-6C,24229,0.00573659631514196,0.00184984516419972,0.00211089979331052,0.00936229283697341,0.00193009956986228
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM25,Transmembrane protein 25,24867,-0.00987526115871252,0.00318859652639849,-0.0161249103504536,-0.00362561196697148,0.0019567075704802
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAT1,Diamine acetyltransferase 1,24111,-0.0109886122745743,0.00356114817681203,-0.0179684627011259,-0.00400876184802273,0.00203308043757974
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,0.00765170301293889,0.0024806336852565,0.00278966098983615,0.0125137450360416,0.00204072089559361
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.0088721099767867,0.00288919704888299,-0.0145349361925974,-0.00320928376097604,0.00213689977320176
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.0103594638704666,0.00337763433049635,-0.0169796271582394,-0.00373930058269377,0.00216402868935372
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.0186025099404261,0.00610912198285228,0.00662863085403567,0.0305763890268166,0.00232902841715552
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACHE,Acetylcholinesterase,24381,0.00709366587767455,0.002331672665069,0.00252358745413931,0.0116637443012098,0.00235021478130621
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTN,Titin,24111,-0.0143937018964799,0.00474297028778382,-0.0236899236605362,-0.00509748013242363,0.0024099635812863
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.0188050023510975,0.00619693032462108,0.00665901891484015,0.0309509857873548,0.00241139221652193
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEF,Thyrotroph embryonic factor,24111,0.00916402797768541,0.00302659328006431,0.00323190514875936,0.0150961508066115,0.00246572150301003
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNG,Uracil-DNA glycosylase,24793,0.00734429922289077,0.002429545277379,0.00258239047922792,0.0121062079665536,0.00250611694634896
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.00720148369274821,0.00238821122218127,-0.0118823776882235,-0.00252058969727293,0.00256834009744872
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.017915638450979,0.00595859511572099,0.00623679202416584,0.0295944848777921,0.0026438159915157
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.00577457888272109,0.001921514053603,0.0020084113376592,0.00954074642778298,0.0026561349177573
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF5,Fibroblast growth factor 5,28931,-0.00698273448157026,0.00233268632600499,-0.01155479968054,-0.00241066928260047,0.00276093375965192
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B4,Protein ATP1B4,24016,-0.00888860745526912,0.0029699205608937,-0.0147096517546208,-0.00306756315591746,0.00276642088054117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PADI2,Protein-arginine deiminase type-2,28931,0.0118977406011807,0.00397574879021594,0.00410527297235743,0.0196902082300039,0.00276864945809537
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100G,Protein S100-G,24867,-0.00980638588651809,0.00327698712692906,-0.016229280655299,-0.00338349111773714,0.00276973861597888
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",24101,0.0153499934586652,0.00513640098940247,0.00528264751943632,0.025417339397894,0.00280658362970638
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HCG22,Protein PBMUCL2,24111,-0.0116959631295969,0.00391616418893058,-0.0193716449399008,-0.00402028131929292,0.00282394681654713
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,29786,0.012373395353043,0.00414667286794091,0.00424591653187884,0.0205008741742072,0.00284799615459123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RYR1,Ryanodine receptor 1,24111,-0.00717796817696059,0.00240978779447233,-0.0119011522541263,-0.00245478409979483,0.00289788502154955
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.0120251819364756,0.00404862858470556,0.00408986991045274,0.0199604939624985,0.00297913491008793
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH4,Myosin-4,24111,-0.00976809758668057,0.00329803261152046,-0.0162322415052607,-0.00330395366810047,0.00306149357599756
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6L,Seizure 6-like protein,29566,0.00569805025475323,0.00193633461514855,0.00190283440906207,0.0094932661004444,0.00325617177851771
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,29434,0.00730131151071223,0.00248363197400265,0.00243339284166704,0.0121692301797574,0.00328709309641851
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,0.00700376047552905,0.0023916207884233,0.00231618373021939,0.0116913372208387,0.00340908712622901
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,0.030907918084617,0.0105625262684549,0.0102053665984454,0.0516104695707886,0.00343407882339991
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNXB,Tenascin-X,29443,-0.00532105870653412,0.0018185311311188,-0.00888537972352697,-0.00175673768954126,0.00343591058892201
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.00804739341606843,0.00276192390360279,0.00263402256500697,0.0134607642671299,0.0035750156886027
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,-0.00420072925694712,0.00144301634514511,-0.00702904129343155,-0.0013724172204627,0.0036051713025804
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,29434,0.00977852121911352,0.00336179260310452,0.00318940771702866,0.0163676347211984,0.00363180504255148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRG3,Proteoglycan 3,24938,-0.0102317262751528,0.00352171400047869,-0.017134285716091,-0.00332916683421457,0.00367193679011858
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",24111,0.0128076324832253,0.00443388634111604,0.0041172152546379,0.0214980497118128,0.00387331034208175
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JUN,Transcription factor AP-1,28931,0.0102039327753803,0.00353334190597327,0.00327858263967273,0.017129282911088,0.00388112567398555
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_DRA,,29322,-0.00733175524222218,0.00254516369306723,-0.0123202760806339,-0.00234323440381042,0.00397129190154293
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.0101564176092789,0.00353189095068743,-0.0170789238726262,-0.00323391134593149,0.00403573328951071
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,24793,0.0075513887905386,0.00262682989845296,0.0024028021895708,0.0126999753915064,0.00404735793950718
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASN,Vasorin,29065,0.00552886788704949,0.00193645133387646,0.00173342327265163,0.00932431250144736,0.00430463500997876
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,24101,0.00881500105422903,0.00309732277495083,0.00274424841532541,0.0148857536931327,0.00443086553504048
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.00822680414960216,0.00289549278373415,0.00255163829348322,0.0139019700057211,0.00449682604922529
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GKN1,Gastrokine-1,28114,0.00561971721286803,0.00198078539235007,0.00173737784386189,0.00950205658187417,0.00455556950347281
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0132874433789905,0.00470245896515425,-0.0225042629506928,-0.00407062380728813,0.00472185174863361
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.00944994843404458,0.00334677083057029,0.00289027760612681,0.0160096192619624,0.00475252047359194
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG1A,Lithostathine-1-alpha,29353,-0.00978069902744249,0.0034658368929301,-0.0165737393375855,-0.00298765871729949,0.00477526494202985
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELL,L-selectin,24966,0.00461042719513108,0.00163674458375077,0.00140240781097958,0.00781844657928258,0.00485386462213868
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.00783575690319075,0.00278205126865761,0.00238293641662183,0.0132885773897597,0.00485835494069696
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00512205100186697,0.00182427054790795,0.00154648072796738,0.00869762127576656,0.00499330520292642
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRDL2,Chordin-like protein 2,29478,0.0105112895171704,0.00375779492495396,0.00314601146426065,0.0178765675700802,0.00515816488886419
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.00786703156180931,0.00281243805093464,-0.0133794101416412,-0.00235465298197741,0.0051583948812397
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,24195,0.0122900653783276,0.00440751636460999,0.00365133330369201,0.0209287974529632,0.00530050260080412
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1B,Protein phosphatase 1B,24229,0.0122901197834361,0.00441422589089903,0.00363823703727397,0.0209420025295982,0.00537003620581
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.0133407380576856,0.00479486828793572,0.00394279621333159,0.0227386799020396,0.00540111219960311
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP6,Guanylate-binding protein 6,24111,-0.00903863087770849,0.00325913510808682,-0.0154265356895587,-0.00265072606585833,0.00555298495012459
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,0.00712760447080412,0.00257244323544786,0.0020856157293263,0.0121695932122819,0.00559691164279526
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.00455359914986908,0.00164821383630695,0.00132310003070746,0.0077840982690307,0.00573602794799415
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTTG1,Securin,24445,0.00807156631873352,0.00292169714138576,0.00234503992161742,0.0137980927158496,0.00573807055697599
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY96,Lymphocyte antigen 96,29218,-0.00688200450870414,0.00250599498655181,-0.0117937546823457,-0.00197025433506259,0.00603238929036028
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK1,Kallikrein-1,29199,-0.0246602957389539,0.00898089662606771,-0.0422628531260466,-0.00705773835186115,0.00603892427580268
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,29434,0.0126637475737731,0.0046145051163096,0.00361931754580632,0.0217081776017399,0.00606703967457632
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK15,Kallikrein-15,24754,0.0100043050193719,0.0036517495192399,0.00284687596166172,0.0171617340770821,0.00615595033706702
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL15,Interleukin-15,29434,0.0063213782532403,0.00230962227724628,0.00179451858983758,0.010848237916643,0.00620442478576539
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,29662,0.00779822381139921,0.00286805902680461,0.00217682811886217,0.0134196195039363,0.0065519686797125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TUBB3,Tubulin beta-3 chain,24101,-0.005399768859637,0.00198721025135943,-0.00929470095230148,-0.00150483676697253,0.00658717167764498
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX1B,Syntaxin-1B,24195,0.00798913724138862,0.00294024515094338,0.00222625674553959,0.0137520177372377,0.00658902248943295
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAC1,Cartilage acidic protein 1,29820,0.00572943325556699,0.00211755098489376,0.00157903332517522,0.00987983318595876,0.00682017205553035
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTNNA1,Catenin alpha-1,24101,-0.00670582142747455,0.0024817424043785,-0.0115700365400564,-0.00184160631489269,0.00689592047654478
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF2,Trefoil factor 2,29536,0.0109552896873131,0.00405955810821522,0.00299855579521123,0.0189120235794149,0.00696628508868028
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMI,N-myc-interactor,24706,0.0137196651868194,0.00508408581586017,0.0037548569877335,0.0236844733859054,0.00696894072230774
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL6,Fc receptor-like protein 6,29434,0.0128589635449236,0.0047836601899258,0.00348298957266903,0.0222349375171782,0.00719000190329518
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.0175437746959727,0.00653619221399351,0.00473283795654539,0.0303547114354,0.0072775880148197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTO1,Protein LTO1 homolog,28931,0.0077689909451019,0.00290048654916751,0.00208403730873357,0.0134539445814702,0.00739916648383753
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.0114985067436412,0.00430322433560206,0.00306418704586122,0.0199328264414213,0.00754277104894113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP7,Retinoid-binding protein 7,24805,0.011338795920783,0.00424616723516264,0.00301630813986425,0.0196612837017018,0.00758193411688085
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,-0.009161141197047,0.00344278608891763,-0.0159090019313256,-0.00241328046276845,0.00779677064778721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOP56,Nucleolar protein 56,24111,0.0208564805698704,0.00784104611061868,0.00548803019305778,0.036224930946683,0.00782131466734275
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.00951724983648027,0.00358816548911823,-0.016550054195152,-0.00248444547780853,0.00799741707254884
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.0180034197226904,0.00685590040259204,0.00456585493360996,0.0314409845117707,0.00864543927396239
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL11,Interleukin-11,28931,0.011535913000687,0.00439902249568396,0.00291382890914644,0.0201579970922276,0.00873635205815999
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.00796322632110524,0.00303716340162616,-0.0139160665882925,-0.00201038605391797,0.00874886660487996
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH17,Protocadherin-17,29478,0.0066440690008626,0.0025366508143866,0.00167223340466486,0.0116159045970603,0.00881739407266928
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.00611702224860955,0.00234034814834667,0.00152993987785008,0.010704104619369,0.0089616937931609
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD33,Myeloid cell surface antigen CD33,29566,0.0145781292758476,0.00558323482758157,0.00363498901378768,0.0255212695379074,0.00903091450069423
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.0115622091192206,0.00445026079826239,-0.0202847202838149,-0.00283969795462633,0.00937988560535405
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.0077383573680984,0.00298794856506689,0.00188197818056729,0.0135947365556295,0.00960644062400667
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,29673,0.00553719120322671,0.00214344913092391,0.00133603090661584,0.00973835149983758,0.00979050676871644
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TJP3,Tight junction protein ZO-3,24101,-0.00780640036130732,0.00302607740462246,-0.0137375120743673,-0.0018752886482473,0.00989421746803797
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHPK,Sedoheptulokinase,24445,-0.00755894554366758,0.00293054641762636,-0.0133028165222152,-0.00181507456511992,0.00990403575506889
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.00668198613506996,0.00259120139570658,-0.0117607408706549,-0.00160323139948507,0.00992148913034398
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.0105187065111283,0.00408439651116942,0.00251328934923625,0.0185241236730204,0.0100200900382172
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF20B,Kinesin-like protein KIF20B,24101,0.0138795634736514,0.00540421940149834,0.00328729344671464,0.0244718335005881,0.010226346480007
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.00887929200907037,0.00346009934585213,-0.0156610867269406,-0.00209749729120019,0.0102880469949849
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.00556984803706094,0.00217327486905663,0.00131022929370993,0.00982946678041194,0.0103865579059349
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.00983210164521039,0.00383912761133273,-0.0173567917634225,-0.00230741152699824,0.0104424221762303
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSB,Lupus La protein,28774,0.0107591005461105,0.00420179184670985,0.00252358852655918,0.0189946125656618,0.0104542722163838
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.0106820384411286,0.00418653347061993,0.00247643283871352,0.0188876440435436,0.0107303327536807
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.00812455648965641,0.0031925296031158,0.00186719846754945,0.0143819145117634,0.0109371528064506
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HYAL1,Hyaluronidase-1,29265,0.00411948321643932,0.00162002988709016,0.000944224637742614,0.00729474179513603,0.0110005382483098
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,24240,0.00682175833855051,0.00268514443951386,0.00155887523710335,0.0120846414399977,0.0110738405139177
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.0125103118566766,0.00492731755944912,-0.0221678542731968,-0.00285276944015629,0.0111239639537426
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00603214635043109,0.00237809523149653,-0.0106932130041643,-0.0013710796966979,0.0112014808130114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPTC,Opticin,29349,-0.0080204400082281,0.00317882891479498,-0.0142509446812263,-0.00178993533522993,0.0116384297901304
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA3,Carbonic anhydrase 3,29761,0.0105910229767581,0.00422479380157322,0.00231042712567464,0.0188716188278416,0.0121857235593936
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYB5A,Cytochrome b5,24016,0.0127956233719351,0.00510508714768368,0.00278965256247512,0.0228015941813951,0.012201739972062
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRNN,Cornulin,28580,0.0117469461470716,0.00470962093778569,0.00251608910901166,0.0209778031851316,0.0126281626634276
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6,Seizure protein 6 homolog,24195,-0.00549173289500825,0.00220548306941128,-0.00981447971105436,-0.00116898607896213,0.0127796673836693
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,24845,0.0123117506371208,0.0049497352509683,0.00261026954522295,0.0220132317290187,0.012876188758411
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK3,Prostate-specific antigen,24938,-0.0155696993030063,0.00627479703236944,-0.0278683014864504,-0.0032710971195622,0.0130966916170942
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUMF1,Formylglycine-generating enzyme,24229,0.0116051305061411,0.00469550626415427,0.00240193822839876,0.0208083227838835,0.0134600839104674
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGF,Beta-nerve growth factor,29218,0.0021068772158128,0.000857081211322041,0.000426998041621596,0.003786756390004,0.0139692935797295
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,29673,0.00727988013240825,0.00298383916453124,0.00143155536992703,0.0131282048948895,0.0147024479349952
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRMD7,FERM domain-containing protein 7,24195,0.0057712901510169,0.00236860844130314,0.00112881760606275,0.010413762695971,0.0148342931723979
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.0168874754170948,0.0069591505294945,-0.030527410454904,-0.00324754037928557,0.0152459150826859
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.00819457918963486,0.00338202643297742,-0.0148233509982706,-0.00156580738099911,0.0154011339038678
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB118,Beta-defensin 118,24101,0.00984439308712025,0.00406904389159274,0.00186906705959848,0.017819719114642,0.0155561360801863
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.00891530168653811,0.00370045990525172,-0.0161682031008315,-0.00166240027224473,0.0159932094269976
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM3,Paralemmin-3,24111,0.0125087704628908,0.00521578099771607,0.00228583970736733,0.0227317012184143,0.0164809694856601
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MN1,Transcriptional activator MN1,24195,-0.00993265697714212,0.00418193697745472,-0.0181292534529534,-0.00173606050133088,0.0175503742820877
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGN,Secretagogin,28931,-0.00737842707099375,0.00310760965599026,-0.0134693419967347,-0.00128751214525284,0.0175882956034931
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNW1,Interferon omega-1,24111,-0.00603895629480329,0.00254627906945475,-0.0110296632709346,-0.00104824931867197,0.0177152848111379
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00588735609335525,0.00249691605508729,0.000993400625384168,0.0107813115613263,0.0183889741640662
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,-0.00480295759721236,0.00204051437565113,-0.00880236577348858,-0.000803549420936136,0.0185907199382412
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YY1,Transcriptional repressor protein YY1,24229,0.00456742465260281,0.00197336600370732,0.000699627285336453,0.00843522201986916,0.0206467173466365
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00629178610731364,0.00271910851125188,0.000962333425259945,0.0116212387893673,0.0206807304664067
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.0107217928807806,0.00463464816627381,0.00163788247488391,0.0198057032866772,0.0207090167345019
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL14,C-X-C motif chemokine 14,28931,0.00968617022100495,0.0041946944614493,0.00146456907656432,0.0179077713654456,0.0209423840983727
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP8,Neutrophil collagenase,29640,0.0117704344694536,0.00509884890865772,0.00177669060848449,0.0217641783304227,0.0209810070465091
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNL1,Interferon lambda-1,28774,0.00736241720265036,0.00319402092118799,0.00110213619712189,0.0136226982081788,0.0211701687212509
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00430588126568828,0.00187378885515572,0.000633255109583063,0.00797850742179349,0.0215729442383512
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,0.0118833949345342,0.00518350527640978,0.00172372459277102,0.0220430652762974,0.0218815083586226
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RETN,Resistin,29362,0.00681390685392777,0.00297284780380687,0.000987125158466304,0.0126406885493892,0.0219099770577757
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,29628,-0.0032602050823722,0.00142499600420535,-0.00605319725061469,-0.000467212914129712,0.0221521289087956
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.0065003957414621,0.0028418777133676,-0.0120704760596626,-0.000930315423261597,0.0221834328246611
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSLNL,Mesothelin-like protein,24195,-0.00605547459735146,0.00266092840004708,-0.0112708942614437,-0.000840054933259183,0.0228726823663469
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,29725,0.00939443202074613,0.00412836422484712,0.00130283814004578,0.0174860259014465,0.022878117024327
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRING1,SREBP regulating gene protein,24016,0.00954505375877994,0.00420694322400361,0.00129944503973286,0.017790662477827,0.0232843984212915
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTR,Methionine synthase,24111,0.0104195757390649,0.00460894494194824,0.00138604365284634,0.0194531078252834,0.0237849214868563
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,24915,-0.00393376394889846,0.00175392454670338,-0.00737145606043709,-0.000496071837359838,0.0249161949266687
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAPPA,Pappalysin-1,28931,0.00742857570935585,0.00332327466238234,0.000914957371086457,0.0139421940476252,0.0254040814225915
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL36G,Interleukin-36 gamma,24149,0.0107351126627417,0.00480618097671753,0.00131499794837532,0.020155227377108,0.025518161994338
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.00745650175378388,0.00334344239607951,-0.0140096488500997,-0.000903354657468049,0.0257441719421507
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF9,Fibroblast growth factor 9,23970,0.00642014302667827,0.00288307454203572,0.000769316924288264,0.0120709691290683,0.0259672898502123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CADPS,Calcium-dependent secretion activator 1,24195,-0.00675856990273371,0.00304391660045431,-0.0127246464396242,-0.000792493365843259,0.0264040362426387
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.0122264112963487,0.00553250180324503,0.00138270776198848,0.023070114830709,0.0271182483094285
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,29216,0.00906032621160047,0.00410826784534755,0.00100812123471928,0.0171125311884817,0.0274346143974751
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMA1,Laminin subunit alpha-1,24111,-0.00842095604965842,0.00381834636239625,-0.0159049149199551,-0.000936997179361766,0.0274359043242515
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB7,Integrin beta-7,29725,0.007086402957349,0.00322789116338775,0.000759736277109006,0.013413069637589,0.0281450497753793
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,24101,0.0183510357978774,0.00836382015857585,0.00195794828706874,0.0347441233086861,0.0282379272466547
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.0109408580820747,0.00499370555111723,-0.0207285209622645,-0.00115319520188495,0.028466418558254
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,29820,0.00466620987059456,0.00213735652919603,0.000476991073370341,0.00885542866781879,0.0290311621615254
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMIGO1,Amphoterin-induced protein 1,24195,0.0077213552766351,0.00354547765125062,0.00077221908018389,0.0146704914730863,0.0294302658989246
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAN,Brevican core protein,29218,0.00521476050560243,0.00239548089161321,0.00051961795804054,0.00990990305316432,0.0294948221819472
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.00464166789974423,0.00213708711770994,-0.00883035865045571,-0.00045297714903275,0.0298684316518444
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,0.00566621843200876,0.00260924779822159,0.000552092747494439,0.0107803441165231,0.02989597875356
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,24111,-0.00582967760126278,0.0027155286936052,-0.011152113840729,-0.000507241361796584,0.031819726136941
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,28931,0.00476850260822527,0.00222841592077294,0.000400807403510306,0.00913619781294024,0.0323742625197633
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.0186023974901822,0.00869431131075489,0.0015615473211026,0.0356432476592618,0.0323950352668349
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00451541004291921,0.00211173857567538,0.000376402434595472,0.00865441765124295,0.0325053891893786
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLI2,Zinc finger protein GLI2,24229,-0.0050313244993193,0.00235715152519795,-0.00965134148870727,-0.000411307509931324,0.032812421329192
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,0.0127583412556942,0.00598635415544664,0.00102508711101875,0.0244915954003696,0.0330778626832315
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.0126304261016563,0.00592949670736324,0.00100861255522432,0.0242522396480882,0.0331733523380078
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.00565967008973811,0.00266027810218324,0.000445525009458964,0.0108738151700173,0.0333894192888894
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,0.00424669775470933,0.0019988663050329,0.000328919796844855,0.00816447571257381,0.0336337812162425
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKKL1,Dickkopf-like protein 1,29349,-0.0128284768990123,0.00604749742125885,-0.0246815718446797,-0.000975381953344991,0.0339060305978299
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.00648322773396886,0.00306239769624262,-0.0124855272186044,-0.000480928249333329,0.0342664129619127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARB1,Scavenger receptor class B member 1,28774,0.00851900383827609,0.00405339479221418,0.00057435004553629,0.0164636576310159,0.0355885846127623
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUCL3,Mucin-like protein 3,24016,-0.00647263766051668,0.00310164187523816,-0.0125518557359835,-0.000393419585049883,0.0369129115387315
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RLN2,Prorelaxin H2,24326,0.0166913633515465,0.00801290649937312,0.000986066612775199,0.0323966600903178,0.0372561972038595
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBLN2,Fibulin-2,24938,-0.00460995241853911,0.00221586327116418,-0.0089530444300209,-0.000266860407057322,0.037496134309691
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH17,Cadherin-17,29478,-0.00993364189226963,0.00478234304961715,-0.0193070342695192,-0.000560249515020015,0.0377963975766532
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,24101,0.0133881570706721,0.00644905566465523,0.000748007967947859,0.0260283061733964,0.0379057158586475
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSMB,Beta-microseminoprotein,29313,0.0101115638882516,0.00489955833864056,0.000508429544516071,0.0197146982319871,0.0390482679556537
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.0181898159049006,0.0088154842549584,0.000911466765182146,0.0354681650446191,0.0390841701404944
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NME3,Nucleoside diphosphate kinase 3,29497,0.00346088128249506,0.00168276459426654,0.000162662677732638,0.00675909988725749,0.0397273413078471
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD5L,CD5 antigen-like,24833,0.0068371354913023,0.00333508401607675,0.00030037081979188,0.0133739001628127,0.0403686744084623
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP29,Dual specificity phosphatase 29,24195,-0.00960312286511123,0.00472097573217033,-0.0188562353001651,-0.000350010430057383,0.0419484309527918
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DENND2B,DENN domain-containing protein 2B,24111,-0.00728682952140871,0.003590398123358,-0.0143240098431904,-0.000249649199627024,0.0424150534219085
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP13,Collagenase 3,28774,-0.00467823678657013,0.00230793656583937,-0.0092017924556153,-0.000154681117524968,0.0426694309328959
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIP1,Huntingtin-interacting protein 1,24111,0.00477341511345755,0.00236425901264849,0.000139467448666505,0.0094073627782486,0.0434993194396215
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,-0.00917528723953972,0.00455653597744508,-0.0181060977553321,-0.000244476723747365,0.0440549209319233
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.0120684180546767,0.00599985643369959,-0.0238281366647279,-0.000308699444625507,0.0442888797942328
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PODXL2,Podocalyxin-like protein 2,29566,0.00393913629247539,0.00196532908997165,8.70912761309472e-05,0.00779118130881982,0.0450455597793528
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKLR,Pyruvate kinase PKLR,29491,0.00907057855315968,0.00454425896283056,0.000163830986011778,0.0179773261203076,0.045937413889692
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTOA,Otoancorin,24101,-0.00756839909261287,0.00379472252862043,-0.0150060552487089,-0.000130742936516837,0.0461137257526192
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THY1,Thy-1 membrane glycoprotein,29694,0.00400242685532855,0.00201118414737789,6.05059264678761e-05,0.00794434778418921,0.0465907612524264
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,0.00450894313929343,0.00226897324651353,6.1755576126905e-05,0.00895613070245996,0.0469092678459941
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDNRB,Endothelin receptor type B,24229,0.00637438959916896,0.00322845015168427,4.66273018677847e-05,0.0127021518964701,0.0483427792222995
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTKN2,Rhotekin-2,24111,-0.00719319252425707,0.00365777434560254,-0.014362430241638,-2.39548068761046e-05,0.0492466855295492
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,24805,0.0203298856087287,0.0103931307425413,-4.06506466522696e-05,0.0407004218641096,0.0504659191435321
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTN,Neuroplastin,28797,0.0112540978383084,0.00575400404815006,-2.37500960657729e-05,0.0225319457726825,0.0504898439491495
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF1,Trefoil factor 1,29319,0.010778081297126,0.00556020598736244,-0.000119922438104415,0.0216760850323563,0.0525801281083878
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.0106623802266003,0.00550346020980148,-0.000124401784610638,0.0214491622378112,0.0527067203762444
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.00407454367652436,0.00212973000863365,-0.00824881449344632,9.97271403975894e-05,0.0557373115598728
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL33,Interleukin-33,28931,0.00524490401982832,0.00274649970563688,-0.000138235403219969,0.0106280434428766,0.0561857913419284
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00821105741719403,0.00430867565484049,-0.0166560617006814,0.000233946866293329,0.0567005986758623
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00395167965067297,0.00209251563106273,-0.00805301028755592,0.000149650986209986,0.0589728079036088
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.00812994947329101,0.00430787592511929,-0.000313487339942803,0.0165733862865248,0.0591415049470866
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CORO6,Coronin-6,24101,-0.00498914787297737,0.00265500357742942,-0.010192954884739,0.000214659138784286,0.0602361863591654
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.00827030438614339,0.00443791962817605,-0.0169686268573684,0.000428018085081663,0.0623964740368769
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.00457387748588687,0.00245521818524129,-0.00938610512895979,0.000238350157186061,0.0624832973603294
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REST,RE1-silencing transcription factor,24016,-0.00461139365144245,0.0024776263619562,-0.0094675413208766,0.000244754017991696,0.0627261341034279
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.00644712652761648,0.00347220229111961,-0.000358389962977965,0.0132526430182109,0.0633542189119561
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEX33,Testis-expressed protein 33,24445,-0.00509573095293055,0.0027541644713392,-0.0104938933167554,0.000302431410894271,0.0642980582145805
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL4,Early placenta insulin-like peptide,24793,-0.00667578011754122,0.00362874328052513,-0.0137881169473705,0.000436556712288039,0.0658250130154878
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,24793,0.00722852842396324,0.003932843307316,-0.000479844458376128,0.0149369013063026,0.0660757769884508
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.0149258510032717,0.00814953610371319,-0.00104723976000612,0.0308989417665496,0.0670383566921086
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCUN1D1,DCN1-like protein 1,24101,-0.009648699837924,0.00529379636538801,-0.0200245407140845,0.000727141038236507,0.0683698999786677
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROK1,Prokineticin-1,29434,0.00787271571292911,0.00432376796093582,-0.000601869490505101,0.0163473009163633,0.0686474523417898
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR1,Toll-like receptor 1,24229,0.00338052013146719,0.00186368549371745,-0.000272303436219018,0.00703334369915339,0.0697070630923593
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00629299527688484,0.00348052874596813,-0.0131148316189824,0.000528841065212687,0.0706100077215143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBX2,Chromobox protein homolog 2,24111,-0.00514612225594764,0.00284652304523408,-0.0107253074246064,0.000433062912711145,0.0706403673451748
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOX2,Transcription factor SOX-2,24826,0.00303868181143128,0.00168238170489768,-0.000258786330168171,0.00633614995303073,0.0709025607762403
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1A,Interleukin-1 alpha,28931,0.00706112942128236,0.00392219122447944,-0.000626365378697339,0.0147486242212621,0.0718233538601169
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBN2,Fibrillin-2,24195,0.007680147239413,0.00426793904872478,-0.000685013296087573,0.0160453077749136,0.0719524217389816
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00453321341379256,0.00251963613363844,-0.000405273408138773,0.00947170023572389,0.0720067878762949
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RELB,Transcription factor RelB,24229,0.00626965851385513,0.00348887688115791,-0.000568540173214361,0.0131078572009246,0.0723413981941868
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.0082219573506938,0.00459238503109557,-0.0172230320116411,0.00077911731025352,0.0734108889759755
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB116,Beta-defensin 116,24101,-0.00972252933045422,0.00545335616059823,-0.0204111074052268,0.000966048744318318,0.0746229169489885
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCN1,Transcobalamin-1,24546,0.00429996348372395,0.00241232079158005,-0.000428185267772937,0.00902811223522084,0.0746799814464289
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00378364689073812,0.00212532161701039,-0.00794927726007848,0.000381983478602245,0.0750443419051856
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,-0.00615157340678808,0.00346682857497022,-0.0129465574137297,0.000643410600153545,0.0760057602024835
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,23037,0.0066564548609806,0.00375682684176856,-0.000706925748885782,0.014019835470847,0.0764361661819247
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTN4,Alpha-actinin-4,28931,0.00399088015389159,0.00225562012257392,-0.000430135286353291,0.00841189559413648,0.0768535132678067
NMR metabolomics,X23495.Concentration of Large VLDL Particles,H2AP,Huntingtin-interacting protein M,24016,-0.00639288300557573,0.00362011611308203,-0.0134883105872165,0.00070254457606506,0.0774197777072325
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAMDC2,MAM domain-containing protein 2,24922,-0.00429964369631188,0.00244498634853213,-0.00909181693943486,0.000492529546811099,0.0786653501849984
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COPE,Coatomer subunit epsilon,28774,0.00585392626722791,0.00333924778763721,-0.000690999396541015,0.0123988519309968,0.0796011005568305
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,29434,0.00578387501154971,0.00330224070544843,-0.00068851677112922,0.0122562667942286,0.0798702191471637
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MERTK,Tyrosine-protein kinase Mer,29786,0.00313698391159629,0.00179200762457409,-0.000375351032568928,0.0066493188557615,0.0800352002445412
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHODH,Dihydroorotate dehydrogenase,24111,0.0058387289046585,0.00334781925795532,-0.00072299684093392,0.0124004546502509,0.0811649595895323
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BEX3,Protein BEX3,24016,-0.00577261858240162,0.00333718999166407,-0.0123135109660632,0.000768273801259958,0.0836816906872322
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL12,Stromal cell-derived factor 1,28931,0.00487007197509126,0.00282166576171304,-0.000660392917866305,0.0104005368680488,0.0843659456711335
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERVV_1,,24111,-0.00562524653061064,0.00326051965339413,-0.0120158650512631,0.000765371990041863,0.0844933161306482
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,0.00315543894963944,0.0018297119598094,-0.000430796491586981,0.00674167439086586,0.0846200868410426
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENOPH1,Enolase-phosphatase E1,24793,0.00671596990041393,0.00391234167295562,-0.000952219778579092,0.0143841595794069,0.0860627152486177
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPLX2,Complexin-2,24016,-0.00372945183790581,0.00217478528586029,-0.00799203099819198,0.000533127322380357,0.0863838445826261
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00525693316454585,0.00307435683337841,-0.000768806228875841,0.0112826725579675,0.0872914405429979
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,24101,0.0130601016161376,0.00764514845302285,-0.00192438935178716,0.0280445925840624,0.0875961345269264
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.00606687128981064,0.0035574730962589,-0.0130395185584781,0.000905775978856805,0.0881350065924
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPHS2,Podocin,24229,-0.0124310297521227,0.0072988314579884,-0.0267367394097799,0.00187467990553459,0.0885521936913309
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,24195,0.00435248160063218,0.00256128714328432,-0.000667641200205079,0.00937260440146945,0.0892691854233359
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC44A4,Choline transporter-like protein 4,24195,-0.0083218980268575,0.00489953544353876,-0.0179249874961935,0.00128119144247847,0.0894248704297607
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TG,Thyroglobulin,24793,-0.0133789408891678,0.00788082203505494,-0.0288253520778755,0.00206747029953987,0.0895848783540253
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRR5,Proline-rich protein 5,24229,0.00571456341368255,0.00336658898547636,-0.000883950997851104,0.0123130778252162,0.0896274438212327
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSLP,Thymic stromal lymphopoietin,28916,0.00723080822303237,0.00426260977007837,-0.00112390692632123,0.015585523372386,0.0898334875118137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.0056005300504839,0.00330824627202221,-0.0120846927436474,0.000883632642679627,0.0904874844721226
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXDC1,Plexin domain-containing protein 1,28797,0.00395271926243856,0.00233839773110459,-0.000630540290526426,0.00853597881540355,0.0909711348318533
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.00837550258412206,0.00495568051660583,-0.0180886363966695,0.00133763122842537,0.0910253566622551
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00420205473101779,0.00250208021789085,-0.000702022496048286,0.00910613195808386,0.0930821352892319
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00591172791956038,0.00352368959108205,-0.000994703678960445,0.0128181595180812,0.0934167692516843
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00678561202951303,0.00404929653704367,-0.0147222332421186,0.00115100918309257,0.093799988023051
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD5,Sushi domain-containing protein 5,24273,-0.0040584155199874,0.00242286403290324,-0.00880722902447775,0.00069039798450296,0.0939375436679255
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAV,Integrin alpha-V,29725,0.00194403220160434,0.0011689105953458,-0.000347032565273428,0.0042350969684821,0.0963000581262001
NMR metabolomics,X23495.Concentration of Large VLDL Particles,L1CAM,Neural cell adhesion molecule L1,29566,0.00337589689566724,0.00203922693025738,-0.000620987887637232,0.00737278167897172,0.0978380368218326
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.00438037740314114,0.00265694530436045,-0.000827235393405335,0.00958799019968762,0.0992319012550183
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHP1,Calcineurin B homologous protein 1,24101,0.00851631721767084,0.00517428457110639,-0.00162528054169769,0.0186579149770394,0.0997988984493991
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.00380863923611611,0.0023158363812499,-0.00834767854336592,0.000730400071133695,0.100064064277059
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCLRE1C,Protein artemis,24016,-0.00360893814028661,0.00219817635155808,-0.00791736378934045,0.000699487508767228,0.100647181296604
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,24805,0.00577912428535634,0.00353297021634403,-0.00114549733867797,0.0127037459093906,0.101900570134167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00322234155832646,0.00198384338145609,-0.000665991469327482,0.00711067458598039,0.104326451960692
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.00537053525966849,0.00331016833019054,-0.00111739466750497,0.011858465186842,0.104723172979192
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.0047108696915804,0.00291381547062838,-0.010421948014012,0.00100020863085122,0.105948424996618
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPE4,NXPE family member 4,24111,-0.00392380556178516,0.00242928048403516,-0.00868519531049407,0.000837584186923751,0.106277655406657
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,24229,0.00369140361168486,0.00228733930807416,-0.000791781432140502,0.00817458865551022,0.106574791702109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD2,T-cell surface antigen CD2,24111,0.00436693802335751,0.00271469837299658,-0.000953870787715789,0.0096877468344308,0.10771095242671
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.00985549399555796,0.00613240003758465,-0.0218749980692239,0.00216401007810796,0.10804110112599
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.0036940910089918,0.00230641167741924,-0.000826475878749913,0.00821465789673351,0.109243569684692
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP10,Bone morphogenetic protein 10,24381,-0.00321957209306905,0.0020139390040682,-0.00716689254104273,0.000727748354904622,0.109912627885484
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN7,Septin-7,24445,0.00595005426453488,0.0037223403718211,-0.00134573286423448,0.0132458413933042,0.109951058835252
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS5,Transmembrane protease serine 5,29079,-0.00428247507640025,0.00268432736240938,-0.00954375670672263,0.000978806553922123,0.110642080394742
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCNE1,G1/S-specific cyclin-E1,24229,0.0104187512339817,0.00653544088459723,-0.00239071289982885,0.0232282153677923,0.110905963493685
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH22,Cadherin-22,24445,-0.00321718984019172,0.00201825718992664,-0.00717297393244793,0.0007385942520645,0.110939218570622
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.00944345632041279,0.00592987330099512,-0.0210660079903632,0.00217909534953763,0.111280532596572
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,24445,0.00431354281130698,0.00273842070308212,-0.00105376176673398,0.00968084738934795,0.115224708390453
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,24867,0.00375459400658943,0.0023874310572119,-0.000924770865545893,0.00843395887872475,0.115812558949753
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.0095941562032274,0.00610259077341216,-0.00236692171266043,0.0215552341191152,0.115929928842421
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",29378,0.00749130543613958,0.0047752530280419,-0.00186819049882254,0.0168508013711017,0.116710766693357
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A3,Protein S100-A3,24793,0.00490721797129437,0.00313459988797862,-0.00123659780914372,0.0110510337517325,0.117478349119909
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.0059930007376627,0.00383834462343548,-0.0135161561995962,0.00153015472427085,0.118454083026886
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,-0.00297897160224352,0.00191754070114332,-0.00673735137648443,0.000779408171997395,0.120305368070526
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD82,CD82 antigen,24445,-0.00453019775727565,0.00293754784463034,-0.0102877915327511,0.00122739601819982,0.123045273107754
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,24016,0.00589145073184243,0.00382080759062331,-0.00159733214577926,0.0133802336094641,0.123101696342886
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD58,Lymphocyte function-associated antigen 3,29409,-0.00191509056402963,0.00124208687552148,-0.00434958084005172,0.000519399711992463,0.123124939125025
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00316482434337237,0.00205265391297366,-0.000858377326055996,0.00718802601280074,0.123128476485482
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPO,Lactoperoxidase,28452,-0.00652659087018126,0.0042467603304658,-0.0148502411178942,0.00179705937753171,0.124343636700844
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN15,Tetraspanin-15,24111,-0.00549090895367412,0.00357396452035013,-0.0124958794135604,0.00151406150621213,0.124462361281421
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBS2,Thrombospondin-2,29443,-0.00402880815274741,0.00263532874061036,-0.00919405248434371,0.0011364361788489,0.126332536414637
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,0.00302089261748142,0.00198121326689395,-0.000862285385630726,0.00690407062059357,0.127329406862982
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGM2,Phosphoglucomutase-2,24195,0.00647084555918921,0.00425081473992587,-0.00186075133106549,0.0148024424494439,0.127957004235183
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD27,CD27 antigen,29566,-0.00445519843924651,0.00292981970986932,-0.0101976450705904,0.00128724819209735,0.12836112506839
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.00786460146414694,0.00517950456667331,-0.0180164304148266,0.00228722748653274,0.128924686321328
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00443008522192486,0.0029582542965695,-0.00136809319935137,0.0102282636432011,0.134267167870371
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GH2,Growth hormone variant,28797,0.0174515290472587,0.0116649218682004,-0.00541171781441411,0.0403147759089316,0.134646615901673
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00389797973265715,0.00261090784707768,-0.00901535911292941,0.0012193996476151,0.135460926800788
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,24229,0.0129062139987587,0.00868313766017638,-0.00411273581518704,0.0299251638127044,0.137198602462054
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESPL1,Separin,24016,-0.00582193035646449,0.00391870118247843,-0.0135025846741222,0.00185872396119324,0.13737729624742
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,24805,-0.00527605665842468,0.00355346755427813,-0.0122408530648098,0.00168873974796045,0.137619367208841
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTA2,"Actin, aortic smooth muscle",28916,-0.00453522385753198,0.00306989086726544,-0.0105522099573723,0.00148176224230829,0.139599668611551
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASA1,Ras GTPase-activating protein 1,28774,0.00338008668910937,0.00229326078974639,-0.00111470445879355,0.00787487783701229,0.14051363728673
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCN2,Transcobalamin-2,29757,-0.00309598380559627,0.00211278180236039,-0.00723703613822264,0.00104506852703011,0.142833570835412
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL4,Interleukin-4,28931,0.00942163351004676,0.00647084380194819,-0.0032612203417717,0.0221044873618652,0.145399847751987
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,28916,-0.00343056887542048,0.00235960005638564,-0.00805538498593633,0.00119424723509537,0.145991195536453
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL25,Interleukin-25,23913,0.00353015919269664,0.0024447531748283,-0.00126155702996683,0.00832187541536011,0.148759492915922
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.00477132107434932,0.00331128922956598,-0.0017188058156,0.0112614479642986,0.149616281623527
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,24195,0.00788632706619275,0.00548314833758726,-0.00286064367547829,0.0186332978078638,0.150366299939531
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,29333,0.00264028995152922,0.00183776611515811,-0.000961731634180663,0.00624231153723911,0.150818353327871
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.00373158633842868,0.00262420220476477,-0.00141184998291028,0.00887502265976763,0.15504026630827
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,29581,0.00282314187803173,0.00198692312087167,-0.00107122743887675,0.00671751119494021,0.155367673793534
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.00571055856333268,0.00405621408325169,-0.00223962103984063,0.013660738166506,0.159187159615073
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL36A,Interleukin-36 alpha,24229,-0.00578683590497252,0.00411437393447399,-0.0138510088165415,0.00227733700659651,0.159590775603097
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.00825907688189266,0.00588840014853378,-0.0198003411730189,0.00328218740923354,0.16074851239511
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN4,Nectin-4,29566,-0.00315778142104361,0.00225140289133932,-0.00757053108806868,0.00125496824598146,0.160751463977477
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD177,CD177 antigen,29413,-0.0126268203200848,0.00902069282560144,-0.0303073782582636,0.00505373761809404,0.16159524247552
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00698086901960639,0.00500368608254188,-0.0167880937413885,0.00282635570217569,0.162984897327721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.00613075675790642,0.00440070897532235,-0.00249463283372538,0.0147561463495382,0.163593181545554
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNLZ,DNL-type zinc finger protein,24101,-0.00888677020645715,0.00638120776712131,-0.0213939374300149,0.00362039701710062,0.163739400614093
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPT,Microtubule-associated protein tau,28774,0.005178089177435,0.00372954466936474,-0.0021318183745199,0.0124879967293899,0.165026897927174
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM25,RNA-binding protein 25,24016,-0.00454517835533407,0.0032829041767077,-0.0109796705416811,0.00188931383101302,0.166218509549665
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,-0.00362443158365712,0.00262286456861119,-0.00876524613813505,0.00151638297082081,0.16702750766596
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDAC8,Histone deacetylase 8,24229,0.0059713862176709,0.00433427895058316,-0.00252380052547209,0.0144665729608139,0.168305092570569
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.00309572396297756,0.00225341778706911,-0.00751242282563302,0.0013209748996779,0.169519559010073
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB6B,Ras-related protein Rab-6B,28774,0.00463186456979213,0.00338737131175905,-0.0020073832012556,0.0112711123408399,0.171513141802958
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNNI3,"Troponin I, cardiac muscle",28916,0.00810121065126306,0.00593460376931776,-0.00353061273659975,0.0197330340391259,0.172238440879688
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXDC2,Plexin domain-containing protein 2,24845,0.00260250577038682,0.00190898579506843,-0.00113910638794731,0.00634411792872095,0.172802745987343
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKAP12,A-kinase anchor protein 12,24381,-0.0020673591610906,0.00152078356357624,-0.00504809494570003,0.00091337662351883,0.17403120462144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,24016,-0.00243924489066845,0.0017968306230004,-0.00596103291174923,0.00108254313041234,0.17462679465094
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM132A,Transmembrane protein 132A,24240,0.00597791555783429,0.00442506405932734,-0.0026952099984473,0.0146510411141159,0.17673309703458
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,0.00423995730133748,0.00315175971400299,-0.00193749173810837,0.0104174063407833,0.178549378460902
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLNS1A,Methylosome subunit pICln,24195,0.003182232807511,0.00236778904985809,-0.00145863373021086,0.00782309934523287,0.178971331545263
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00430035920108444,0.0032193159527168,-0.0106102184684094,0.00200950006624049,0.181627583495181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00332811511644277,0.00249758451522171,-0.00156715053339178,0.00822338076627732,0.182695479058178
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHH,Sonic hedgehog protein,24229,-0.00403283399562524,0.00303732062188454,-0.00998598241451894,0.00192031442326847,0.184269794094424
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTLA,B- and T-lymphocyte attenuator,24016,0.00810635214717842,0.00616735185986403,-0.00398165749815508,0.0201943617925119,0.18872501601596
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,24445,-0.00372105975524572,0.00283482274075984,-0.00927731232713501,0.00183519281664356,0.189321605627413
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBH,Dopamine beta-hydroxylase,24919,0.0100694686147174,0.00770879107189174,-0.00503976188619037,0.0251786991156252,0.191485779677372
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.00452507478647938,0.00346447305574205,-0.0113154419757338,0.00226529240277504,0.191518651788231
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA10,Annexin A10,28774,0.00754780042418463,0.00578544544019876,-0.00379167263860493,0.0188872734869742,0.192033149944583
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN1,Tetraspanin-1,28916,0.00518533058492876,0.00399808477464022,-0.00265091557336608,0.0130215767432236,0.1946574934623
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.00426038186191508,0.00328874223244706,-0.00218555291368116,0.0107063166375113,0.195179090702199
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.00453926750395838,0.00350776754507319,-0.0114144918923018,0.00233595688438508,0.195656524229248
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.00456787429781678,0.0035314968200138,-0.00235385946941026,0.0114896080650438,0.195862344193784
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.00694936686580569,0.00544348350123699,-0.0176185945282302,0.00371986079661881,0.201741804876217
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00335831668466947,0.00263408253284906,-0.00852111844905364,0.00180448507971469,0.20234015184134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD70,CD70 antigen,29434,-0.00383723682935854,0.00301019600234901,-0.00973722099396259,0.00206274733524551,0.202409048679531
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.00638164426919045,0.00503603788491515,-0.00348898998524325,0.0162522785236241,0.205097617751486
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL5A1,Collagen alpha-1(V) chain,24381,0.00360662987591083,0.00285120039927281,-0.00198172290666388,0.00919498265848553,0.205900854864933
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB5,Serpin B5,28916,0.00433675267389378,0.0034293241197819,-0.00238472260087875,0.0110582279486663,0.206021876331711
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00488279286908416,0.00387730471781887,-0.00271672437784084,0.0124823101160092,0.207922618645927
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDAN1,Codanin-1,24845,0.00200553204842636,0.00159270665586247,-0.00111617299706407,0.0051272370939168,0.207970884263123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.00244788695965952,0.00194402741635931,-0.00136240677640472,0.00625818069572377,0.207974015886803
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.00361687523302475,0.00289144368410537,-0.00928410485387128,0.00205035438782179,0.210986971099136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRAS,GTPase Hras,24421,0.00870559880696326,0.00695963185431848,-0.00493527962750097,0.0223464772414275,0.21099368584678
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FZD10,Frizzled-10,24195,0.00520418431082551,0.00425394198433209,-0.00313354197846538,0.0135419106001164,0.221198412131504
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF12,Fibroblast growth factor 12,24229,0.00404531332709575,0.00330736367459344,-0.0024371194751074,0.0105277461292989,0.221295060272415
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS1,"Nitric oxide synthase, brain",28774,-0.0046666274122675,0.00381593002119977,-0.0121458502538191,0.00281259542928405,0.221364958284152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOC,Myocilin,29443,-0.00391768948074174,0.00321747957947353,-0.0102239494565099,0.00238857049502638,0.223375574475175
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.00411283067849226,0.00339467042001466,-0.010766384701721,0.00254072334473648,0.225694500765628
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAP1,Antigen peptide transporter 1,24445,-0.00509160439320833,0.00424155696357156,-0.0134050560418086,0.00322184725539192,0.229992060922428
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NENF,Neudesin,24793,0.00930110436621349,0.00775781243644867,-0.00590420800922591,0.0245064167416529,0.230565111786212
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADA2,Adenosine deaminase 2,29328,-0.00361148321969834,0.0030131497428804,-0.00951725671574392,0.00229429027634724,0.230703286285953
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PYDC1,Pyrin domain-containing protein 1,24240,-0.00354174945363135,0.00296374454893379,-0.00935068876954158,0.00226718986227887,0.232088878875329
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR1,TGF-beta receptor type-1,24229,0.0018293271504577,0.00153220869200003,-0.00117380188586235,0.00483245618677775,0.232522861365601
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_A,,24867,0.00274787830481462,0.00230721004321865,-0.00177425337989393,0.00727000998952318,0.233666466308245
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNC5D,Netrin receptor UNC5D,24229,0.00220889385149093,0.0018651241025904,-0.00144674938958626,0.00586453709256812,0.236300144906038
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,24195,0.00861017204494446,0.00728513976734399,-0.00566870189904976,0.0228890459889387,0.237264338840111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUOX2,Dual oxidase 2,28916,0.00594005988424961,0.00502953041414502,-0.00391781972747463,0.0157979394959739,0.237597872220868
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF7,Fibroblast growth factor 7,24016,-0.00662706790479991,0.00561129750364201,-0.0176252110119383,0.00437107520233843,0.237605537254683
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,24111,-0.00606404371686326,0.0051480044038857,-0.0161541323484792,0.00402604491475272,0.238831895782935
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRP15,RRP15-like protein,24101,-0.00756587680457151,0.00643197350754996,-0.0201725448793694,0.00504079127022642,0.239489971707527
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP1,DNA topoisomerase 1,24805,0.00936488189803832,0.00799254830511468,-0.00630051277998645,0.0250302765760631,0.241328127806743
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC123,Cell division cycle protein 123 homolog,24016,0.00520852575460658,0.00447907900983698,-0.00357046910467389,0.0139875206138871,0.244899325147333
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WIF1,Wnt inhibitory factor 1,29725,-0.00278072265632839,0.00239872003489238,-0.00748221392471746,0.00192076861206067,0.246362515799173
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.0112132347048439,0.00973165185950783,-0.0302872723494793,0.0078608029397914,0.249231989686468
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMCH,Pro-MCH,24111,-0.00681091531564741,0.00591176945605865,-0.0183979834495224,0.00477615281822755,0.249293794940277
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,29169,-0.00272762843190568,0.00236931930903441,-0.00737149427761312,0.00191623741380176,0.249647594357893
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,0.00576223652961466,0.00501183140575801,-0.00406095302567104,0.0155854260849004,0.25026572519971
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10,Interleukin-10,28931,0.0065916538428394,0.00576690625950485,-0.00471148242579009,0.0178947901114689,0.253042295238447
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.00255976149830461,0.00224028558664746,-0.00183119825152441,0.00695072124813362,0.253212096366166
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDF15,Growth/differentiation factor 15,29820,-0.00357243937766793,0.00312734097029635,-0.00970202767944876,0.00255714892411291,0.253328182071789
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSTN,Osteocrin,24195,-0.00337051751838005,0.00295353789597692,-0.00915945179449481,0.00241841675773471,0.253806447437012
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,0.00954412901914363,0.0083675926906952,-0.00685635265461895,0.0259446106929062,0.25404307246572
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL19,Interleukin-19,28654,0.00563020719369993,0.00495809712845153,-0.00408766317806507,0.0153480775654649,0.256151069286732
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA4C,Semaphorin-4C,29349,0.00224327005710145,0.00198182720321643,-0.00164111126120275,0.00612765137540564,0.257677277568234
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POF1B,Protein POF1B,24229,0.00365948240601683,0.00324070893557808,-0.00269230710771621,0.0100112719197499,0.25881504577645
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KDM3A,Lysine-specific demethylase 3A,24229,-0.00722208715148625,0.00640333731068144,-0.0197726282804219,0.00532845397744938,0.259388961942288
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.0035278302323049,0.00313402252351649,-0.00967051437839722,0.00261485391378742,0.26032244952045
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,24405,-0.00418367100050304,0.00373425552955333,-0.0115028118384276,0.00313546983742148,0.262575922990204
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00438411703517573,0.00392939901861065,-0.0120857391116526,0.00331750504130114,0.264552226601066
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNR,Tenascin-R,29218,-0.00331080674392895,0.00297341746655971,-0.00913870497838599,0.00251709149052808,0.265516425748818
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,28916,0.00378557192683239,0.00343961998863842,-0.0029560832508989,0.0105272271045637,0.271089298184328
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00618008499196204,0.00561862626766225,-0.0171925924765801,0.00483242249265598,0.27137428223845
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA5,Annexin A5,28650,0.00233582987172749,0.00214605045207239,-0.0018704290143344,0.00654208875778938,0.276413624349487
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZPR1,Zinc finger protein ZPR1,24101,0.00742657212482048,0.00682962382940561,-0.00595949058081452,0.0208126348304555,0.276868418294363
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.00528532887685095,0.00486053406236932,-0.0148119756390948,0.00424131788539291,0.276870447088977
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.00348475099509007,0.00320612197068309,-0.00976875005762893,0.00279924806744878,0.277087486058322
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL22,Interleukin-22,24793,-0.00516338823853119,0.00477338123124359,-0.0145192154517686,0.00419243897470626,0.279394353651653
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.00317421879049456,0.00294737207383727,-0.0026026304742265,0.00895106805521562,0.281506309030546
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.00305345909712604,0.00284930844149419,-0.00863810364245466,0.00253118544820257,0.28388648259397
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP9,Matrix metalloproteinase-9,29411,0.00454812518424983,0.00426203749364514,-0.00380546830329465,0.0129017186717943,0.285924324432199
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,24111,0.0073987477930767,0.00693383673050316,-0.0061915721987095,0.0209890677848629,0.285960123606839
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,0.0047301861661333,0.00445470593493524,-0.00400103746633978,0.0134614097986064,0.288318699523948
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSN,Gelsolin,24845,-0.0014251664364289,0.00134423736822424,-0.00405987167814842,0.00120953880529061,0.289061910367876
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,0.0044529515181438,0.0042026928866469,-0.00378432653968413,0.0126902295759717,0.289361261343628
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,-0.00239055671530887,0.00225738637145821,-0.00681503400336695,0.00203392057274921,0.289613516510973
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.00282478762229725,0.00266959469012953,-0.00805719321495113,0.00240761797035664,0.29000514517568
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FZD8,Frizzled-8,24101,0.00328738014318072,0.00310931086659263,-0.00280686915534083,0.00938162944170227,0.290399124304331
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.00361725665534909,0.00343384938808203,-0.00311308814529169,0.0103476014559899,0.292162968779469
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00386429198403202,0.00367504197463736,-0.0033387902862572,0.0110673742543212,0.293041093667658
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA10,Ephrin type-A receptor 10,28774,0.00482090730618396,0.00461276671100164,-0.00422011544737925,0.0138619300597472,0.295975037080454
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB5,Integrin beta-5,29566,0.0027705935319516,0.00265438668608283,-0.00243200437277074,0.00797319143667395,0.296596109042524
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEB,Nebulin,24111,-0.00278983766116755,0.00267818217400125,-0.00803907472220999,0.00245939939987489,0.297565518742054
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,-0.00308726681855271,0.00298074066316593,-0.00892951851835792,0.0027549848812525,0.300334396837181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA8,Carbonic anhydrase-related protein,24229,0.00198471069316142,0.00192414379851469,-0.00178661115192738,0.00575603253825021,0.302327339266749
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCP11,T-complex protein 11 homolog,24445,-0.00432130848701336,0.00419283801111106,-0.012539270988791,0.00389665401476432,0.302719659020774
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAD1,Glutamate decarboxylase 1,24016,-0.00187883208528183,0.00183889905084466,-0.00548307422493736,0.00172541005437369,0.306925761793865
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.0188106568630972,0.0186365671545821,-0.0553383284860782,0.0177170147598837,0.312821061898049
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.004036134205742,0.00401439892389737,-0.0119043560965809,0.00383208768509685,0.314707517930727
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00520629814915863,0.00520681571674302,-0.00499906065565768,0.015411656953975,0.317368659567739
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAU,Urokinase-type plasminogen activator,29443,0.0020484144155744,0.00204918294533426,-0.00196798415728074,0.00606481298842954,0.317500259320168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.00487969883488891,0.00491047714263767,-0.00474483636468092,0.0145042340344587,0.320363247104155
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA11,Carbonic anhydrase-related protein 11,28797,0.00222931840643128,0.00224793143966187,-0.00217662721530598,0.00663526402816855,0.321342503683152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00460417849397718,0.00465685636526498,-0.0137316169698965,0.00452325998194218,0.322825730990687
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PITHD1,PITH domain-containing protein 1,23970,-0.00557340329843778,0.00563741387750541,-0.0166227344983484,0.00547592790147283,0.322846650464339
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.00314042883722497,0.00318744761564289,-0.00310696848943509,0.00938782616388503,0.324509957197605
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00217287195180503,0.00220676171524571,-0.00215238101007655,0.00649812491368662,0.324807819332721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,24101,-0.00410460385612803,0.00417089294125717,-0.0122795540209921,0.00407034630873602,0.325072917923006
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCUN1D2,DCN1-like protein 2,24016,-0.00557666435456646,0.00566971097633504,-0.0166892978681831,0.00553596915905023,0.325327636541601
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00230944384866988,0.00235256833297554,-0.00230159008396217,0.00692047778130194,0.32627106615707
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGN,Cingulin,24195,0.00274633638697378,0.00281910482849947,-0.00277910907688517,0.00827178185083274,0.329973247556276
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.0033223569251747,0.00345691396456217,-0.00345319444536714,0.0100979082957165,0.336523569872541
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK12,Kallikrein-12,28797,-0.0093887153726445,0.00976907415798983,-0.0285361007223046,0.00975866997701556,0.33652755377803
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00278414302665566,0.00289901404497671,-0.00289792450149869,0.00846621055481001,0.336875601196041
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSCA,Prostate stem cell antigen,24805,0.0174249491955888,0.0183045995459072,-0.0184520659143893,0.0533019643055668,0.341134789012564
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAD2,Glutamate decarboxylase 2,24229,-0.00310248008627068,0.00327385094988417,-0.00951922794804366,0.00331426777550229,0.343314750064423
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLHL41,Kelch-like protein 41,24867,0.00332081747356364,0.00350943754654985,-0.00355768011767407,0.0101993150648014,0.344028516851577
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP15,Matrix metalloproteinase-15,24922,0.00328151475146068,0.00347336021745167,-0.00352627127474459,0.010089300777666,0.344787207157775
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,24016,0.00222533028497943,0.00236367345290077,-0.00240746968270609,0.00685813025266494,0.346472959320869
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBQ1,Hemoglobin subunit theta-1,29725,-0.00398192276394184,0.00423612892530491,-0.0122847354575395,0.00432088992965578,0.347229855467849
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.00274315735502007,0.00292790894838458,-0.00848185889385385,0.00299554418381371,0.348819450762261
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,-0.00413458158139384,0.00442030786538402,-0.0127983849975465,0.00452922183475884,0.349611899156249
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",24845,0.003935360083321,0.00423192249111038,-0.00435920799925534,0.0122299281658973,0.352420235276287
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGN,Mimecan,29443,0.00274544219738616,0.00296643064241149,-0.00306876186174037,0.00855964625651268,0.3547116082743
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.00408315230810107,0.00442147242880446,-0.0127492382685578,0.00458293365235566,0.355765074999954
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.00229358767273629,0.00249416272477587,-0.00718214661329699,0.00259497126782441,0.357800331294504
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.00332414407350094,0.0036235064236693,-0.0104262166638928,0.00377792851689088,0.3589510000574
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.00422523393561271,0.00462492212057468,-0.00483961342071366,0.0132900812919391,0.360945362384149
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,-0.00325148925132905,0.0035611413512023,-0.0102313262996856,0.00372834779702746,0.361226877065081
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSG1,Tryptase gamma,24229,0.00171942186638293,0.00188922065980851,-0.00198345062684176,0.00542229435960761,0.362767070206257
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.00163073573293336,0.00179338812790289,-0.00514577646362302,0.0018843049977563,0.363198256283737
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,24445,0.00501402078660421,0.00551719847404333,-0.0057996882225207,0.0158277297957291,0.363465550418628
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,-0.00267337474768155,0.00294253384674249,-0.00844074108729682,0.00309399159193372,0.363608305002829
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF75D,Zinc finger protein 75D,24445,0.00385581838491296,0.00424742875716556,-0.00446914197913154,0.0121807787489575,0.363992534122018
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAP1A,Ras-related protein Rap-1A,24229,-0.0044241294812115,0.00489647606216589,-0.0140212225630566,0.00517296360063365,0.366251877978569
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,-0.00327212024230336,0.00362362973106616,-0.010374434515193,0.00383019403058632,0.366537470415167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.00426581657228191,0.00473376368093774,-0.0135439933869199,0.00501236024235606,0.367519213748835
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,-0.00439439197129019,0.00490051519568009,-0.0139994017548232,0.00521061781224278,0.369877087760193
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.00181729876664591,0.00203263743663908,-0.00216667060916669,0.00580126814245852,0.371297287489588
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00148619242303358,0.00168113014298624,-0.00478120750328662,0.00180882265721946,0.376681203443407
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BSND,Barttin,24016,-0.00209007551958419,0.00239470585123657,-0.00678369898800786,0.00260354794883948,0.38278623690257
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GJA8,Gap junction alpha-8 protein,24016,0.0038303576547754,0.00439597046317423,-0.00478574445304609,0.0124464597625969,0.383580634602872
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL31,Interleukin-31,24229,-0.00349604355523452,0.00402131427635369,-0.0113778195368878,0.00438573242641871,0.384648839933957
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.00266897660030307,0.00308216728561391,-0.0033720712795002,0.00871002448010634,0.386530740150597
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00269733585256585,0.00312721089199409,-0.00882666920087426,0.00343199749574256,0.388400567126643
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTF,Ciliary neurotrophic factor,24101,-0.00207883247542033,0.00241089057630902,-0.00680417800498601,0.00264651305414535,0.388548943261591
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLN1,Cerebellin-1,24101,-0.00580990495204542,0.00675044144051192,-0.0190407701754488,0.00742096027135795,0.389428181735338
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCNA,Proliferating cell nuclear antigen,24016,0.00380680207932447,0.00447244034109136,-0.00495918098921459,0.0125727851478635,0.394684033284281
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,28586,0.00227606646390435,0.00270342354621092,-0.00302264368666905,0.00757477661447775,0.399839758113424
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHIT1,Chitotriosidase-1,29579,0.00887604991853838,0.010736013136929,-0.0121665358298424,0.0299186356669192,0.408382751253675
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAYN,Layilin,29163,-0.00203090405996852,0.00246351716064752,-0.00685939769483766,0.00279758957490063,0.409723553661717
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,24229,-0.00280055471735553,0.00341528238465477,-0.00949450819127889,0.00389339875656782,0.412220312269245
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH4,Cadherin-4,24101,0.00278593725506749,0.00339922589754942,-0.00387654550412936,0.00944842001426435,0.412463739629686
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FH,"Fumarate hydratase, mitochondrial",24101,0.00484786260344406,0.00593263397684413,-0.00678009999117044,0.0164758251980586,0.41384975898614
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,24229,-0.00249044531789177,0.0030672503553241,-0.008502256014327,0.00352136537854347,0.416829914193187
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBQLN3,Ubiquilin-3,24111,-0.00284201467185171,0.00355662604800785,-0.0098130017259471,0.00412897238224367,0.424254195480914
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00308590979940036,0.00388982219807011,-0.0107099613076178,0.00453814170881706,0.42759385070537
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,0.00445684317407371,0.00563641656367231,-0.00659053329072403,0.0155042196388714,0.429113571907188
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSV,Cathepsin L2,29618,0.0023027430012136,0.00291850577337473,-0.00341752831460087,0.00802301431702807,0.430109924992856
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNIP4,Kv channel-interacting protein 4,28774,0.00283423192042416,0.00359955838192196,-0.00422090250814288,0.0098893663489912,0.431064046957021
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMCN2,Hemicentin-2,24343,0.00318450973883099,0.00407050979321312,-0.00479368945586673,0.0111627089335287,0.434024260146832
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.00203535615147288,0.00265040783318727,-0.00315944320157416,0.00723015550451992,0.442529917490024
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP1,Retinol-binding protein 1,24195,0.00376035499772814,0.00490117030831385,-0.00584593880656701,0.0133666488020233,0.442948619005434
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WNT9A,Protein Wnt-9a,28931,0.00154900105939374,0.0020336909394362,-0.00243703318190121,0.0055350353006887,0.446263289892762
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,29278,0.00146897131915131,0.00193687014511171,-0.00232729416526764,0.00526523680357026,0.44820252510131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCL2,Phosducin-like protein 2,24016,0.00283364555190578,0.00374906304241832,-0.00451451801123413,0.0101818091150457,0.449759947161603
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",24111,0.00208878517273442,0.00276755263345518,-0.00333561798883772,0.00751318833430657,0.450411835117628
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,24845,0.00148318685013097,0.00198418019837826,-0.00240580633869043,0.00537218003895236,0.454765185892055
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF830,Zinc finger protein 830,24793,-0.00417147390162605,0.00559372127826692,-0.0151351676070292,0.00679221980377711,0.455830247678311
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNPO1,Transportin-1,24445,0.00184899552525911,0.00250058389381146,-0.00305214890661134,0.00675013995712957,0.459655759952
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCN15,Lipocalin-15,24867,-0.00323529941769621,0.00439513782026534,-0.0118497695454163,0.00537917071002386,0.461671464079423
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17A,Interleukin-17A,28879,-0.0022145621662675,0.00301029200616707,-0.00811473449835496,0.00368561016581995,0.461941442255131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00294605555213621,0.00407675574402367,-0.00504438570615018,0.0109364968104226,0.469903789152637
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYTH3,Cytohesin-3,24016,0.0037323146991552,0.00518273611068312,-0.00642584807778371,0.0138904774760941,0.471443543385596
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A16,Protein S100-A16,28722,-0.00310780408344325,0.00433596119722966,-0.0116062880300134,0.00539067986312689,0.473533644737746
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.00332108435040009,0.00464989023415452,-0.012434869209343,0.00579270050854277,0.475092784893184
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAX,Integrin alpha-X,24445,0.00267627240251531,0.00378147156142312,-0.004735411857874,0.0100879566629046,0.479117800380757
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL5,Interleukin-5,28931,0.00706273059053541,0.0100191581025647,-0.0125748192904914,0.0267002804715623,0.480864106582294
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFL4,Insulin growth factor-like family member 4,24229,0.00373393734246444,0.00532297735130326,-0.00669909826608995,0.0141669729510188,0.483013160785622
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.00268568736510537,0.00383658508633475,-0.00483401940411074,0.0102053941343215,0.483921400410379
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBR1,T-box brain protein 1,24195,0.00238671262823831,0.00341331544263608,-0.00430338563932842,0.00907681089580503,0.484411356409727
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,0.00169024868155919,0.00242546751341914,-0.00306366764474234,0.00644416500786071,0.485886233645469
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRR1B,Cornifin-B,24445,0.00417792411812688,0.00604458592201543,-0.00766946428902337,0.0160253125252771,0.489456168481456
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAGE2A,G antigen 2A,24016,0.00308674016814234,0.00449125570622533,-0.0057161210160593,0.011889601352344,0.491914350477446
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM171A2,Protein FAM171A2,24867,0.0075538716444308,0.0111821985589281,-0.0143632375310684,0.02947098081993,0.499347595143327
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBZ,Hemoglobin subunit zeta,24922,0.00500357133338697,0.00747272709309724,-0.00964297376908363,0.0196501164358576,0.503133247617869
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF20,Fibroblast growth factor 20,24229,-0.00207196227425406,0.00310256835885456,-0.00815299625760899,0.00400907170910087,0.504253819196016
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRND,Prion-like protein doppel,24845,-0.00242830562322658,0.00363669699388958,-0.00955623173125016,0.004699620484797,0.504316737266901
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.00236666659096711,0.003548213623713,-0.00458783211151037,0.0093211652934446,0.504777063786585
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG1B,Lithostathine-1-beta,29820,0.00264091476187054,0.00396842465109851,-0.00513719755428254,0.0104190270780236,0.505747468579666
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOH,Beta-2-glycoprotein 1,29443,-0.0016661943701929,0.00253164846199949,-0.00662822535571189,0.0032958366153261,0.510449452491481
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,-0.00136577709463011,0.00208748083425876,-0.00545723952977727,0.00272568534051706,0.512943772363359
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAND5,DAN domain family member 5,24229,-0.00251331778909219,0.00384560507336401,-0.0100507037328857,0.00502406815470127,0.513404185749821
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC39A14,Zinc transporter ZIP14,28774,0.00153465016163392,0.00236252009616155,-0.00309588922684272,0.00616518955011056,0.515967551463952
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHGB,Secretogranin-1,29590,0.00188001768715452,0.00289929991820016,-0.00380261015251779,0.00756264552682683,0.516706410818486
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,28797,-0.00223486952569131,0.00345243151496321,-0.0090016352950192,0.00453189624363657,0.51742223385957
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR3,Folate receptor gamma,29461,-0.00852555604360672,0.0132076068848613,-0.0344124655379349,0.0173613534507214,0.518606001344799
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN4,Prefoldin subunit 4,24016,0.00243909958920521,0.0037829170126973,-0.00497541775568149,0.00985361693409191,0.519084432000766
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC4A1,Band 3 anion transport protein,24938,-0.00212037091565759,0.00330072574320817,-0.00858979337234559,0.00434905154103042,0.520622417687576
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSP90B1,Endoplasmin,28626,0.0030334683278096,0.0047310099416548,-0.00623931115783381,0.012306247813453,0.521405471487471
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.00417473719791028,0.00660920758223946,-0.0171287840590996,0.00877930966327906,0.527618534268578
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00287370453137744,0.00455805962656536,-0.0118075013994456,0.00606009233669067,0.528395220373699
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,24195,0.0018875229614025,0.00299716462621174,-0.0039869197059725,0.00776196562877751,0.528851333374797
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PI16,Peptidase inhibitor 16,24951,0.00107910149041503,0.00173114832120466,-0.0023139492191461,0.00447215219997617,0.533063973559498
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLGAP5,Disks large-associated protein 5,24867,-0.00222784044167496,0.00365139413196351,-0.00938457294032345,0.00492889205697353,0.541778491042824
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00307704404118268,0.00504936176470893,-0.0129737931000122,0.00681970501764682,0.542269863025569
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC51B,Organic solute transporter subunit beta,24111,-0.00327486613476101,0.00539638324124199,-0.0138517772875953,0.00730204501807329,0.543947452255221
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEX101,Testis-expressed protein 101,24195,0.00217061773346537,0.003577187349268,-0.00484066947109991,0.00918190493803065,0.543992972440001
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.00246479759432512,0.0040817981376187,-0.00553552675540755,0.0104651219440578,0.545948413090398
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.00154365477094853,0.0025616066847529,-0.00347709433116715,0.00656440387306422,0.5467725271838
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL4,Myosin light chain 4,24240,-0.00220798827973221,0.00367406539479733,-0.00940915645353497,0.00499317989407056,0.547868273613274
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN7,Tetraspanin-7,24101,-0.00398673228712688,0.00665518005872027,-0.0170308852022186,0.00905742062796485,0.549150519627866
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP4,Caspase-4,24445,-0.00704267553206708,0.0118896871152344,-0.0303464622779266,0.0162611112137924,0.553631893620684
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,0.00237664611408833,0.00403811842994604,-0.00553806600860591,0.0102913582367826,0.556165774509435
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MB,Myoglobin,29820,-0.00214777560346461,0.00369478720520126,-0.00938955852565909,0.00509400731872986,0.5610434420631
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM2,Intercellular adhesion molecule 2,29820,-0.00129998695959256,0.00224206970019064,-0.00569444357196622,0.0030944696527811,0.562043367663
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESR1,Estrogen receptor,24229,0.0023390629971499,0.00406908781328896,-0.00563634911689647,0.0103144751111963,0.565406753836231
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISM2,Isthmin-2,24938,-0.00177933518476743,0.00310352369434798,-0.00786224162568947,0.0043035712561546,0.566428206111087
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,24867,0.00309231923810115,0.00539851026065174,-0.00748876087277627,0.0136733993489786,0.566778708090803
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOS,Proto-oncogene c-Fos,23970,-0.00141850219580215,0.00250791915274108,-0.00633402373517466,0.00349701934357036,0.571664756081374
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPA33,Cell surface A33 antigen,29349,0.00536088829683827,0.00950202348492209,-0.013263077733609,0.0239848543272856,0.572633323502483
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PXDNL,Peroxidasin-like protein,24793,0.00229727076963277,0.00408464354541872,-0.00570863057938793,0.0103031721186535,0.57383739365633
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRC1,Protein regulator of cytokinesis 1,24793,0.00180067251075314,0.00320628177233829,-0.00448363976302991,0.00808498478453619,0.574388416702016
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAGLN3,Transgelin-3,24016,-0.00238118415138309,0.00427100396984167,-0.0107523519322728,0.00598998362950659,0.577175155702867
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVI2B,Protein EVI2B,24016,-0.00159727990338119,0.00290360044580071,-0.00728833677715058,0.0040937769703882,0.582253709322365
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.00287983320097479,0.00526848862115255,-0.0132060708984338,0.0074464044964842,0.584648547508753
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,24195,0.00192782006608664,0.0035492589153683,-0.00502872740803522,0.00888436754020851,0.587023760165899
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,24229,0.00180328689465739,0.00333108504267467,-0.00472563978898497,0.00833221357829974,0.588270514731716
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.00152118895595546,0.00281086757083281,-0.00703048939478776,0.00398811148287685,0.588387630726103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.00216218709167015,0.0040067464346825,-0.0100154101036478,0.00569103592030755,0.589452645212877
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVPL,Envoplakin,24445,-0.00128392884899352,0.00239701056257341,-0.0059820695516374,0.00341421185365036,0.592213952351718
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYBB2,Beta-crystallin B2,24845,0.0025975097390848,0.00488163735778857,-0.0069704994821808,0.0121655189603504,0.594662845656292
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,-0.00183919842903345,0.00349227013162314,-0.0086840478870148,0.00500565102894789,0.598442650939039
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGS8,Regulator of G-protein signaling 8,28931,0.00236708128685341,0.00459529287407054,-0.00663969274632484,0.0113738553200317,0.606480096508576
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP350,Centrosome-associated protein 350,24016,0.00131024161945189,0.00261411516047441,-0.00381342409507795,0.00643390733398173,0.616222291603004
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPBGL,Trophoblast glycoprotein-like,24195,-0.00144123477723741,0.00290873709549646,-0.00714235948441048,0.00425988992993566,0.620262509909219
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDAC9,Histone deacetylase 9,24101,-0.00226759010688799,0.00458106660509805,-0.0112464806528802,0.00671130043910419,0.620610469728379
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,29434,-0.00143456965298562,0.00291530123396433,-0.00714856007155571,0.00427942076558447,0.622664468301458
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHD,SH2 domain-containing adapter protein D,24059,0.00296043253710884,0.00602275330572997,-0.0088441639421219,0.0147650290163396,0.623048071474314
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTNL10,Butyrophilin-like protein 10,24016,-0.00141649386288996,0.00289005805960364,-0.00708100765971308,0.00424801993393317,0.624048910781419
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KHDC3L,KH domain-containing protein 3,24016,-0.00231995381604477,0.0047761710477556,-0.0116812490696457,0.0070413414375562,0.627159443710247
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.00201814832529517,0.00416479512918436,-0.00614485012790618,0.0101811467784965,0.627983496503146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00192622766084473,0.00399078269354181,-0.00974816174018668,0.00589570641849721,0.62933506295762
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20,Interleukin-20,28931,0.00165563003807122,0.00345241602243123,-0.00511110536589399,0.00842236544203644,0.631546103002178
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLL1,Delta-like protein 1,29566,0.000983381485850652,0.00210582423102873,-0.00314403400696566,0.00511079697866696,0.640516377551593
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,0.00120185704235137,0.00257385216576313,-0.00384289320254436,0.0062466072872471,0.640540005042744
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPGN,Epigen,24793,-0.00157382845442444,0.00338760431713625,-0.00821353291601148,0.00506587600716261,0.642233116945249
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.00159249318389773,0.00345099813522383,-0.00835644952893644,0.00517146316114098,0.644473712639365
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STC2,Stanniocalcin-2,29396,0.000842958842337141,0.00182795261285692,-0.00273982827886243,0.00442574596353671,0.64469499547902
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,29443,0.00112952124438839,0.00247775374537484,-0.0037268760965463,0.00598591858532308,0.648490413276323
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRN1,Neuritin,24867,-0.00113369024930712,0.00252181618852171,-0.00607644997880968,0.00380906948019544,0.653036642664506
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.00188024681547679,0.00419387989136453,-0.0101002514025513,0.0063397577715977,0.653917612719933
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,-0.00106929888388208,0.00240424694166492,-0.00578162288954532,0.00364302512178116,0.656501418665533
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.0017615107808099,0.00396447436143217,-0.00600885896759715,0.00953188052921694,0.656812403036809
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB2,Integrin beta-2,29274,0.000891229909042213,0.0020249376760175,-0.00307764793595208,0.00486010775403651,0.659848319795023
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFRC,Transferrin receptor protein 1,29565,-0.00119056316043537,0.00271462816146805,-0.00651123435691274,0.004130108036042,0.660974025430381
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.0019546291737664,0.00450921767890423,-0.00688343747688588,0.0107926958244187,0.66467425777468
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALLD,Palladin,24229,-0.00122273527409637,0.00282091381918946,-0.00675172635970771,0.00430625581151497,0.66468912302598
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGLON5,IgLON family member 5,24016,-0.00285083350271643,0.00659486721754724,-0.015776773249109,0.0100751062436762,0.66554133078477
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NLGN1,Neuroligin-1,24195,-0.00208579789217692,0.00483382033672874,-0.0115600857521652,0.0073884899678114,0.666108035245639
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF3,Fibroblast growth factor 3,24229,0.000911238162023678,0.00212122202607373,-0.00324635700908084,0.0050688333331282,0.667503774262797
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENG,Endoglin,29820,0.000519948813683376,0.00121212179418565,-0.0018558099029205,0.00289570753028725,0.667957206557678
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,-0.0015797343003876,0.00370902361233252,-0.00884942058055935,0.00568995197978414,0.670172506192784
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL9,Interleukin-9,24445,-0.00168735816027034,0.00401030423745534,-0.0095475544656828,0.00617283814514213,0.67393722187564
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD2,Bromodomain-containing protein 2,24101,0.00103096903751893,0.0024519060556272,-0.00377476683151037,0.00583670490654824,0.674141096282401
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.00507534918715197,0.0121124262429181,-0.0186650062489675,0.0288157046232714,0.675204595938149
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANK2,Ankyrin-2,24111,-0.00211407323765944,0.00509764248722139,-0.0121054525126134,0.00787730603729449,0.67835360532202
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAM1,Neural cell adhesion molecule 1,29594,0.000881173424748959,0.0021265142452202,-0.00328679449588263,0.00504914134538055,0.678602814894874
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RUVBL1,RuvB-like 1,28797,0.00300315602252514,0.00729331725275146,-0.0112917457928677,0.017298057837918,0.680512407292226
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,29478,-0.000785623337319653,0.00190856397054127,-0.00452640871958054,0.00295516204494124,0.68061319173555
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,24101,0.00170143163084646,0.00424176383043612,-0.00661242547680833,0.0100152887385013,0.688339617655651
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,-0.000838551435470389,0.00210333191959788,-0.00496108199788222,0.00328397912694145,0.690134150462094
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,24938,-0.000604818191758316,0.00152058648670132,-0.00358516770569289,0.00237553132217626,0.690815499790457
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPB41L5,Band 4.1-like protein 5,24195,0.00176210579293145,0.00444268055508349,-0.00694554809503218,0.0104697596808951,0.691642929465387
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.00176402920690491,0.00447772645499151,-0.00701231464487844,0.0105403730586883,0.693616693941916
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABO,Histo-blood group ABO system transferase,24951,0.00396024127531584,0.0101786436879143,-0.0159899003529962,0.0239103829036279,0.697225043577873
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC1A4,Neutral amino acid transporter A,24195,0.00138895894790275,0.00364900141239523,-0.0057630838203919,0.0085410017161974,0.703473119261585
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALMS1,Alstrom syndrome protein 1,24445,-0.00118018310030133,0.00315538352809349,-0.00736473481536458,0.00500436861476192,0.708391137141077
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RSPO1,R-spondin-1,29218,-0.000916013631421498,0.00247019473710215,-0.00575759531614171,0.00392556805329872,0.710769463171805
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EXOSC10,Exosome component 10,24111,-0.00158309468555517,0.00428661982670314,-0.00998486954589332,0.00681868017478299,0.711899375696264
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00437525889918246,0.0121721494099142,-0.0282326717426142,0.0194821539442493,0.719262779099743
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHC1,SHC-transforming protein 1,24016,-0.00294599719028861,0.00824476392314267,-0.0191057344796482,0.013213740099071,0.720857384863689
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.00158839764946565,0.00444797254124144,-0.0103064238302989,0.00712962853136757,0.721015542797011
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,29388,0.00121118561302463,0.00339212493361159,-0.00543737925685409,0.00785975048290334,0.72105089160108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,0.000701636012665699,0.0020055158381715,-0.00322917503015043,0.00463244705548183,0.726451429859885
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.00189723916846476,0.00549084925001712,-0.0088648253615688,0.0126593036984983,0.729700879148613
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.000786210438966116,0.00229941820569161,-0.00372064924418945,0.00529307012212168,0.732416250904102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,0.00343380449022432,0.0101472305547039,-0.0164547673969954,0.023322376377444,0.735066095087561
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.00181603886003094,0.00541057489310763,-0.0124207656505219,0.00878868793046001,0.737140528107168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,24751,0.000952680235729416,0.00284731946260531,-0.004628065910977,0.00653342638243583,0.737938387546789
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCIN,Adseverin,24101,0.00173132039610039,0.00519105641513757,-0.00844315017756926,0.01190579096977,0.738744805662041
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR2,Toll-like receptor 2,24445,0.000537067495852762,0.00162522141873574,-0.00264836648486928,0.00372250147657481,0.741056721090644
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMA1,Proteasome subunit alpha type-1,28797,0.00105591425959442,0.00326794965291563,-0.00534926706012021,0.00746109557930905,0.74661265132228
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,24951,0.000731098258778501,0.00226744160843248,-0.00371308729374916,0.00517528381130616,0.747127304253983
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,0.00114501816206822,0.00357720728220274,-0.00586630811104914,0.00815634443518558,0.748904539797064
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKIV2L,Helicase SKI2W,24111,-0.000879894881625724,0.00282874994421939,-0.00642424477229573,0.00466445500904428,0.755762019965076
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STEAP4,Metalloreductase STEAP4,24101,0.00158654638023715,0.00523456200607151,-0.008673195151663,0.0118462879121373,0.761823458196116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,0.00125168826701485,0.00420842259764781,-0.00699682002437486,0.00950019655840457,0.766144955348405
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNL2,Interferon lambda-2,24101,0.00129365947118586,0.00437483466076934,-0.00728101646392204,0.00986833540629376,0.767458104136611
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL6B,Myosin light chain 6B,24195,0.00189781740740561,0.00648217741148074,-0.0108072503190966,0.0146028851339079,0.769696896357334
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.00159256368271197,0.00545250807741789,-0.012279479514451,0.0090943521490271,0.77022824685933
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN3B,Sodium channel subunit beta-3,24101,0.00095033693509484,0.00325953000451806,-0.00543834187376057,0.00733901574395025,0.770628302314572
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF3,Trefoil factor 3,29426,-0.000926169050393304,0.0032628281674036,-0.00732131225850436,0.00546897415771775,0.776523745453791
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY2B,Alpha-amylase 2B,27585,-0.000978841747809934,0.0034587424549823,-0.00775797695957524,0.00580029346395537,0.777175053629623
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.00117145684723223,0.00418867000394869,-0.00703833636050721,0.00938125005497167,0.77973057840608
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC25A,M-phase inducer phosphatase 1,24016,-0.000797056780921716,0.00286023815068891,-0.00640312355627198,0.00480900999442855,0.780502040211095
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPEP,Glutamyl aminopeptidase,24111,0.000869964388631759,0.00314692585139074,-0.0052980102800941,0.00703793905735761,0.782205625136505
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCARE,Photoreceptor cilium actin regulator,24101,0.0016219078027707,0.00598472929995597,-0.010108161625143,0.0133519772306844,0.786387422018032
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPT1,Translationally-controlled tumor protein,28931,0.00121669667536074,0.00460234908595723,-0.00780390753311543,0.0102373008838369,0.791501121675108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDSN,Corneodesmosin,29676,-0.000773307581103106,0.00305446706655876,-0.00676006303155827,0.00521344786935206,0.800136539767848
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,-0.000536741473763889,0.00215665555773853,-0.00476378636693142,0.00369030341940364,0.803457878974661
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEBP1,Heme-binding protein 1,28916,-0.000932680143952014,0.00375428699816494,-0.0082910826603553,0.00642572237245127,0.803802948472569
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,-0.000954040288811938,0.00384704533119355,-0.0084942491379513,0.00658616856032742,0.804141930486706
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.000849610438716307,0.00347021274603042,-0.00595200654350331,0.00765122742093592,0.806590539635784
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSD1,Tryptase delta,24867,0.000645225742700237,0.00263970481113228,-0.00452859568711904,0.00581904717251951,0.806899036628105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASQ2,Calsequestrin-2,24111,0.000834277866219671,0.003453953309309,-0.00593547062002596,0.0076040263524653,0.809136433724527
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAG,Myelin-associated glycoprotein,24195,0.000797359340896175,0.00335168802759066,-0.00577194919318153,0.00736666787497388,0.811962346781447
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.000609498912938117,0.00257815820391808,-0.00566268899261754,0.00444369116674131,0.813117529176056
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,24229,0.000661385327325741,0.0028843699436314,-0.0049919797621918,0.00631475041684328,0.818637878868385
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL3A1,Collagen alpha-1(III) chain,24938,0.000367193260412632,0.00164439804752956,-0.0028558269127453,0.00359021343357057,0.823304247054695
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HK2,Hexokinase-2,28916,-0.000421090335714942,0.00193427463278425,-0.00421226861597208,0.0033700879445422,0.82766490479851
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,0.0010193512354255,0.00485686049732114,-0.00850009533932393,0.0105387978101749,0.833764150336853
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,-0.000925858547277065,0.00445184755666025,-0.00965147975833116,0.00779976266377703,0.835252494382772
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORN4,MORN repeat-containing protein 4,24016,0.00113266146900968,0.00554475378969129,-0.00973505595878526,0.0120003788968046,0.838139366345056
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARG2,"Arginase-2, mitochondrial",24793,0.00062357398163908,0.00305966214699746,-0.00537336382647594,0.0066205117897541,0.838507677121388
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53BP1,TP53-binding protein 1,24229,0.00124272530095942,0.00617500585641782,-0.0108602861776195,0.0133457367795384,0.840504106935169
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,24195,-0.000511178389489646,0.00258808505314914,-0.00558382509366197,0.00456146831468268,0.843428390317596
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,29349,-0.000626747855768973,0.00323579616773075,-0.00696890834452123,0.00571541263298329,0.84641839145106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRX,Cone-rod homeobox protein,28916,-0.00145922969707254,0.00756244519660168,-0.0162816222824118,0.0133631628882668,0.846993693549607
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP73,Tumor protein p73,24195,0.000470159786203834,0.00244278528753025,-0.00431769937735546,0.00525801894976313,0.847376674734965
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN5,Contactin-5,29511,0.000500385902052819,0.00261032892412086,-0.00461585878922406,0.0056166305933297,0.847982772686337
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2,Interleukin-2,28931,0.000421219591702667,0.00222565044046146,-0.00394105527160179,0.00478349445500712,0.849892841014655
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCLN,Nicalin,28931,-0.000695917919191613,0.00368772637182271,-0.00792386160796412,0.0065320257695809,0.850319933985268
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNB2,Ephrin-B2,24195,0.000766160481785566,0.00408014585859382,-0.00723092540105832,0.00876324636462945,0.851052478439196
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPEP2,Dipeptidase 2,29349,-0.000382397285061137,0.00206292526773296,-0.00442573080981775,0.00366093623969547,0.852942845314636
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL21R,Interleukin-21 receptor,24229,0.000718394296063517,0.00388864805616179,-0.00690335589401358,0.00834014448614062,0.853433417618237
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.000346893039858293,0.00192574478208893,-0.00342756673303601,0.0041213528127526,0.85704822732499
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,24445,-0.000851519781431557,0.00473273287314669,-0.0101276762127991,0.00842463664993595,0.857215790489769
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF174,Zinc finger protein 174,24229,0.000477734484141628,0.00267194088815908,-0.00475926965665016,0.00571473862493342,0.858098752796908
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13,Interleukin-13,28931,-0.000606437925945204,0.00339567260696517,-0.00726195623559694,0.00604908038370653,0.858259798578608
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD4,Sushi domain-containing protein 4,24793,-0.000520311353390094,0.00295711695414881,-0.00631626058352176,0.00527563787674157,0.860332901384785
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS2,"Nitric oxide synthase, inducible",24111,-0.000473743827311112,0.00280254631891491,-0.00596673461238433,0.0050192469577621,0.865766205260429
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,0.000581631776226893,0.00344124333580082,-0.00616320516194272,0.00732646871439651,0.865783968055384
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMOD2,Leiomodin-2,24101,0.000751709785889545,0.00447541644375168,-0.00802010644386374,0.00952352601564284,0.866612845720223
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IKZF2,Zinc finger protein Helios,28797,0.00107531630919574,0.00644041806130879,-0.0115479030909695,0.013698535709361,0.867399749797513
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,24101,-0.000892287786174841,0.00545889975985321,-0.0115917313154871,0.00980715574313746,0.870161093034476
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.000729191375592646,0.00467737978572229,-0.00989685575560833,0.00843847300442304,0.876115178034043
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL24,Interleukin-24,28931,0.000533138345175112,0.0034355421523225,-0.00620052427337699,0.00726680096372722,0.876677993714965
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTN3,Myeloblastin,28671,-0.00051873142208426,0.0033455302474264,-0.00707597070704,0.00603850786287148,0.876781352170059
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,0.000515792131642182,0.00335238150677408,-0.00605487562163502,0.00708645988491939,0.877722446898153
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACRV1,Acrosomal protein SP-10,24229,-0.000824969260695956,0.00542413407753176,-0.0114562720526582,0.00980633353126629,0.879115370433009
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MLLT1,Protein ENL,24016,-0.000742981589087526,0.00488832636610268,-0.0103241012666488,0.00883813808847373,0.879195315420974
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.000603156156688893,0.00448767988118141,-0.00939900872380445,0.00819269641042666,0.893085083004102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMMR,Hyaluronan mediated motility receptor,23975,0.000458289816917195,0.00342368686463267,-0.00625213643776283,0.00716871607159722,0.89351553843471
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGR,Progesterone receptor,24229,0.000955705113519384,0.00719346815502949,-0.0131434924703384,0.0150549026973772,0.894307301829395
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,24229,0.000360030717313595,0.0029840872144005,-0.00548878022291139,0.00620884165753858,0.903969106896845
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.000731416238609324,0.00609793067065074,-0.0112205278758661,0.0126833603530848,0.904527724105185
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.000241025032938978,0.00209725339041337,-0.00435164167814919,0.00386959161227123,0.908506180794449
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,0.000255308376431005,0.00224182009329824,-0.00413865900643355,0.00464927575929556,0.909330193831184
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,24111,-0.000905312786875344,0.00800652841372789,-0.016598108477782,0.0147874829040313,0.909974553301755
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,24805,-0.000364107122479603,0.00328647206003308,-0.00680559236014444,0.00607737811518523,0.911784041754705
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN6,Prefoldin subunit 6,24195,0.000506368792993581,0.0046217887755593,-0.00855233720710264,0.0095650747930898,0.912758280646162
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,29725,-0.000364927829316235,0.00405578239673771,-0.00831426132692214,0.00758440566828967,0.928305962041831
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,28931,-0.0002325262833912,0.00265443824024452,-0.00543522523427045,0.00497017266748805,0.930195959264126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,24445,0.000441920165557171,0.00518829621407067,-0.00972714041402134,0.0106109807451357,0.932121885349607
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,-0.000153219186172656,0.00184908018726705,-0.00377741635321607,0.00347097798087076,0.933961634416248
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL3,Interleukin-3,24016,0.000345504724482868,0.004279594481999,-0.00804250046023517,0.0087335099092009,0.935654923901618
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,-0.000444503761805745,0.00552341497797913,-0.0112703971186448,0.0103813895950334,0.935859145349774
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAGEA3,Melanoma-associated antigen 3,24445,0.000437058950301128,0.00601072239767972,-0.0113439569491511,0.0122180748497534,0.94203492753983
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPK3A,Uroplakin-3a,24101,-0.000251376746942881,0.00348027158411343,-0.00707270905180521,0.00656995555791945,0.942420218300071
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP2BP,LRP2-binding protein,24195,-0.000417857429563721,0.00584087478364814,-0.0118659720055141,0.0110302571463866,0.942968412357773
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.000201572557991763,0.00314961636633674,-0.00597167552002824,0.00637482063601177,0.948971473532412
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17F,Interleukin-17F,28931,-0.000336738883653133,0.00540246851427994,-0.0109255771716418,0.0102520994043355,0.950300023836468
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.000395026926702176,0.00640952790218565,-0.0121676477615817,0.0129577016149861,0.950857034992903
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLINT1,Clathrin interactor 1,24016,0.000204994964375044,0.00337065703738619,-0.00640149282890189,0.00681148275765198,0.951505052405411
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXK,Tyrosine-protein kinase TXK,24445,0.000302653797333651,0.00526431278230777,-0.0100153992559896,0.0106207068506569,0.954154062513721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.000152427879894744,0.00283748653420603,-0.00540904572714908,0.00571390148693857,0.957159226193991
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA2,Protein disulfide-isomerase A2,24016,-0.000133801713113251,0.00288208945854512,-0.00578269705186169,0.00551509362563519,0.962971700761616
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA3,GDNF family receptor alpha-3,29157,-9.09736046755204e-05,0.00198512202870569,-0.00398181278093868,0.00379986557158764,0.963447883396106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,29566,-0.000127082140845436,0.00297831225901272,-0.00596457416851037,0.00571040988681949,0.965965536527994
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY2A,Pancreatic alpha-amylase,28334,0.000135915991918644,0.0033763563531251,-0.00648174246020655,0.00675357444404384,0.967889932149526
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,9.49683267697012e-05,0.00243285662449709,-0.00467343065724459,0.004863367310784,0.968862228442201
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPN3,Calpain-3,24793,7.26842269596167e-05,0.00267815794691226,-0.00517650534898842,0.00532187380290765,0.978348581440946
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMP,Olfactory marker protein,24101,8.48665853958889e-05,0.00348794962994962,-0.00675151468930537,0.00692124786009715,0.980588494181236
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,-3.91202356721254e-05,0.00182847755037311,-0.00362293623440342,0.00354469576305917,0.982930757332867
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,24195,-8.5763392107439e-05,0.00464850202494797,-0.00919682736100546,0.00902530057679058,0.985280269520724
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,24445,6.64395031592055e-05,0.00381403546232293,-0.00740907000299373,0.00754194900931214,0.986101904164991
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF6,Fibroblast growth factor 6,24229,-2.9840556624783e-05,0.0029095116454516,-0.00573248338170993,0.00567280226846036,0.99181695793489
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TET2,Methylcytosine dioxygenase TET2,24421,-6.33434893602499e-05,0.00708995814479607,-0.0139596614531605,0.01383297447444,0.992871664248258
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,24016,-3.03057418556963e-05,0.00393627897405382,-0.00774541253100118,0.00768480104728978,0.993857144541832
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,2.16975193728208e-05,0.00348287601461541,-0.00680473946927339,0.00684813450801903,0.995029445060076
